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INTRODUCTION 
One that cures physical aliments is medicine 
One that cures psychological aliments is medicine 
One that prevents aliments is medicine 
One that bestows immortality is medicine 
     _ Thirumandhiram 
 
 In the view of Siddhar Thirumoolar definition of medicine means, that one 
ensures aliments of physical, mental, preventive aspect and also postponement of death. 
 Siddha system of medicine is an unique traditional system of medicine in the 
world. Siddha system was originated since ancient ago by siddhar‟s who attained siddhi. 
Siddha system is also called Tamil Maruthuvam. The traditional siddha system is 
commonly followed by Tamil people from ancient.  
According to siddha system of medicine perfect health is maintained by the three 
uyirthathukkal (humors) namely vaatham, pitham, kabam. Whenever there is 
derangement in these three thathukkal, the resultant will be the diseases. The salvation is 
the ultimate aim of siddhar‟s, for that they have to maintain their health physically and 
mentally. Dermatological disorders comes under psycho-somatic disorders because the 
state of mind reflects through the skin. 
 Siddha system has the wonderful principle which is Panchapootham theory. 
According to Panchapootham theory the universe and the human body both are made 
by five elements i.e Space, Air, Fire, Water, and Earth. Likewise the diseases and the 
medicines are also based on the Panchapootham theory.  
 In Siddha system of medicine, the skin disorders are classified into 18 varieties 
by the great sage Yugi. In the textbook Siddha Maruthuvam Sirappu skin diseases are 
classified as kuttam. The clinical features of „Virpodaga kuttam‟, Thethru kuttam‟, and 
„Sadharu kuttam‟ resembles Kaalanjaga padai (Psoriasis). Kaalanjaga padai is a 
chronic non-infectious, recurrent, inflammatory disorder of the skin characterized by 
circumscribed red patches covered by white silvery dry scales. 
 The clinical features of Kaalanjaga padai may be correlated to Psoriasis as 
described in Modern science. Psoriasis is a lifelong disorder subject to unpredictable 
remissions and relapses. Single episodes are uncommon and in the most frequent 
variety an episode in the teenage years is followed by a series of attacks, each lasting 
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weeks or months in the succeeding years. Psoriasis affects approximately 125 million 
people on a global basis, which is 2.2% of the world wide population. The prevalence 
varies in different areas of the world, however, with higher rates reported in developed 
countries accounting for 4.6% of the population. The incidence of psoriasis is most 
common between the ages of 15 and 25, but may affect individuals of any age.  
 Prevalence studies from India are mostly hospital-based. The prevalence of 
psoriasis to be 0.8% among the skin patients. Highest incidence was noted in the age 
group of 20-39 years and the mean age of onset is males and females was comparable. 
The exact cause of psoriasis remains unknown. There may be a combination of 
elements, including genetic predisposition, environmental factors and stress is also 
trigger for a psoriasis flare. Psoriasis is independently associated with stress related 
disorders. 
 The visitation of Psoriasis patients increased considerably from the past few 
years in National Institute of Siddha. Patients suffering from Psoriasis facing much 
social stigma than other dermatological problems. 
 The siddha system approaches diseases by holistic way to prevent and treat the 
condition. Hence the proper assessment of disease through various diagnostic tools 
mentioned in siddha literature and with modern scientific methods. The treatment 
consist of internal and external medicine along with life style modification and dietary 
regimen.  
In our day to day life human mind encounter‟s many kind of stress. This is 
affirmed by the Siddhar‟s in their literature as root cause of most of the diseases is 
psychosomatic problems. The uniqueness of siddha system is rejuvenation (Karpam) 
which included Iyamam, Niyamam, Pranayamam.  
Eventhough manyformulated drugs are available in Siddha system to treat 
dermatological conditions, the author very much interestedin Karunchooraichooranam 
to evaluate its clinical efficacy to treat psoriasis because of its bitter taste and the known 
Anti Inflammatory potential of the ingredients of Karunchooraichooranamand also it is 
cost effective. So, theauthor is going to evaluate the therapeutic efficacy of this 
formulationKarunchooraichooranamfor the treatment of  Kaalanjagapadai (Psoriasis) 
  KARUNCHOORAI CHOORANAM – Internal drug and 
  KODIVELI THYLAM – External drug 
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AIM AND OBJECTIVES 
AIM  
 The purpose of the trial is evaluate the therapeutic efficacy of Siddha 
herbal formulation of “Karunchoorai chooranam” (Internal) and 
“Kodivelithylam” (External) in the treatment of Kaalanjaga padai 
(Psoriasis). 
OBJECTIVES  
PRIMARY OBJECTIVE 
 To evaluate the therapeutic efficacy of siddha herbal formulation of 
“Karunchoorai chooranam” (Internal) and Kodiveli thylam (External) in 
the treatment of Kaalanjaga padai(Psoriasis). 
SECONDARY OBJECTIVE 
 To study the Siddha diagnostic methods such as Envagaithervu, 
Neerkkuri and Neikkuri in Kaalanjaga padai patients. 
 To study the incidence of Kaalanjaga padai with reference to age, 
sex, occupation, socio-economic status, habits, family history and 
also that related to psychosomatic problems, 
paruvakaalams(seasons), poripulangal, udalkattugal, mukkutram 
etc. 
 To analyse the trial drug by biochemical methods  
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REVIEW OF LITERATURE 
SIDDHAASPECT OF DISEASE (KAALANJAGA PADAI) 
In siddha system, skin diseases are brought under “Kuttam”,Kuttam means 
cutaneous affections in general, the term used for various skin diseases. 
DEFINITION OF SKIN DISEASES: 
Skin diseases may appears all over the body on a sudden or gradually spreads  and 
affects the nerves,blood vessels, mucus membrane etc. The affected part may be 
increased or decreased sensitiveness and inflammation. Skin become glossy and 
thick red or yellowish white patches with various size. 
           It is marked by  
 Itching 
 Burning sensation 
 Blisters 
 Perforating ulcers 
FACTS OF SKIN DISEASES: 
1. It is a diseases believed due to a reflection of one‟s  previous births 
(karma) 
2. Some authors of Indian medical science attribute the origin of this disease 
to several pathological causes 
              Such as 
 Venereal diseases 
 Syphilis 
 Ring worm 
 Snake bite 
 Poisonous insects bite or sting 
 Infection 
 Inheritance. 
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AETIOLOGY: 
 The Siddha literatures explain the causes of Kuttam have been mentioned in below 
 
 In the text Yugimuni 800 
 
  “Å¢ÇõÀ§Å Á¢Ìó¾¯‰ ½ó¾ý É¡Öõ  
 Á¢Ìó¾ º£¾Çò¾¡Ö ÁÆüº¢ Â¡Öõ 
ÅÇõÀ§Å Áó¾ò¾¡ø Å¡ó¾¢ Â¡Öõ 
 Á¸ò¾¡É ¦Àñ§½¡Î ÁÕÅ Á¡Öõ 
¸¢ÇõÀ§Å ¸¢§Äíº¸û Á¢Ì¾ Ä¡Öõ 
 ¦¸ÊÂ¡É ×Ãì¸í¸Ç ¨¼¾ Ä¡Öõ 
¾ÇõÀ§Å ÁÂ¢Õ¸ü¸û ¾Å¢Î Áñ¸û 
 º¡¾ò¾¢ü ÀÕ¸Ä¡øÁ¢ìÌí Ì‰¼õ”.  
  Excessive heat and cold, laziness, sleep in day time, sexual indulgence, robbery 
etc. These habits are prominent among the factors which lower the immune 
mechanism of the body (Udalvanmai) and make the body liable to disease. Added to 
the above excessive intake of food items which are hard to digest, imbalanced diet, and 
vomiting due to indigestion, food contaminated with stone and hair, chronic mental 
depression, intention to spoil others, greed, abusing God and elderly people, neglecting 
orphans and beggars, cursing the elders would also affect the body and mind 
disturbing the mechanism of the body.  
 In ThirumoolarVaithiyam 
“Å¢Â¡¾¢Ôû ãÅ¡ÚÅ¢Çí¸¢Â Ìð¼í§¸û 
 ÍÂ¡¾¢ì ¸¢Ãó¾¢ ÍÆø §Á¸ò¾¡ Ä¡Úõ 
 ÀÂ¡¾¢ ÁñÏÇô ÀÄ ÅñÊÉ¡ ¦ÄðÎõ 
 ¿¢Â¡¾¢ ÒØ¿¡Ä¡ö ¿¢ýÈ¾¢ì Ìð¼§Á”. 
 Six types of skin diseases are caused by venereal disease 
 Eight types of skin diseases are caused by insect bites 
 Four types of skin diseases are caused by worm infestations 
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 In Guru NaadiNool  
  “¸¢ÕÁ¢Â¡ø Åó¾ §¾¡¼õ ¦ÀÕ¸×ñÎ 
  §¸ð¸¢ Ä¾ý À¢Ã¢×¾¨É ¸¢ÃÁÁ¡¸ô 
  ÒØì¸Ê §À¡ø ¸¡ÏÁÐ ¸¢ÕÁ¢Â¡§Ä 
  ¦ºÕÁ¢ ÅÕõ À×ò¾¢Ãí¸û ¸¢ÕÁ¢Â¡§Ä 
  §¾¸Á¾¢ø ¦º¡È¢ìÌð¼õ ¸¢ÕÁ¢Â¡§Ä 
  ÐÕÁ¢ ÅÕï Í§Ã¡½¢¾í ¸¢ÕÁ¢Â¡§Ä 
ÝðºÓ¼ý ¸¢Ã¢¨ºôÀ¡ø ¦¾¡Æ¢ø ¦ºöÅ£§Ã”. 
 As per Guru naadinool text, the skin disease caused by worn infestations. 
 The text book Siddha Maruthuvam Sirappu, 
 Unknown etiology 
 Genetic cause 
 The textAgathiyarParipooranam – 400 describes the Psycho-social causes 
(KanmaVaralaru); 
“ÀÆÅ¢¨ÉÂ¡ø Å¢„ôâîº¢ ¸Êò¾ §¾¡„õ 
   À¡¾¸÷ìÌ ´Õ ¿¡Ùõ ¾£÷Å¾¢ø¨Ä 
 ¯ÇÅ¢¨ÉÂ¡ø æ¼¡À¢ì ¦¸¡ûÇ Åó¾ 
 ¯ñ¨ÁÂÐ «È¢Â¡Áøã÷ì¸ï ¦ºöÅ¡÷  
 ¸ÇÅ¢¨ÉÔó ¾£÷Å¾¢ø¨Ä ¸ÊÉ¦Áò¾ 
 ¸Õ¨½ÔûÇ âÃ½ò¾¢ø ¸ñ¸¡ðº¢ 
 «¼Å¢¨É ¿£¸¡ÏÓý¦É «¸Äî ¦º¡øÄ¢ 
 «¨¼Â¡Çõ Å¢Ãø ÌÚÌ Á¢ýÉí¸§¸§Ç”. 
 “Å¢ÃøÌÚÌí¸¡Ä ¾¢Á¢Õõ Å¢„õ §À¡§ÄÚõ 
  ¦ÁöÂØóÐó ¾¨Ä ÍÆÖõ ¦ÅÙìÌõ §ÁÉ¢ 
  ÀÃÁ¡É §¾¸¦ÁøÄ¡ó ¾ÊòÐ Å£íÌõ 
 À¡¾¦ÁøÄ¡õ ¦ÅÊòÐÁ¢ìÌÒñÏ ¸¡Ïõ 
  ºÃºÓ¼ý ¦º¡È¢ ¸ÃôÀ¡ý À½õ §À¡ø §¾¡Ïõ 
 ºó¨¾Â¡§Á Å¢ó¨¾¦¸Îò ¾ÊòÐ Å£íÌõ 
  À¡ÕÄ¸¢ Ä¢ó§¿¡öìÌ ÁÕ¾£Â¡§¾ 
 ¿ø§Ä¡¨Ãô ÀÆ¢ò¾ Ìð¼í¸ýÉÁ¡§Á”.  
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 In AgathiarParipooranam 400 it has been mentioned that diseases which are 
caused due to sins committed in the previous birth will be cured only if Kanmam is 
expiated. 
  
 Siddhar Agathiyar mentioned that Kanmam (Genetic  predisposition) is the 
main cause for Kuttam in the text Kanma Kandam as follows: 
“§º÷ó¾ Ìð¼¦Á¡Î Ì¨È§¿¡ö¸û 
 §º¾¢§¸û ÁÄÃ¡¾ ÅÕõÀ ¦¸¡ö¾ø  
¾¡Ã¢ó¾ º£÷ ¦ºóÐ Å¨¾¸û ¦ºö¾ø 
 ¾¡ö ¾ó¨¾ ÁÉÐ ¦¿¡óÐ §Ã¡¸ó¾¡§É. 
¾¡¦ÉýÈ ¦¾öÅ×Õò ¾¨ÉÂÆ¢ò¾ø 
 º¡÷Å¡É ¦ÀÃ¢§Â¡÷¸û ¾¨Áô ÀÆ¢ò¾ø 
¸¡¦ÉýÈ ¿ó¾ÅÉõ âï¦ºÊ¸û ¦Åð¼ø 
 ¸ÕÁÁ¼¡ ºÃ£Ãò¾¢ü ¸¡Í §À¡§Ä 
ä¦ÉýÈ ×¼õ¦ÀøÄ¡õ ¦Á¡ðÎ ¦Á¡ð¼¡ 
 Ô¼ý ¦ÅÙòÐ Ì¨È§Â¡Ô¾¢Ãï º¢óÐõ 
Å¡¦ÉýÈ ¸ÕÁí¸û ¾£÷ôÀ¾üÌ 
 Å¨Ã¦Â¡ýÚ ¦º¡ø§Åý §¸û ¿ó¾Åý¨Á§Â”. 
 Plucking the flower buds 
 Cruel to animals 
 Destroying statues of god 
 Abuse elderly people 
 Destroying forests and gardens. 
 
SIGNS AND SYMPTOMS: 
The predominant symptoms are 
 Roughness of skin 
 Itching sensation 
 Anesthesia  of the parts 
 Black color of the blood 
 Rapid growth and spread of ulcers. 
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CLASSIFICATION OF KUTTAM:  
According to Thiru T.V. SambasivamPillai there are 18 types of Kuttam, as listed 
below: 
1. Neerkuttam  - Leprosy with serous exudation  
2. Venkuttam  - White Leprosy  
3. SoriKuttam  - Psoriasis  
4. Karunkuttam  - Black Leprosy  
5. Perumkuttam  - True Leprosy  
6. Senkuttam  - Macular Leprosy  
7. Pori kuttam  - Leprosy with Granules  
8. Virikuttam  - Leprosy with Fissures  
9. Yerikuttam  - Leprosy with burning sensation  
10. Viral kuraikuttam - Lepramutilans 
11. Sadaikuttam  - Leprosy with confluent ulcers  
12. Yaanaikuttam - Thick skinned Leprosy  
13. Thimirkuttam - Anesthetic Leprosy  
14. Viranakuttam - Ulcerated Leprosy  
15. Kaaikuttam  - Nodular Leprosy  
16. Azhikuttam  - A form with sloughing ulcers  
17. Kirumikuttam - Leprosy with microbes  
18. Aarakuttam  - Incurable Leprosy  
 Classification by Dhanvanthri:  
"Å¡¾À¢ò¾î º¢§ÄüÀÉò¾¢ý Å¡¾§Ã¡¸ó ¾¡¦ÉÉ¢Ûõ 
 ¾£Ð Ìð¼§ÁØó ¾£Õõ Ìð¼õ À¾¢¦É¡ýÚ 
 §Á¡Ðí Ìð¼õ À¾¢¦ÉðÎ¼ý§È¡Â ¨ÅÂ¢ÛüÀÅÓõ 
 §À¾ìÌ½ÓÅ¢Â¡¾¢Â¢ýÓýÀ¢ÈìÌõÌ½Ó Ó¨Ãô§À§É". 
 
1. Kabala Kuttam 
2. Sarmeega Kuttam 
3. Kideepa Kuttam  
4. Mudhumba Kuttam  
5. Visharchiga Kuttam  
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6. Mandalakira Kuttam  
7. Aguvai Kuttam  
8. Thathru Kuttam  
9. Pundareegha Kuttam  
10. Bama Kuttam  
11. Kaghanandhi Kuttam  
12. Sithma Kuttam  
13. Vibadhiga Kuttam  
14. Sadhariga Kuttam  
15. Vispodaga Kuttam  
16. Sarmathala Kuttam  
17. Ven Kuttam  
18. Alasa Kuttam 
 
 Classification by YugiMuni VaidhyaChinthamani: 
 In his Siddha literature the “Kuttam” has been classified into 18 types, 
  "Óò¾¡Ìí Ìð¼ó¾¡ý À¾¢¦ÉðÎìÌõ 
  ÓÉ¢Â¡É ä¸¢¿¡ý ¦º¡øÄì §¸Ç¡ö 
   Òò¾¡Ìõ Òñ¼Ã£¸ Ìð¼ò §¾¡Î  
   ¦ÀÕ¸¢ýÈ Å¢ü§À¡¼¸ Ì‰¼ Á¡Ìõ 
  Àò¾¡Ìõ ÀÃÁÌ‰¼õ §¸ºÃ Ì‰¼õ 
   ÀÃ¢Å¡É ¸÷½Ìð¼õ º¢ÌÁ Ìð¼õ 
  ¸¢ò¾¡Ìí ¸¢Õ‰½Ìð¼ «×ÐõÀÃ Ìð¼õ 
   ¦¸ÊÂ¡É Áñ¼ÄÌð ¼ÓÁ¡ ¦Áý§É 
  Ìð¼Á¡õ ÀÃôÀÃ¢º Ìð¼ ¦Á¡Î  
   ÌÊÄÁ¡õ Å¢º÷îº£¸ Ìð¼ Á¡Ìõ 
  Åð¼Á¡õ ¨ÅÂ¡¾¢ Ìð¼ §Á¡Î 
   ÁÕÅÄ¡í ¸¢ËÀÌð¼ï º÷Á §¾Åõ 
  ¾¢ð¼Á¡ §¾ò¾¢Õì Ìð¼ §Á¡Î  
   º¢òÐÁ¡ Ìð¼ïº¡ ¸¡ÚÌð¼õ 
   Ðð¼Á¡ï Í§Å¾Ìð¼ó ¾ý§É¡ ¦¼¡ì¸î 
   ÍÂõÀ¡É À¾¢¦ÉðÎ Ìð¼ Á¡î§º”. 
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1. Pundareegam - Padarthamarai 
2. Virpodagam - Koppulaperunoi 
3. Bamam  - Siranguperunoi 
4. Gajasarmam - Yaanaitholperunoi 
5. Karnam  - Kaadhuperunoi 
6. Sikuram  - Tholperunoi 
7. Krishnam  - Karuperunoi 
8. Avudhumbaram - Athikkaiperunoi 
9. Mandalam  - Valayaperunoi 
10. Abarisam  - Valiperunoi 
11. Visharchigam - Soriperunoi 
12. Vibhadhigam - Senkuttam 
13. Sarmathalam - Tholvedippuperunoi 
14. Kidepam  - Pandritholperunoi 
15. Thethuru  - Thadippuperunoi 
16. Sithuma  - Naaperunoi 
17. Sadharu  - Puraiperunoi 
18. Suvedham  - Venkuttam 
 
 According to sage Yugi, Kuttamhave been classified as 7 types as per 
alteration of three humors 
1) Valikuttam 
2) Azhalkuttam 
3) Iyyakuttam 
4) Valiiyyakuttam 
5) Valiazhalkuttam 
6) Azhaliyyakuttam 
7) Mukkutrakuttam 
 
 According to sage Yugi, ten types of kuttam are curable  
1) Virpodagam 
2) Bamam 
3) Kajasarmam 
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4) Kiruttinam 
5) Avuthumbaram 
6) Thaththuru 
7) Siththuma 
8) Kideebam 
9) Satharu 
10) Sarumam 
 According to sage Yugi, eight types of kuttam are uncurable 
1) Pundareegam 
2) Karanam 
3) Siguram 
4) Mandalam 
5) Abarisam 
6) Vasarchigam 
7) Vibathigam 
8) Suvetham 
The clinical features of Virpodagakuttam, Sadharukuttam and Thethrukuttamare 
resemble as Kaalanjaga padai.  
Å¢ü§À¡¼¸ì Ìð¼õ: 
“ÒÐ¨ÁÂ¡öî ºÃ£Ã¦ÁíÌó ¾¢É×ñ ¼¡Ìõ 
 ¦À¡Õ¦ÅÊÂ¡öò ¾¢ì¦¸Éò¾£ì ¦¸¡ØóÐ §À¡Ä 
 ¦ÁÐ¨ÁÂ¡ö Å¢ð¦¼Ã¢Ôõ ¿øÄÀ¡õÀ¢ý 
 Å¢„ôÀ¼õ §À¡ø ¾ÊòÐ ¦ÅÙôÒÁ¡Ìõ 
 ÍÐ¨ÁÂ¡öÁ¢¸ì ¦º¡Ã¢Ôïº¢ÅôÒÁ¡Ìõ 
 àì¸¦Á¡Î ºïºÄÓõ Á¢¸ ×ñ ¼¡Ìõ 
 ¸Ð¨ÁÂ¡ö §¾¡¦ÄøÄ¡ó ¾ÊôÒñ¼¡Ìõ 
 ¸Éò¾ Å¢ü§À¡¼¸Á¡É Ìð¼ó¾¡§É”. 
            -ä¸¢ ÓÉ¢ ¨Åò¾¢Â º¢ó¾¡Á½¢ 800, ¦ºöÔû- 498. 
 
 Characterized by elevated skin lesions with erythema and itching. Burning 
sensation will be present.  These entities are associated with anxiety and despair. 
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§¾òÐÕ Ìð¼õ: 
“º÷Áó¾¡ý º¢ÅôÀ¡¸ Åð¼½¢òÐî 
 ºÄ¨Å§À¡ø ¦ÅÙìÌ§Á ¾¢É×ñ ¼¡Ìõ 
Ü÷Áó¾¡ý §Ã¡¸ÁÐ Á¢¸×ñ¼¡Ìõ 
 ÁÂ¢¦ÃøÄ¡ïÍÕñÎ§Á ¯ñ¨¼Â¡Ìõ 
¸÷Áó¾¡ý À¢ò¾ §ºðÎÁÁ¢ ÌìÌõ 
 ¸¡Âó¾¡ý ¸¾¢òÐ§Á ¾¢Á¢Õñ¼¡Ìõ 
¾÷Áó¾¡ý º¼¦ÁøÄ¡ ã¾Ä¡Ìõ 
 ¾¡ì¸¡É §¾òÐÕì Ì‰¼ó¾¡§É”. 
                         -ä¸¢ ÓÉ¢ ¨Åò¾¢Â º¢ó¾¡Á½¢ 800, ¦ºöÔû 511.
  
 Annular erythematous lesions with whitish appearance, itching, oedema and 
curling of hairs are the characteristic clinical features in this disorder. 
º¾¡Õ Ìð¼õ: 
“º¢ò¾¡É¾ñÊôÀ¡ö Ãò¾Å÷½õ 
 ¦ºØõÀî¨º ¦Åû¨ÇÂ¡öî º¢ÅôÒÁ¡Ìõ 
±ò¾¡ý ¦ÅÃ¢ô§À¡Î ¾¢É×Á¡Ìõ 
 ±Ç¢¾¡É §ºðÎÁÅ¡¾ò ÐüÀò¾¢ 
Àò¾¡É ¸ÃÎ¸ðÊôÒñÏÁ¡Ìõ 
 À¡õÒ §¾¡ø §À¡üÈ¢¨ÃóÐÀÕòÐì¸¡Ïõ 
¦Åò¾¡É ãì§¸¡Î ¸¡Ð ¸ýÉõ 
  Á¢¸òÐÊôÀ¡ï º¾¡Õ Ì‰¼ó ¾¡§É”.   
                       -ä¸¢ ÓÉ¢ ¨Åò¾¢Â º¢ó¾¡Á½¢ 800, ¦ºöÔû- 513.
  
 Characterized by skin lesions covered with silvery white scales, erythema, 
itching, burning sensation and thickening of ears, cheeks and nose 
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KAALANGA PADAI 
Synonyms  
 Venparusedhil, Sedhiludhirnoi 
Definition  
 According to the definition in Siddha Maruthuvam Sirappu, Kalanjagap padai 
is a chronic non-infectious, recurrent, inflammatory disorder of the skin characterized 
by reddish, slightly elevated patches covered with silvery white scales. In Siddha 
system, Skin disorders are brought under the clinical entity “Kuttam”. 
Aetiological  Factors 
 Unknown etiology 
 Genetic cause 
Triggering Factors  
 a) Tonsilitis 
 b) Respiratory disorders  
 c) Allergic disorders  
 d) Stress and strain 
 e) Anxiety, Depression 
 f) Seasonal variations 
 g) Certain drugs (eg) Thambira chendhuram 
Clinical Features 
 The lesions are patches and macules which are red in colour with 
raised margin   and the lesions are covered by silvery, white and 
rough thick scales. 
 The patches are coin shaped over them. In some, the shape may be 
either round or oval. 
 There are variations in the size and shape of patches according to 
the site. 
 The skin lesions occur all over body, commonly front of the knee 
and back of the elbows affected 
 Excessive scaling and generalized erythema develops all over the 
body. 
 In children this lesion may be like water drops and these may occur 
in scalp and face. 
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 Mild oozing will be present if flexure region (axilla, groin & infra 
mammary regions) are involved in females. 
 One fourth of patients have nail involvement like pitting and 
dimpling in nature 
 7% of patients develop affection of joints as psoriatic arthropathy. 
 
Prevalence of Kaalanjaga padai 
 2% of population affected by psoriasis 
 5-25 years is the commonest age group  
 Remission and relapses occur 
 Females are commonly affected than males 
 
Pathology of Kaalanjaga padai 
 The kaalanjagapadai affects the skin and mucous membrane 
 
Seasonal variations of Kaalanjaga padai 
Vaatham  
The vaatham activities increased during the period of Aani (june-july), Aadi 
(july-august)  
Iyyam  
The iyyam activities increased during the period of Maasi, (february-march) 
Panguni (march - april)   
The signs and symptoms of Kaalanjaga padai will aggravated in above 
mentioned months. 
 
Psoriatic Arthropathy: 
 Kaalanjaga padai is often associated with painful joints known as “Kaalanjaga 
vaatham”. It may affect any joint. The most often affected joints are terminal inter-
phalangeal joints. In these cases, the affected fingers show nail changes. This 
combination is termed “Psoriatic arthropathica”. 
 
15 
 
Yugi muni describes the clinical features of Kaalanjaga vatham as follows: 
 “Å¡¾ Á¡í ¸¡ø¨¸Â¢øÌÃí¸¢ ÃñÎõ 
   ÅÕòÐ ºóÐÓÚì¸¢§Â Ì¨¼óÐ ¦¿¡óÐ 
  ¿¡¾Á¡ ¿¨¼¾¡Ûó ¾¡ý¦¸¡¼¡Áø 
   ¿Ä¢óÐ§Á Ó¼Á¡¸¢ì ¸ÃÎ ¸ðÊî 
  §º¾Á¡ï º¼ó¾¡Û Á¢¸¦Å ÙòÐó 
   ¾¢É §Å¡Î º¢ÃíÌÁ¡öî §ºðÀ Á¡¸¢ì 
 ¸¡¾Á¡Â Õº¢¦Â¡Î ÁÂì¸ Á¡Ìõ 
  ¸Õ¾¢Â ¸¡Ç¡ï º¸Á¡õ Å¡¾Á¡§Á”. -     (¦ºöÔû- 259) 
 The joints of fingers, feet, ankles, knees and sacroiliac are selectively affected 
and these joints are painful. The deforming erosive arthritis targets fingers and toes. 
Marked cartilage destruction and bony articulation results in loss of joint space and 
marked instability. The whole body becomes pale (anaemic). Lesions of well-defined 
erythematous papules which are sharply demarcated appear on the skin. There is also 
loss of taste and giddiness. 
 
MUKKUTTRA VERUPADUGAL: 
           Human body is influenced by three Thathus such as Vaatham, Pitham and 
Kabam. They are responsible for normal physiological conditions of the body. In 
Kaalanjaga padai, the following Mukkutram are commonly affected, 
Vatham 
1. Abanan  -  Habitual Constipation 
2. Viyanan  -  Erythematous changes in the affected areas of 
skin 
3. Samanan  -  Due to other vaayu, it is affected 
4. Kirukaran  -  Loss of appetite 
5. Devathathan -  Insomnia like condition 
Pitham 
1. Aakkanal  - Indigestion of food 
2. Vannaeri  -  Paleness of the conjunctiva and tongue 
3. Aatralangi  -  Difficulty to do the routine works and       
                                              sluggishness 
4. Olloli thee  -  Dryness and roughness of skin  
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Kabam 
1. Neerpiyaiyam -  Loss of appetite 
2. Niraivaiyam -  Burning sensation of eyes may be present 
3. Ondriyaiyam -  Joint pain present in very few cases 
 
 
Udalthathukkal  
 Our body consists of seven Udalthathukkal. It gives strength and structure to 
our body. In Kaalanjaga padai patients, Saaram, Senneer, KozhuppuandEnbu are 
commonly affected. 
 Saaram :  Dryness, roughness, tiredness 
 Senneer :  Erythematous patches present 
 Kozhuppu :  Synovial fluid secretion affected 
 Enbu  :  Joint pain present in few cases             
Udalvanmai 
 It is classified into 3 types, they are 
 IyarkaiVanmai 
  Natural immunity of the body by birth 
 SeyarkaiVanmai 
  Improving the health by intake of nutritious food materials and 
medicines. 
 KaalaVanmai 
  Development of immunity according to age and the environment. When 
the Udalvanmai is affected there may be possibilities of occurrence of Kaalanjaga 
padai. 
Iymporigal  
             In Kaalanjaga padai, Mei is affected. Roughness of the skin, white silvery 
scales is seen. 
Kanmenthriyam 
 In Kaalanjaga padai,Kai, Kaal affected: Difficulty in using the limbs.  
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Piniyariyum muraimai (Diagnostic Methods) 
 Piniyariyum muraimaiis the method of diagnosing disease. It is based on the 
following principles: 
 Poriyalaridhal 
 Pulanalaridhal 
 Vinaathal 
 Poriyalaridhal and Pulanalaridhal means examining the patient‟s „Pori‟ and 
„Pulan‟ with that of physician‟s „Pori‟ and „Pulan‟. „Vinaathal‟ is a method of 
enquiring about the details of the patient‟s problem from his own words or from his 
parents or attenders who are taking care of the patient, when the patient is not able to 
speak (or) if the patient is a child. 
ENVAGAI THERVUGAL (Eight tools of examination) are: 
 “¿¡ÊôÀÃ¢ºõ ¿¡¿¢Èõ ¦Á¡Æ¢Å¢Æ¢ 
  ÁÄõ ãò¾¢ÃÁ¢¨Å ÁÕòÐÅÃ¡Ô¾õ”. 
 Naadi (Pulse):  
 In Kalanjaga padai, the following types of Naadi could be felt.  
They were, 
a) Vaathapitham 
b) Vaathakabam 
c) Pithakabam 
 Sparism:  
 In case of Kaalanjaga padai, slightly raised well defined dry 
erythematous    
 macules or plaques, covered with white silvery scales can be noticed in 
affected areas. 
 Naa (tongue):  
 In case of Kaalanjaga padai abnormality of tongue like geographical 
tongue may be noted. 
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 Niram (complexion): 
 In case of Kaalanjaga padai, white patches with silvery scales could be 
noticed at affected areas. 
 Mozhi (voice):  
 In case of Kaalanjaga padai no abnormalities were observed. 
 Vizhi (eye):  
 In case of Kalanjaga padai, no abnormality was seen in Vizhi. 
 Malam (stool): 
  In case of Kalanjaga padai, constipation was reported in some cases. 
 Moothiram (urine):  
 Collection of urine for the determination of Neerkkuri and Neikkuri, is 
an important diagnostic method 
 Neerkkuri 
  Prior to the day of urine examination the patient is instructed to 
take a balanced diet. The patient should have good sleep. After waking up in 
the morning, the first urine voided is collected in a clear wide mouthed glass 
container and is subjected to analysis of “Neerkkuri” within one and a half an 
hour. In a Kalanjaga padai patients, straw colored urine was noticed.  
 Neikkuri 
   The collected specimen (Urine) is kept open in a glass 
dish or china clay container. It is to be examined under direct sunlight, without 
any shaking of the vessel. Then add one drop of gingelly oil without disturbing 
the urinary specimen and the neikkuri was noted in direct sunlight and 
conclude the diagnosis as follows,  
Character of Vaathaneer 
 “«Ã¦ÅÉ ¿£ñÊÉ·§¾ Å¡¾õ” 
 When the oil drop spreads like a snake, it is called “Vaathaneer” 
Character of Pithaneer 
“¬Æ¢ §À¡üÀÃÅ¢ý «·§¾ À¢ò¾õ” 
 When the oil drop spreads like a ring, it is called “Pithaneer” 
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Character of Kabaneer 
“Óò¦¾¡òÐ ¿¢ü¸¢ý ¦Á¡Æ¢Å¦¾ý ¸À§Á” 
When the oil drop appears like a pearl, it is called “Kabaneer” 
Character of Thonthaneer 
 Snake in the ring, ring in the snake, snake in the pearl and ring in the pearl are 
the characters of Thonthaneer (mixed type). In Kaalanjagapadai, theNeikkuri 
wasVaathaneer, PithaneerandKabaneer. 
LINE OF TREATMENT 
 “§¿¡ö¿¡Ê §¿¡öÓ¾ É¡Ê ÂÐ¾½¢ìÌõ 
  Å¡ö¿¡Ê Å¡öôÀî ¦ºÂø”.                -¾¢ÕÅûÙÅ÷ 
 Thiruvalluvar says in “Thirukkural” about physician‟s duty to study the 
disease, study the cause, seek subsiding ways and do what is proper and effective. 
“¯üÈÅý ¾£÷ôÀ¡ýÁÕóÐ¨Æî ¦ºøÅ¡¦Éý 
 ÈôÀÉ¡üÜü§ÈÁÕóÐ”.                    -¾¢ÕÅûÙÅ÷ 
            In Siddha system of medicine, the main aim of the treatment is to cure 
Udalpini and Manapini. Treatment is not only for perfect healing but also for 
prevention and rejuvenation. 
Line of treatment is as follows: 
 Neekam (Treatment) 
 Niraivu (Restoration) 
 Kaappu (Prevention) 
Neekam (Treatment) 
 Å¢§ÃºÉõ 
 ¯ûÁÕóÐ 
 ¦ÅÇ¢ÁÕóÐ 
 Àò¾¢Âõ 
Virechanam: 
“Å¢§ÃºÉò¾¡ø Å¡¾õ ¾¡Øõ 
 ÅÁÉò¾¡ø À¢ò¾õ ¾¡Øõ 
 ¿º¢Â «ïºÉò¾¡ø ¸Àõ ¾¡Øõ”. 
 “«È¢ó¾¢Îõ Å¡¾õ «¼íÌõ ÁÄò¾¢É¢ø”. 
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 According to the body constitution and age of the patients, Meganatha kuligai 
with hot water quantity was administered at early morning as purgative (Kazhichal 
Medicine) before starting the treatment to bring the vitiated vaatham to normal.  
Internal Medicine: Karunchoorai chooranam, two times a day with butter. 
External Medicine: Kodiveli thylam 
 
Anubanam:  
“«ÛÀ¡Éò¾¡¦Ä ÂÅ¢ú¾õ ÀÄ¢ìÌõ 
 þÉ¢¾¡É ÍìÌþïº¢ - À¢ÛÓÐ¸¡ø 
 §¸¡ÁÂõÀ¡øÓ¨ÄôÀ¡ø §¸¡¦¿ö§¾ý ¦ÅüÈ¢¨Ä¿£÷ 
 ¬Á¢¨¾Â¡ Ã¡öóÐ ¦ºöÂÄ¡õ”              - §¾¨ÃÂ÷ ¦ÅñÀ¡ 
Pathiyam (Dietary Regimen): 
           In mild conditions of the disease, salt and tamarind can be taken in little 
quantities. When the condition is severe, tamarind should be avoided and salt must be 
consumed after frying. 
“Àò¾¢Âò¾¢É¡§É ÀÄÛñ¼¡Ìõ ÁÕóÐ 
 Àò¾¢Âí¸û §À¡É¡øÀÄý §À¡Ìõ Àò¾¢Âò¾¢ø 
 Àò¾¢Â§Á ¦ÅüÈ¢ ¾Õõ ÀñÊò÷ìÌ ¬¾Ä¢É¡ø  
 Àò¾¢Â§Á ¯ò¾¢¦ÂýÚÀ¡ø”                  - §¾¨ÃÂ÷ ¦ÅñÀ¡ 
 
“¦ÀÕÌï §º¡Ç Á¢ÚíÌõ ¦ÀÕõ¸õÒ 
 ÅÃÌ ¸¡Õ¼ý Å¡¨ÆÂ¢ý ¸¡¦Â¡Î 
 ¯¨Ã¦¸¡û À¡¸ü ¦¸Ç¢üÚÁ£ý ¯ñÊÊø 
 Å¢Ã¢Å ¾¡öì¸Ãô À¡ÛÁ¢Ìó¾§¾”         - À¾¡÷ò¾ Ì½ º¢ó¾¡Á½¢ 
 
“ÒÇ¢ÐÅ÷ Å¢ïÍ ¸È¢Â¡÷ ÒÃ¢ìÌõ Å¡¾õ”   -À¾¡÷ò¾ Ì½ º¢ó¾¡Á½¢ 
 
Diet Restriction (Pathiyam) 
 Fish, crab, prawn are some seafoods should be avoided. 
 Curd, Jaggery, oil, White gram should be avoided. 
 Non vegetarian diet should be avoided.  
 Alcohol beverages should be avoided. 
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 Brinjal should be avoided. 
 In severe cases tamarind should be avoided. 
 Dietary taken salt in minimum quantities.  
NIRAIVU: 
                Substances used for neutralizing the three humors are: 
 "´ýÈ¢Â Å¡¾ À¢ò¾ ¸ÀÁ¢¨ÅÔÂÃ¡ Åñ½õ 
  ¿ýÚÚ ¸È¢¸¦ÇøÄ¡õ ¿¡Ù§Á º¨ÁôÀÃ¡öóò §¾¡÷ 
  ¾¢ýÈ¢Î Á¢ÇÌ Áïºû º£Ã¸ ÓÂ÷ó¾ ¸¡Âõ 
  ¦ÅýÈ¢ ¦¸¡û Íì §¸¡§¼Äõ ¦Åó¾¢Âõ ¯ûÇ¢ §º÷ò§¾" 
                                           -À¾¡÷ò¾ Ì½ º¢ó¾¡Á½¢ 
The patients are well motivated. The nature and course of the disease is 
explained to them, Life-style modification advised. 
Substances advised for Vaatha disease are: 
 “¦ºí¸Ø¿£÷ §¸¡¨¼ò §¾ýÁ¢ÇÌ ¿ø¦Äñ¦½ö 
¾íÌ ¦ÀÕí¸¡Âò ¾Ø¾¡¨Æ - ±í¦¸íÌõ 
¸ðÎ º¢Ú ÓòÐ ¦¿ö §¸¡¾¢ø ¯Ùó¾¢¨Å¸û 
Å¡ðÎ ÁÉ¢Äò¨¾ Á¾¢.” 
            -À¾¡÷ò¾Ì½ º¢ó¾¡Á½¢ 
Honey collected during summer, pepper, gingely oil, asafoetida, castor oil and 
black gram are very useful in Vatha disease. 
KAAPPU (Prevention) 
 As per siddha system the aetiology of the diseases are various. The ultimate 
speciality of siddha system is to prevent the diseases. 
 In the siddha classical text Patharthagunachinthamani has given so many ideal 
measures to prevent the diseases. These are given below 
  “¾¢ñ½ Á¢ÃñÎû§Ç º¢ì¸ Å¼ì¸¡Áü 
   ¦Àñ½¢ýÀ¡ ¦Ä¡ý¨Èô ¦ÀÕì¸¡Áø ¯ñÏí¸¡ø 
   ¿£÷ÍÕì¸¢ §Á¡÷¦ÀÕì¸¢ ¦¿öÔÕì¸¢ ÔñÀÅ÷¾õ 
   §ÀÕ¨Ãì¸¢ü §À¡§Á À¢½¢” 
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“¬Ú ¾¢í¸ð ¦¸¡Õ¾¼¨Å ÅÁÉÁÕó ¾Â¢ø§Å¡õ 
  «¼÷¿¡ýÌ Á¾¢ì¦¸¡Õ¸¡ü §À¾¢Ô¨È Ñ¸÷§Å¡õ 
 §¾ÚÁ¾¢ ¦Â¡ýÈ¨Ãì§¸¡÷ ¾Ã¿º¢Âõ ¦ÀÚ§Å¡õ 
   ¾¢í¸Ç¨Ãì ¸¢ÃñÎ¾Ãï ºÅÃÅ¢ÕôÒÚ§Å¡õ 
Å£ÚºÐ÷ ¿¡ð¦¸¡Õ¸¡ø ¦¿öÓØì¨¸ò ¾Å¢§Ã¡õ 
   Å¢Æ¢¸Ùì¸ï ºÉãýÚ ¿¡ð¦¸¡Õ¸¡ Ä¢Î§Å¡õ 
¿¡Ú¸ó¾õ ÒðÀÁ¢¨Å ¿Î¿¢º¢Â¢ý Ó¸§Ã¡õ  
   ¿ÁÉ¡÷ì¸¢í §¸Ð¸¨Å ¿¡Á¢ÕìÌ Á¢¼ò§¾”. 
 
 The Siddhar Theraiyar explains above lines are the rules to maintain healthy 
life and prevent diseases. 
Yogam: 
 Skin is the reflex of mind and so we should treat not only the physical but also 
treat mind and soul. There by patients are advised to do yogam practice. 
Asanas like, 
 Savasanam (Resting posture) 
 Padhmasanam (Lotus posture) 
 Pranayamam  (Breathing excersise)  these are all beneficial to relieve stress 
and strain.  
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MODERN ASPECT OF DISEASE (PSORIASIS) 
ANATOMY OF SKIN: 
The skin is the protective covering of the body, Skin which covers the entire 
surface of the human body. The human skin shows wide variations in structure. 
1. Thick skin found in Scalp, Ear lobes, Palms, Soles. 
2. Thin skin over the rest of the body. 
 The average thickness of the skin is about 1 to 2 mm. 
 In the sole of the foot, palm of the hand and inter scapular region, it is 
considerably thick measuring about 5 mm. 
 Skin is very thinnest in eyelids and penis measuring about 0.5mm only. 
The skin is composed of a 
 Superficial epithelial layer – The epidermis. 
 Connective tissue layer – The dermis or Corium. 
 Another Connective tissue layer loose in texture – The hypodermis or 
subcutaneous layer. 
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STRUCTURE OF EPIDERMIS: 
 The epidermis is formed of nonvascular stratified epithelium. 
 The average thickness of the skin is between 0.07 mm to0.12 mm. 
 Certain parts like the soles of the feet and the palms of the hands it is 
very thick ranging from 0.8mm to1.4mm. 
 Squamous epithelium is 10 to 11 cells thick in the palms and soles. 
 Squamous epithelium is 3 to 4 cells over the eyelids. 
 The nutrition is provided to epidermis by the capillaries of dermis. 
 
The epidermis is mainly divided into two main systems, 
1. Malpighian system which forms the bulk (Keratinocytes) 
2. Pigmentary system which produce pigment ( Melanocytes) 
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In addition of four types of cells. These are  
1. Keratinocytes 
2. Melanocytes 
3. Langherhans cell 
4. Intermittent cells 
          In the epidermis, another unique cell known as Markel cell or Hascheiben or 
Touch cells here found at the base of epidermal ridges, which are in contact with nerve 
fibers, they are mostly present in palms, soles, nail beds, oral and genital epithelium, 
and act as slow touch receptors. 
LAYERS OF EPIDERMIS: 
          Epidermis layer can be made out microscopically in a section of perpendicular to 
the skin surfaces, the following 5 main layers of the epidermis. 
            These are 
1. Stratum germinatum 
2. Stratum malpighii 
3. Stratum granulosum 
4. Stratum lucidum 
5. Stratum corneum. 
1. SRATUM  GERMINATUM: 
 This is the deepest potion of the epidermis and it is composed of 
columnar cells placed perpendicular to the skin surface, it is also 
known as basal cell layer. 
 The whole of the epidermis germinates from this stratum hence the 
name” stratum germinatum” 
 Any trauma to this layer would result in scarring; trauma above the 
level of this layer heals without scarring. 
 Melanoblasts or melanocytes are found in this layer. 
 Stratum germinatum contain granules of pigment called melanin. 
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2. STRATUM  SPINOSUM: 
 It is also known as stratum malpighii or the prickle cell layer. 
 It is superficial to the basal cell layer. 
 It is composed of several layers of polyhedral cells connected to each 
other by intercellular bridges. 
 Desmosomes present in this layer only. 
 Half size desmosomes occur on the under surface on the under 
surface of the basal cells, which play an important part in the 
anchoring the epidermis and dermis. 
 All keratinocytes adhere together by desmosomes. 
3. STRATUM  GRANULOSUM: 
 It is superficial to the stratum malpighii 
 It is composed of flat, fusiform cells which are one to three layers 
thick, the. Cells contain irregular granules of keratohyalin and 
lysosomal enzymes and cystine rich proteins. 
 Lamellar granules also known as odland bodies. 
 These odland bodies take part in the waterproof barrier function of 
the epidermal permeability. 
4. STRATUM  LUCIDUM: 
 Superficial to the stratum granulosum. 
 It is pale, wavy looking layer known as stratum iucidum 
 It is made up of many layers of flattend epithelial cells. 
 This layer contains refractile droplets of eleidin. 
5. STRATUM CORNEUM: 
 This is the most superficial layer, the outer surface of which is 
exposed to the atmosphere. 
 It is also known as horny layer. It is outer most layers and consists of 
dead cells, which are called as corneocytes. 
 It consists of many layers of non nucleated, flattened, cornified cells 
 It is this layer which becomes thicker with the application of 
intermittent mechanical pressure. 
 This layer is thickest in the palms of the hands and the soles of the 
feet, but thinnest on the outer surface of the lips, on the glans penis 
and the eyes. 
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DENDRITIC CELLS OF EPIDERMIS: 
 These are melanocytes, Langherhans cells, and indeterminate cells. 
 The melanocytes are the pigment producing cells and are derived in 
foetal life from neural crest. 
 The cells of langherhans are found about the middle of epidermis. 
 The junction of epidermis and dermis is formed by basement 
membrane(Basal lamina) 
DERMIS: (CUTIS VERA OR CORIUM) 
Dermis is profusely supplied with blood vessels, Thickness of dermis is 1 to 3 
mm, it is made up of dense collagen fibers and fibroblasts. The collagen fibers contain 
the enzyme collagenase which is responsible for wound healing. Dermis is made up of 2 
layer, these are 
1. Superficial papillary layer 
2. Deeper reticular layer 
1. SUPERFICIAL  PAPILLARY  LAYER: 
 The layer projects in to the epidermis, it contain blood vessels, 
lymphatics and nerve fibers 
 Dermal papillae are finger like projections arising from the superficial 
papillary dermis. 
2. DEEPER RETICULAR LAYER: 
 It is made up of reticular and elastic fibers. 
 It is found around the hair, sweat glands and sebaceous glands. 
 It also contain mast cells, Nerve ending, lymphatics and fibroblasts. 
 
APPENDAGES OF THE SKIN: 
The appendages of the skin are five these are, 
1. Sweat gland 
2. Sebaceous gland 
3. Hair 
4. Arrectorpili muscle 
5. Nails. 
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1. SWEAT GLAND: 
These are 2 types 
i. Eccrine gland. 
ii. Apocrine gland. 
 ECCRINE GLAND: 
 They are the ordinary, small sized 0.3 mm to 0.4 mm. 
 Sweat glands are distributed all over the skin except on the beds of 
nail, margins of lips and the glans penis 
 Over 3 million sweat gland present at birth. 
   APOCRINE GLAND:  
 Glandular portion is very large and may measure 3 mm to 5 mm in 
diameter. 
 They occur in the axilla, areola and nipples of breasts, umbilicus, 
around the anus and the genitalia. 
 They are specialized sweat glands, and their secretion is odoriferous 
with a secondary sexual significance. 
2. SEBACEOUS GLAND: 
 They are scattered all over the integument in association with the 
hair follicles. 
 They are absent from the hairless portions of the body like the palms 
of the hands, the soles of the feet. 
 The ducts of the sebaceous glands are lined by stratified squamous 
epithelium which is continuous with the external sheath of the hair, 
and with the malpighian layer of epidermis. 
3. HAIR: 
 Hair is fund on almost every part of the body surface except on the 
palms, soles, the dorsal surface of the terminal phalanges, the inner 
surface of the labia, the inner surface of the prepuce and the glans 
penis. 
 Hairs differ in length, thickness and colour in different parts of the 
body and in different races. 
 There are three types of hair, long, short, thick bristles. 
 Hair grows about 1-2 cm per month. 
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 Hair follicle and its hair can be anatomically divided in to 3 
segments 
 Infundibulam 
 Isthumus 
 Inferior. 
4. ARRECTOR PILI: 
 Arrectorpili muscles are the small bundles of plain muscles fibers, 
which is extend from the connective tissue sheath of the hair 
follicles to the epidermodermal junction. 
 When these contract under the effect of cold or emotions. 
 They move the hair into a more vertical portion is called appearance 
of ”ghoose flesh” 
5. NAILS: 
 These are semi transparent, plate like horny structure, covering the 
dorsal surfaces of the distal phalanges of the fingers and toes. 
 Nail parts are 
 Root 
 Nail plate 
 Nail bed 
 Lunula 
 Lateral and posterior nail fold 
BLOOD VESSELS OF SKIN: 
 The blood supply of the skin originates from the large number of arteries 
forming anastomosis in the deepest part of the dermis. From the single 
vessels run upwards and form a second network in the upper dermis. 
 Finally terminal arterioles ascend in to the papillae ending in capillary 
loops, which drain into connective venules. 
 The blood is returned to the large veins in the subcutaneous tissues. 
LYMPHATICS OF THE SKIN:      
 The skin contains a rich network of lymphatics which drains in to a larger 
vessel in the hypodermis. 
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NERVE SUPPLY OF SKIN: 
 The nerve supply of the skin consists of a motor sympathetic portion 
derived from the sympathetic ganglia. 
 Sensory spinal portion arising from the dorsal root ganglia. 
PHYSIOLOGY OF SKIN: 
The skin performs a multiple of functions, though the primary function of skin is 
the protection of organs, it has many other important functions. These are : 
1. Protective function. 
2. Sensory function. 
3. Storage function. 
4. Synthetic function. 
5. Regulation of body temperature. 
6. Regulation of water and electrolyte balance. 
7. Excretory function. 
8. Absorptive function. 
9. Secretory function. 
10. Gaseous exchange. 
 
1. PROTECTIVE FUNCTION: 
                  Skin forms the covering of all organs of the body and protects these organs 
from the     following factors:     
i. Bacteria and toxic substances 
ii. Mechanical flow 
iii. Ultraviolet rays. 
2. SENSORY FUNCTION: 
Skin is considered as the largest sense organs in the body. It has many nerve 
endings,  
Which form the specialized cutaneous receptors. These receptors are stimulated by the 
sensations of touch, pain, pressure or temperature sensation and convey these sensations 
to the brain via afferent nerves. 
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3. STORAGE FUNCTION: 
Skin stores fat, waters, chlorides and sugar. It can also store blood by the 
dilatation of                        the cutaneous blood vessels.      
4. SYNTHETIC FUNCTION:  
  Vitamin D3 is synthesized in skin by the action of ultraviolet rays on cholesterol. 
5. REGULATION OF BODY TEMPERATURE: 
Skin plays an important role in the regulation of body temperature. Excess heat 
is lost from body through skin by radiation, conduction and evaporation. 
6. REGULATION OF WATER AND ELECTROLYTE BALANCE: 
  Skin regulates water balance and electrolyte balance by excreting water and salts 
through sweat. 
7. EXCRETORY FUNCTION: 
Skin can excrete small quantities of waste materials like urea, salts and fatty 
substances. 
8. ABSORPTIVE FUNCTION: 
            Skin can absorb the fat soluble substances and some ointments. 
9. SECRETORY FUNCTION: 
Skin regulates sweat through sweat glands and sebum through sebaceous glands. 
Sebum keeps the skin smooth and moist. 
 
10. GASEOUS EXCHANGE: 
A small amount of gaseous exchange through the skin. 
EMBRYOLOGY OF THE SKIN: 
  The whole of the skin epidermis and dermis is a unified integrated organ system, 
but it develops from two different primitive embryonic layers epidermis from the 
ectoderm and dermis from the mesoderm. 
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MODERN ASPECT OF KAALANJAGA PADAI (PSORIASIS) 
INTRODUCTION: 
             The word psoriasis is derived from the Greek word “PSORA” meaning 
“ITCH” or “RASH”. It has been known since ancient times and was originally 
considered a type of leprosy, It is one of the most common human skin diseases. 
          Psoriasis was considered to be a chronic inflammatory dermatosis, it is now 
considered a multifactorial disorder that has several factors like genetic predisposition, 
Environmental, immunologically mediated inflammation and several modifying factors 
including obesity, Trauma, infection are involved in psoriasis. 
DEFINITION: 
  It is a common chronic and non-infectious skin disorder, characterized by dry 
erythematous plaques, well defined slightly raised covered by a white silvery scales 
typical in extensor distribution ,it affects all over the body. 
EPIDEMIOLOGY: 
1. PREVALANCE: 
 It is distribution in world wide. 
 Fairly common in the tropical countries. 
 It is pandemic in temperate climate.  
 Attacks are more common in winter than summer. 
 Natural tendency to clear up with the warm weather. 
 A fair number of attacks develop in the monsoon. 
 It affects 0.6%-4.8% of people worldwide. 
 150,000-260,000 new cases of psoriasis are diagnosed each year. 
 About 400 people die from complications caused by psoriasis every 
year. 
 About 11% patients have psoriatic arthritis. 
 Plaque type is most common in 80% of psoriasis patients.  
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2. AGE OF ONSET: 
 First peak of onset between 20-30 yrs. 
  Second peak of onset between 50-60 yrs. 
 Early onset family history present. 
 Late onset family history is not present. 
3. SEX: 
 Men and women are equally affected. 
4. SEASON: 
 Most patients worse in winters. 
AETIOLOGY:  
1. The exact cause is unknown - AUTOIMMUNE DISEASE 
2. Stress. 
3. Disturbed fat metabolism. 
4. Hormonal imbalance. 
5. Septic focus. 
6. Allergy. 
7. Anxiety states. 
8. Lowered response of the cyclic AMP system to prostaglandin E1 in 
epidermis. 
9. Mental trauma. 
10. Fever. 
11. Digestive upsets. 
12. Physical injury: 
 Scratches. 
 Surgical incisions and injuries. 
13.  Infection: 
 β - Hemolytic streptococcal infection- precipitates guttate 
lesions. 
 HIV infection-Explosive psoriasis. 
14. Herido familial and Genetic factors21: 
 Increased in familial cases. 
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 Greater concordance in monozygotic twins (70%) 
 Dizygotic twins (30%) 
 Increased association of HLA- CW6 20 times increased risk 
with early onset of psoriasis. 
PRECIPITATING FACTORS: 
 Diabetic‟s mellitus. 
 Psychological stress. 
 Hot water bathing 
 Skin dryness. 
 Obesity. 
 Local Pressure. 
 HIV 
 Trauma. 
 Purines in the diet. 
 Identical twins. 
 Immune system reacting to skin cells. 
 Microbes. 
i. Staphylococcal aureus 
ii. Candida albicans. 
 Drugs: 
i. Anti malarial drugs. 
ii. Lithium. 
iii. Beta adrenergic blockers drugs. 
iv. NSAID drugs. 
v. Corticosteroid withdrawal may aggravate 
psoriasis.(Pustular psoriasis) 
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PATHOGENESIS OF PSORIASIS:  
Psoriasis appears to be largely a disorder of keratinization 
↓ 
The basic defect is rapid replacement of epidermis in psoriatic lesion.  
            3 to 4days instead of 28 days in normal skin. 
↓ 
There are marked vascular changes in upper dermis in the form of    
Recently the presence of abnormal neural cells has been demonstrated in  
                                                       Psoriatic plaques.   
 
 PATHOGENESIS OF PSORIASIS 
 Psoriasis was long considered either a disorder of keratinocytes growth or a 
chronic inflammation. 
 Advancement in immunologic techniques and in genetic analyses has 
resulted in a reappraisal of the pathophysiology involved. 
 Psoriasis consider as an organ specific autoimmune disease that is triggered 
by an activated cellular immune system and it similar to other immune 
mediated disease. 
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 The definition of autoimmune disease as “ a clinical syndrome caused by 
the activation of T cells and Bcells, or both, in the absence of an 
ongoing infection or other discernable cause”  
 Pathogenesis of psoriasis still poses a challenge to the scientific community 
to once and for all, establish how and why it occurs and consequently to 
develop the magic drug to treat it.   
 Psoriasis is an immunological disease, characterized by interplay of 
I. Immunological factors. 
II. Cellular components. 
III. Signaling molecules. 
IV. Biochemical changes. 
V. Histological changes. 
 These are plays major role in pathogenesis. 
I. IMMUNOLOGICAL FACTORS IN PSORIASIS:  
Both innate or acquired immune changes are thoughtbe responsible for 
the     
                        Developmentof psoriatic plaques 
↓ 
Different types of helper T subsets, dendritic cells, plasmacytoid 
dendritic cells as well as Langherhans cells have been found to play a 
role in psoriasis. 
↓ 
T cells plays important role in psoriasis 
↓ 
Autoimmunity as a major factor in pathogenesis. 
↓ 
The presence of T cells in the inflammatory infiltrate in psoriatic plaque 
obviously Indicated in immune mediated or an autoimmune basis for the 
                        Pathogenesis of psoriasis. 
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II. CELLULAR COMPONENTS IN PATHOGENESIS OF PSORIASIS:   
Cellular components are : 
a) T cells 
b) Keratinocytes 
c) Langherhans 
 
CELLULAR COMPONENTS OF PSORIASIS 
 
A. T CELLS: 
 T cells play a key role, with the epidermal T cells being CD8+ & 
Dermal cells being CD4+. 
 These cells include memory T cells, natural killer cells T cells& 
Th17& Th22. 
 Th17& Th22 cells which are subsets of CD4+ cells are now 
considered important in pathogenesis of the psoriatic plaque. 
 They are stimulated by IL-23 & respectively produce IL-17& IL-22 
which mediate dermal inflammation and epidermal hyperplasia. 
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B. KERATINOCYTES: 
 Keratinocytes cells express transcription factor STAT- 3, which may 
be pathogenic. 
C. LANGERHANS CELLS: 
 Langherhans cellssecrete cytokines, which are mitogenic and 
chemotatic. 
III. SIGNALLING MOLECULES IN PATHOGENESIS OF PSORIASIS: 
 Include cytokines growth factors like interleukins, Chemokines, 
Interferon‟s and their respective receptors. 
 Characterized by up regulation of Th1 cytokines and reduction of anti 
inflammatory cytokines IL-10. 
 Other important molecules include TNF-α, IL-15, IL-17, IL-22 and 
IL-23 
IV. BIOCHEMICAL CHANGES INPATHOGENESIS OF PSORIASIS: 
 Cyclic nucleotide increased levels in cGMP or decreased levels of 
cAMP.  
 Arachidonic acid level is increased and it metabolites. 
 Polyamines also increased in levels. 
 PROTEINASE: increased in levels of plasminogen activator and their 
inhibitors. 
 Calmodulin also increased in levels. 
V. HISTOLOGICAL  CHANGES INPATHOGENESIS OF PSORIASIS: 
 Epidermal changes is increased epidermal proliferation in two ways  
 One is increased growth fraction from normal of 30 to 100% in 
psoriasis. 
 2nd is shortened epidermal turn over time from normal of 60 to10 
days in psoriasis. 
 Important changes seen in dermal layer. 
 Include dilated and tortuous capillary loops and proliferation of 
fibroblasts. 
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MOST COMMON SITES: 
1. AREAS COMMONLY AFFECTED: 
 Scalp 
 Back of elbows 
 Front of knees and legs 
 Lower part of the back of the trunk 
2. MAY ALSO BE AFFECTED: 
 Nail 
 Sole 
 Palm 
3. RARELY AFFECTED: 
 Mucus membrane 
CLINICAL FEATURS OF PSORIASIS:   
 Typical distribution is extensor 
 Lesions are bilaterally symmetrical 
  Typical coin shaped lesion 
 Big plaques of the size of palm of the hand 
 The lesions are slightly raised above the surface of skin 
 Absence of itching 
 But itching present in tropical countries 
 Slight or moderate purities present 
 Secondary psychogenic stress present 
 Secondary lichenification present 
 Scalp is involved almost all cases 
 No matting of hair 
 Nail also involved 3types of lesion 
I. Pitting 
II. Seperation of nail from the nail bed and walls 
III. Thickening of the nail and collection of hyperkeratotic 
debris under the nail. 
 The palms of the hands and soles of the feet also involved in patches 
of hyperkeratosis and fissures on erythematous bases. 
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IMPORTANT SIGNS OF PSORIASIS: 
1. Candle greeze sign. 
2. Auspitz sign. 
3. Koebner‟s phenomenon. 
 
1. CANDLE GREEZE SIGN( Tache de bouge) : 
Psoriatic lesion is scratched with the point of a dissecting forceps a candle 
greeze like scale can be repeatedly produced even from the non scaling lesions 
this is called candle greeze sign (Tache de bouge). 
 
2. AUSPITZ  SIGN: 
The complete removal of scale produces pin point bleeding.  
3. KOBNER’S PHENOMENON: 
Psoriatic lesions may develop along the scratch lines in the active phase this is called 
Koebner‟s phenomenon. 
SITES OF PREDILECATION OF PSORIASIS:     
 Lesions are usually bilaterally Symmetrical. 
 Favours pressure points are extensor surface of 
                               Elbows 
                                Knee  
                                Scalp 
                                Fore head 
                                Nape of neck 
                                Trunk 
                                Buttocks 
                                 Lumbosacral region                                                                             
       Periumblical area    
                                 Palms and soles. 
 Usually with lesions at other sites, but sometimes in isolation. 
 Infrequent involvement of photo exposed sites, involvement of face 
uncommon and indicates refractory psoriasis. 
 Intertriginous involvement in flexural psoria 
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CLINICAL TYPES OF PSORIASIS: 
CLASSIFICATION: 
Psoriasis is classified based on its onset, evolution and morphology into    
1. Chronic plaque psoriasis (psoriasis vulgaris) 
2. Acute guttate psoriasis 
3. Pustular  psoriasis 
1.CHRONIC PLAQUE PSORIASIS: 
There are several variants of chronic plaque psoriasis 
A) MORPHOLOGICAL VARIANTS: 
a) Small plaque psoriasis 
b) Rupioid psoriasis 
c) Para psoriasis 
B) VARIATION OF MORPHOLOGY DUE TO SITE: 
a) Flexural psoriasis 
b) Annular psoriasis 
c) Scalp psoriasis (Corona psoriatica) 
d) Penile psoriasis 
e) Psoriasis of palms and soles (psoriasis inverses) 
 ASSOCIATIONS OF PSORIASIS: 
In a patient with chronic psoriasis, always check for nails and joint involvement. 
a) Psoriatic nails 
b) Musculoskeletal system(Psoriasis arthopathica) 
c) Metabolic syndrome. 
 
1. CHRONIC PLAQUE PSORIASIS(CPP):  
          Chronic plaque psoriasis is the commonest form of psoriasis      
 MORPHOLOGY: 
                 The prototype lesion of CPP is a mildly itchy papule which is 
 Well demarcated 
 Erythematous - Deep pink to red 
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 White silvery scales, but is profuse adherent in elephantine 
 Indurated and raised. 
 Size and number of lesions variable 
 Koebner‟s phenomenon +ve 
 Auspitz sign +ve 
 
A) MORPHOLOGICAL VARIANTS: 
a) SMALL PLAQUE PSORIASIS (SPP): 
 Smaller 1- 2cm lesions 
 Resemble like guttate psoriasis 
 SPP occurs in older patients 
 It is scalier and has a more chronic course. 
 
b) RUPINOID PSORIASIS: 
 Lesions with heaped up scales so appear conical 
 Scales are firmly adherent to the underlying skin look like limpet 
 Lesions are classically present in Reactive arthritis(Reiter‟s syndrome) 
 Characterized by HLA B27 +ve, Antecedent infection, Arthritis,      
     Conjunctivitis, Keratodermablennorrhagicum. 
 
c) PARAPSORIASIS: 
 Para psoriasis is a group of rather infrequent, idiopathic and 
asymptomatic erythrodermic or scaly papule dermatoses. 
 It is a non specific reaction pattern of the skin which may represent an 
intermediary stage of psoriasis. 
 
B) VARIATION OF MORPHOLOGY DUE TO SITE:  
a) FLEXURAL PSORIASIS: 
 Commonly occurs in elderly females, because lesions are present in 
moist    
     friction prone areas. 
 Lesions are well defined and erythematous (Salmon pink) 
 Occurs in flexur like the axilla, inframammary folds, vulva and gluteal 
cleft. 
 
b) ANNULAR PSORIASIS: 
 The central clearing of the circular lesions produces ringed lesion. 
43 
 
c) SCALP PSORIASIS: 
 Lesions may occur along the scalp border is called corona 
psoriatica. 
 Sharply defined, indurated, scaly plaques present. 
 Scaling looks like Asbestos, especially on the occipit. 
d) PENILE PSORIASIS: 
 In uncircumcised males, scaling is absent on glans but lesions  
continue                  
          to be erythematous and well defined. 
 In circumcised patients, the lesions on the glans are similar to  
psoriatic lesions. 
e) PSORIASIS OFPALMSANDSOLES:                
 Lesions are bilaterally symmetrical (Psoriasis inversus) 
 Lesions are well defined, Symmentrical, erythematous, thick  
plaques with white silvery scales may be profuse or minimal. 
2. ACUTE GUTTATE PSORIASIS: 
 Occurs in children and adolescents 
 May be precipitate by streptococcal tonsillitis 
 Lesions appear in several crops of small, erythematous papules   
         withminimal scaling 
 Side of predilection is trunk. 
3. PUSTULAR PSORIASIS: 
 It occurs mostly in withdrawal of topical or systemic steroids 
 LOCALIZED: Inchronicplaque psoriasis, when plaques are  
surrounded with pustules 
 Pustules and crusts are seen on distal part of fingers and in nail   
bed 
 GENERALISED: Is a serious condition 
 Constitutional symptoms like high fever, chills and tachypnea  
seen 
 Is characterized by generalized fiery red Erythema followed by  
appearance of waves of tiny. 
 Appearances of new pustules as the old ones are crusting. 
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ASSOCIATION OF PSORIASIS: 
NAILPSORIASIS: 
 
 Nail changes due to 
                    Nail matrix psoriasis 
                    Nail bed psoriasis 
 Nail matrix psoriasis: Manifests as pitting 
 Nail bed psoriasis: Nail plate thickening, subungual hyperkeratosis, 
discoloration and dystrophy of nail plate, oncholysisand oil spots are 
specific for psoriasis. 
A. MUSCULOSKELETAL SYSTEM (PSORIASIS ARTHOPATHICA): 
 Dactylitis and enthesitis is typically seen there are also seen 5 clinical    
 patterns seen these are 
                             Asymmentricaloligoarthritis 
       Symmetrical rheumatoid arthritis 
                                      Distal interphalangeal arthritis 
       Arthritis mutilans 
       Axial arthritis 
B. METABOLIC SYNDROME: 
In patients with psoriasis, there is an increased prevalence of 
 Hypertension 
 Diabetes mellitus (Insulin resistance) 
 Obesity 
 Dyslipidemia 
 Coronary artery disease 
COMPLICATIONS 
 Complications of psoriasis may include the following: Secondary infections, 
Psoriatic arthritis, possible increased risk of lymphoma, cardiovascular disease, 
ischemic heart disease, and Mitral valve prolapse. Among these, Psoriatic arthritis is a 
major complication.                                 (Ref: ard.bmj.com › Volume 64, Issue suppl2) 
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Psoriatic arthritis facts 
 About one in 10 people with psoriasis also develop inflammation of joints 
(psoriatic arthritis). 
 The first appearance of the skin disease (psoriasis) can be separated from the 
onset of joint disease (arthritis) by years. 
 Psoriatic arthritis belongs to a group of arthritis conditions that cause 
inflammation of the spine (spondyloarthropathies). 
 Patients with psoriatic arthritis can develop inflammation of tendons, cartilage, 
eyes, lung lining, and, rarely, the aorta. 
(Ref: http://www.medicinenet.com/psoriatic_arthritis/article.htm) 
Risk for psoriatic arthritis: 
 Affecting men and women equally, about 10% to 30% of people with psoriasis 
develop psoriatic arthritis. Psoriatic arthritis may develop at any age, but usually 
affects people between the ages of 30 and 50. While the cause is not known, genetic 
factors, along with the immune system likely play a role in determining who will 
develop the disorder. 
 As many as 40% of people with psoriatic arthritis have a family history of skin 
or joint disease. Having a parent with psoriasis triples the chance of getting psoriasis 
yourself and thus increases the chance of developing psoriatic arthritis. 
Different types of psoriatic arthritis: 
 There are five types of psoriatic arthritis. It is important to know which type of 
psoriatic arthritis you have and to understand the characteristics so that it may be 
treated properly. 
Symmetric psoriatic arthritis: 
 Symmetric arthritis affects the same joints usually in multiple matching pairs 
on opposite sides of the body. Symmetric psoriatic arthritis can be disabling, causing 
varying degrees of progressive, destructive disease and loss of function in 50% of 
people with this type of arthritis. Symmetric psoriatic arthritis resembles rheumatoid 
arthritis. 
Asymmetric psoriatic arthritis: 
 Asymmetric arthritis typically involves one to three joints in the body large or 
small such as the knee, hip, or one or several fingers. Asymmetric psoriatic arthritis 
does not affect matching pairs of joints on opposite sides of the body. 
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Distal interphalangeal predominant (DIP): 
 It involves primarily the small joints in the fingers and toes closest to the nail. 
DIP psoriatic arthritis is sometimes confused with osteoarthritis, a chronic disease that 
causes the deterioration of joint cartilage and bone as well as bone spurs at the joints. 
Spondylitis: 
 Spondylitis affects the spinal column and may cause inflammation and stiffness 
in the neck, lower back, spinal vertebrae, or sacroiliac region (pelvic area), making 
motion difficult. Spondylitis also can attack connective tissue, such as ligaments, or 
cause arthritic disease in the joints of the arms, hips, legs, or feet. 
Arthritis mutilans: 
 Arthritis mutilans is a severe, deforming, and destructive form of psoriatic 
arthritis that primarily affects the small joints in the fingers and toes closest to the nail. 
This leads to lost function of the involved joints. It also is frequently associated with 
lower back and neck pain. Fortunately, this type of psoriatic arthritis is rare.  
(Ref: http://arthritis.webmd.com/psoriatic-arthritis/default.htm). 
 
SEVEARITY OF PSORIASIS: 
 A PASI score is a tool used to measure the severity and extant of 
psoriasis (Psoriasis area and severity index), it takes few minutes and 
experience to calculate it accurately. 
 A representative area of psoriasis is selected for each body region. The 
intensity of redness, thickness, scaling of the psoriasis is assessed as 
none(0) , mild(1), moderate(2), severe(3), very severe(4). 
  The percentage area affected by psoriasis is evaluated in the four 
regions of the body. In each region the area expressed as nil(0), 1-9%(1), 
13-29(2), 30-49%(3), 50-69%(4), 70-89%(5), 90-100%(6). 
 Head and neck, upper limbs, trunk, lower limbs calculations for area, 
each of the body area scores is multiplied by the area affected.  
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DIFFERENTIAL DIAGNOSIS 
Nummular eczema 
  Rounded, circular desquamative erythematous lesions covered with vesicles, 
crusts, and scales, very itchy. Patients have whether atopic or allergic diathesis. 
Epicutaneous allergy tests are frequently positive. 
Pityriasis rubra pilaris  
 In typical cases follicular papules and infiltrating scales are observed as well as 
typical hyperkeratosis. 
Lichen simplex chronic 
This disease shows dry and itchy oval plaques and resembles psoriasis as a shape 
but not have silvery scales Auspitz and candle signs. And shows violaceous tint. 
Pityriasis alba  
It shows a white plaque, like psoriasis but have not an erythema. It has been seen 
only face.  Psoriasis usually affects more than one area of the body. Red skin covered 
with greasy-looking white or yellowish scales. 
HISTOPATHOLOGICAL CHANGES  
EPIDERMAL CHANGES: 
 Parakeratosis 
 Loss of granular layer and regular acanthosis 
 Supra papillary thickening 
 Collection of polymorphs in the epidermis to form spongiform pustule 
of kogoj and Munro‟s micro abscess seen in epidermis. 
DERMAL CHANGES: 
 Dilatation and tortuosity of capillary loops in the dermal papillae 
 Lymphocytic infiltrate in the upper dermis is seen. 
HISTOLOGICAL CHANGES: 
 Thinning of supra papillary portion of stratum malpinghii 
 Elongation of ridges 
 Oedema and clubbing of papillae seen in histological study. 
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HISTOCHEMICAL CHANGES: 
 Histochemical studies have revealed an increase in both oxidative and 
anaerobic metabolism with increased pentose, glycon, purines, 
sulphydral groups, soluble proteins increased in level. 
 Decreased in activity of dipeptidases. 
 It has been discovered that apparently normal skin of both the psoriatics 
and their relations show these changes in miniature is called latent 
psoriasis. 
RADIOLOGICAL CHANGES: 
 . Simultaneous presence of ankylosis, periosteal new bone formation, 
erosions and osteolytis are strongly suggestive of psoriatic arthritis. 
RULE OUT OTHER TEST FOR PSORIASIS: 
 Metabolic syndrome, diabetes, hypertension and dyslipidemia 
 Hypocalcaemia especially in pustular psoriasis 
 Anaemia and hypoproteinemia in erythrodermic psoriasis. 
DIAGNOSIS OF PSORIASIS 
 There are no laboratory tests which will positively identify psoriasis. The blood 
count, Urine analysis, ESR and other hematologic chemical and serologic studies are 
within normal limits in most cases of psoriasis. 
The diagnosis of psoriasis is based upon: 
1. The family history of psoriasis 
2. The typical distribution of the lesions on the scalp, elbows, knees, the front of 
the legs, back and nails 
3. Well-defined non-indurated dry erythematous areas with silvery layer-upon-
layer scaling 
4. The candle – grease sign (when a psoriatic lesion is scratched with the point of 
a dissecting forceps, a candle-grease-like scale can be repeatedly produced 
even from the non-scaling lesions. This is CG sign) 
5. Auspitz sign (Complete removal of a scale produces pin-point bleeding) 
6. Koebner‟s phenomenon (Psoriatic lesions may develop along the scratch lines 
in the active phase) 
7. Little or no itching 
8. History of previous attacks and seasonal variations of the disease. 
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TREATMENT OF PSORIASIS PATIENTS: 
      Depending on the type of psoriasis, various therapeutic options are available 
 Topical agents like liquid paraffin, petroleum gel, vegetable oils etc. 
 Systemic agents like Methotrexate, Acitretin, and Cyclosporine. 
 Corticosteroids mostly in cream base. 
 Photochemotherphy and phototherapy in PUVA methods. 
 Biological response modifiers used in treatment of psoriasis. 
 
DIET FOR PSORIASIS PATIENTS: 
TO TAKE: 
1. All green leafy vegetables. 
2. Low consumption of animal fats and the quantity of food. 
3. High protein diet 
4. Fish and sea foods 
5. Carrot 
6. Tomatoes 
7. Grains. 
TO AVOID: 
1. Oil foods. 
2. High fat diet 
3. Alcohol 
4. Junk foods 
5. Red meat 
6. Dairy products 
7. Night shade vegetables 
8. Citrus fruits 
9. Gluten protein in diet 
10. Condiments. 
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PROGNOSIS: 
 A permanent cure is not yet known 
 Individual attacks can, almost always controlled satisfactorly 
 Disease non infectious 
 The disease does not leave scar 
 Flexural, erythrodermic and pustular psoriasis take longer to heal 
than the typical variety 
 The palmar and nail lesions are rather resistant to treatment. 
 Patient suffer from the disease on and off throughout their lives. 
 Complications in psoriasis are infrequent. 
 
MANAGEMENT: 
 The general health of the patient should be maintained. 
 The patient‟s life should be regulated so that no undue stress 
affects either body (or) mind. 
 A moderate, warm climate, frequent sunbaths before the onset of 
the winter, and visits to sulphur springs, all of which are useful in 
bringing down the relapse rate. 
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PROPERTIES OF TRIAL DRUGS 
INTERNAL MEDICINE 
KARUNCHOORAI 
Botanical Name : Capparis sepiaria 
Family : Capparaceae 
Part used                         :  Bark 
 
Organoleptic Characters 
 Taste                :  Pungent 
 Potency        :   Hot 
 Pirivu             :  Pungent 
Chemical Constituents:  
Alcoloids, Glycosides, Carbohydrates, Anthocyanins, Sterols, Terpenes, 
flavonoids, tannis.       
     (Ref; Indian Journal of pharmaceutical 
sciences) 
Medicinal uses: 
 The plant is credited with antipyretic and antiseptic properties. It is useful in skin 
diseases. The juice of the inner bark of the root is used for scabies and eczema. 
   (Ref ; Encyclopaedia of medicinal plants, volume 1, page no 
428.) 
CHITHIRAMOOLAM 
Botanical Name : Plumbagoindica 
Family : Plumbaginaceae 
Part used                         :  root 
 
Organoleptic Characters  
 Taste              :  Pungent 
 Potency          :   Hot 
 Pirivu           :  Pungent 
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 ¸ðÊîÝ ¨ÄÅ£ì¸í ¸¡úãÄõ - ÓðÊÃò¾ì 
 ¸ðÎ¿£ §ÃüÈí ¸Éò¾ ¦ÀÕÅÂ¢Úõ 
 «ðÎí ¦¸¡Ê§ÅÄ¢ Â¡õ 
      (Ref; Agaththiyar guna vaagadam) 
Chemical constiuents 
Plumbagin,Tannins, steroids, glucoside, triterpenes 
Actions 
Tonic, stomachic, antiperiodic 
Medicinal uses 
 Roots are used in the treatment of paralytic affections, ulcers, leprosy, enlarged 
spleen, piles, skin diseases and influenza. The plumbagin shows antimicrobial activity. 
Plumbagin is an important naphthaquienone which has anticancer activity, anti bacterial, 
antifungal, antimutagenic anti inflammatory, and insecticidal activities. 
 
VELLARUGU 
 
Botanical Name : Enicostemmaaxillare 
Family : Gentianaceae 
Part used                           :  root 
  
Organoleptic Characters 
 Taste            :  Bitter 
 Potency         :   Hot 
 Pirivu                     :  Pungent 
¦À¡Ð Ì½õ 
 
  ÌýÁ¦Á¡ÎÅ¡ö× Ì¼øÅ¡¾õ Ý¨ÄÂ¢¨Å 
¦ºýÁõÅ¢ð §¼¡Êî º¢¨¾Ôí¸¡ñ - ÅýÓ¨ÄÂ¡ö 
¯ûÙÚ¸¢ Ãó¾¢¦º¡È¢ ¦Â¡ðÊÂ º¢ÃíÌÁÚõ 
¦ÅûÇÚÌ ¾ý¨É Å¢ÕõÒ 
 (Ref; Agaththiyar guna vaagadam) 
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Chemical constituents 
           Alkaloids, tannins, phenolic, sapponins, flavonoids 
Medicinal uses 
           The whole plant is dried powdered and given with honey as a blood purifier and 
in dropsy, rheumatism, abdominal ulcers, hernia, swellings, itches and insect poisoning. 
The plant is acrid, anti inflammatory, antipyretic, and liver tonic. 
Ref ; Encyclopaedia of world medicinal plants volume 2, pg no 866. 
Actions 
   Stomachic, tonic, alternative, laxative, febrifuge 
 
MILAGARANAI 
Botanical Name : Toddaliaasiatica 
Family : Rutaceae 
Part used                      :  root 
  
Organoleptic Characters 
 Taste            :  Astringent 
 Potency        :   Cold  
 Pirivu            :  Pungent 
¦À¡Ð Ì½õ 
 
 ³ÂÁ ¸üÚõ «º£Ã½Å¡ ¾õ§À¡ìÌï 
¦ºöÂÀ¢ò¾ Ý¨Ä¸¨Çò ¾£÷ìÌí¸¡ñ - ¨ÀÂÅÕõ 
®¨Ç þÕÁøþ¨ÃôÒôÒ ºó¦¾¡¨ÄìÌõ 
¿¡Ù Á¢Ç¸Ã¨½ ¿ýÚ 
Ref; Agaththiyar guna vaagadam 
Chemical constituents 
       Toddaline, toddalinine, glycosides, resin,essential oil 
Medicinal uses 
       The root bark is credited with diaphoretic, stomachic, antipyretic and antimalarial 
properties. Essential oil shows antimicrobial activity. 
Ref ; Encyclopaedia of world medicinal plants volume 2, pg no 866. 
Actions 
        Stimulant, tonic, carminative, diaphoretic, antiperiodic 
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MILAGU 
Botanical Name : Piper nigrum 
Family : Piperaceae 
Part used                        :  Seed 
  
Organoleptic Characters 
 Taste         :  Bitter, Pungent 
 Potency         :   Hot 
 Pirivu            :  Pungent 
 
¦À¡Ð Ì½õ 
¾£Â¡¸¢ ¦ÂíÌõ ¾¢Ã¢ÔÁ¨¾ Â¡ÅòÐ 
§Á¡Â¡Á ¦ÄôÀÊÔ Óñ¼¡ì¸¡ü - À¡Â¡Ð  
§À¡ó¾¢Á¢÷Å¡ ¾í¸¢Ãó¾¢ Òñ½£Õõ ÁýÉÅ÷ìÌõ 
¸¡ó¾¢¦ÁöÅ¡ ¾îºÖô¨Àì ¸¡ö 
(Ref; Agaththiyar guna vaagadam) 
Chemical constituents 
           Piperine, Piperidine, piperetine, Chavicine 
Medicinal uses 
          Fruits used in indigestion, asthma, fever, cough arthritis and haemorrhoids, 
(Ref ; Encyclopaedia of world medicinal plants volume 2, pg no 866.) 
Actions 
          Stimulant, acrid, carminative, rubefacient, antiperiodic, resolvent, anti vadha, 
antidote. 
    
SIRUKURINJAN 
Botanical Name : Gymnemasylvestre 
Family : Asclepidaceae 
Part used                         :  Leaf 
  
Organoleptic Characters 
 Taste            :  Bitter 
 Potency          :   Hot 
 Pirivu            :  Pungent 
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¦À¡Ð Ì½õ  
º¢ÚÌÈ¢ïº¡ý Å¡¾¦Á¡Î º£¾ò¨¾ ¿£ìÌõ 
ÁÈ×¾¢Ãõ þøÄ¡¾ Á¡¾÷ì-ÌÚÓÄ¸¢ø 
«ò¾¢ ÍÃÓõ «¸Ä¡ì ¸ÊÅ¢¼Óõ 
¾ò¾¢Â¸ Äò¾¸÷ìÌó ¾¡ý. 
(Ref; Agaththiyar guna vaagadam) 
Chemical constituents 
            Gymnemicaid, quercitol, stigmasterol. The leaves contain tartaric acid, formic 
acid, butyric acid, anthroquinone derivatives, gymnemic acid.  
Medicinal uses 
            Leaves used for treating diabetes, cardiac stimulant. 
(Ref ; Encyclopaedia of world medicinal plants volume 2, pg no 866.) 
Actions 
          Astringent, stomachic, tonic, refrigerant, diuretic and laxative 
 
AGASAKARUDAN 
Botanical Name : Corallocarpus epigaeus 
Family : Cucurbitaceae 
Part used                        : tuber 
  
Organoleptic Characters 
 Taste           :  Bitter 
 Potency       :   Hot 
 Pirivu             :  Pungent 
¦À¡Ð Ì½õ  
 
Ðð¼Å¢¼õ À¡ñÎ¦ÅôÒ Ý¨ÄÅ¡ ¾í¸¢Ãó¾¢ 
Ìð¼õ «Ã¢ôÀì¸¢ ¦¸¡ñÌ¼ø§¿¡ö-¦¸ð¼¸ñ¼ 
Á¡¨Ä§À¡õ ¦¸¡øÄý§¸¡ ¨Åì¸¢Æí¸¡ø Óò§¾¡¼ 
§Å¨Ä§À¡õÀ¡Ã¢øÅ¢ÇõÒ. 
(Ref; Agaththiyar guna vaagadam) 
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Chemical constituents 
            Bryonin 
Medicinal uses 
            The root has bitter and acid taste and is created with alternative and laxative 
properties and is used in syphilitic rheumatism, later stages of dysentryand chronic 
mucous enteritis. 
(Ref ; Encyclopaedia of world medicinal plants volume 2, pg no 634.) 
Actions 
            Alternative, tonic 
 
KARUVEL 
Botanical Name : Acasianilotica 
Family : Mimosoideae 
Part used                        :  Bark 
   
Organoleptic Characters 
 Taste             :  Astringent 
 Potency          :      Cold 
 Pirivu             :  Sweet 
¦À¡Ð Ì½õ  
¾ó¾õ þÚÌó ¾É¢îÝ¾ô Òñ½¡Úõ 
Åó¾ÍÃõ À¢ò¾õ ÁÊÔí¸¡ñ-Àó¾ 
ÁÕ§Å Â¸Ä¡ ÁÄÃÇ¸ Á¡§¾! 
     ¸Õ§ÅÄõ Àð¨¼ìÌì ¸¡ñ. 
(Ref; Agaththiyar guna vaagadam) 
Chemical constituents 
         The leaves contain tartaric acid, formic acid, butyric acid, anthroquinone 
derivatives, gymnemic acid.  
Medicinal uses 
        The decoction of bark used in asthma, bronchitis, diabetes, dysentery, diarrhoea 
haemorrhages, wounds, ulcers and skin diseases.  
(Ref ; Encyclopaedia of world medicinal plants volume 1, pg no 26.) 
Actions 
        Demulcent, emollient, nutrient, pectoral 
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ATHTHI PATTAI 
Botanical Name : Ficusracemosa 
Family : Moraceae 
Part used                         :  Bark 
   
Organoleptic Characters 
 Taste          :  Astringent 
 Potency       :   Cold 
 Pirivu          :  Sweet 
 
¦À¡Ð Ì½õ  
Å£Ú ¸ÎôÀ¢ò¾õ ¦Åñº£¾ Ãò¾¦Á¡Î 
¿¡ÚÅ¢Ã½í¸¦ÇÄ¡õ ¿¡¼¡Å¡õ - ÜÚí¸¡ø 
«ò¾¢¾Õ §Á¸õ§À¡õ ¬Â¢¨Æ§Â! ±ï»¡ýÚõ 
  «ò¾¢ôÀ¡ü Àð¨¼ì ¸È¢    (Ref; Agaththiyar guna vaagadam) 
Chemical constituents 
      Tannins, glycosides, flavonoids, stigmasterol 
Medicinal uses  
      The bark is astringent and a decoction of it is used as a wash for wounds. The root is 
reported to be useful in dysentery. The bark has antidiabetic, antioxidant, antidiarrhoeal, 
anti-inflammatory, antipyretic, antifungal, antibacterial, hypolipidemic, antifilarial, and 
hepatoprotection   
                              (Ref ; Encyclopaedia of world medicinal plants volume 1, pg no 26.) 
Actions 
      Astringent . 
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EXTERNAL MEDICINE 
KODIVELI 
Botanical Name : Plumbagoindica 
Family : Plumbaginaceae 
Part used                          :   root 
Organoleptic Characters  
 Taste          :  Pungent 
 Potency       :   Hot 
 Pirivu          :  Pungent 
¦À¡Ð Ì½õ 
 ¸ðÊÅ¢Ã ½í¸¢Ãó¾¢ ¸¡ø¸û «¨ÃÂ¡ôÒì 
 ¸ðÊîÝ ¨ÄÅ£ì¸í ¸¡úãÄõ - ÓðÊÃò¾ì 
 ¸ðÎ¿£ §ÃüÈí ¸Éò¾ ¦ÀÕÅÂ¢Úõ 
 «ðÎí ¦¸¡Ê§ÅÄ¢ Â¡õ 
      (Ref; Agaththiyargunavaagadam) 
Chemical constiuents 
Plumbagin, Tannins, steroids, glucoside 
Actions 
Tonic, stomachic, antiperiodic 
Medicinal uses 
 Roots are used in the treatment of paralytic affections, ulcers, leprosy, enlarged 
spleen, piles, skin diseases and influenza. The plumbagin shows antimicrobial activity. 
Plumbagin is an important naphthaquienone which has anticancer activity, anti bacterial, 
antifungal, antimutagenic and insecticidal activities. 
PASUMPAAL (Cow’s milk) 
General properties: 
“À¡Ä÷¸¢ÆÅ÷ ÀÆïÍÃò§¾¡÷ Òñ½¡Ç¢ 
Ý¨ÄÂ÷ §Á¸ò§¾¡÷ Ð÷ÀÄò§¾¡÷ ²ÖÁ¢Å÷ 
±øÄ¡÷ìÌÁ¡Ìõ þ¨Çò¾Å÷ìÌï º¡¾¸Á¡ö 
¿øÄ¡öÀÍÅ¢ýÀ¡ø ¿¡ðÎ” 
- Pathartha guna sindhamani 
It is a good nutritive supplement for new born, young adults and older adults. It 
cures vatha diseases, veneral disease, and also useful in the treatment of emaciated 
individuals. 
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Other aspects about milk: 
 
 Milk is a translucent white liquid produced by the mammary glands of 
mammals, a pH ranging from 6.4 to 6.8, making it slightly acidic. Cow‟s milk is the 
primary source of nutrition for young mammals before they are able to digest other 
types of food. 
 Cow‟s milk contains , on a average 3.4 %protein, 3.6 % fat,and4.6% lactose 
0.7% minerals and supplies 66 k cal of energy per 100 gms.The largest structures in 
the fluid portion of the milk are casein protein micelles. 
 
NUTRIENTS IN MILK  
 Biotin 
 Pantothenic acid 
 Iodine 
 Potassium 
 Magnesium 
 Selenium 
 Thiamine 
 Vitamin A 
 Vitamin B 12 
 Riboflavin 
 Vitamin D 
 Vitamin K 
 
KARUNCHEERAGAM 
Botanical name  : Nigella sativa 
Family   : Ranunculaceae 
Part used  : Seed 
Organoleptic characters: 
Taste   :  Kaippu 
Potency     :  Veppam 
Division  : Kaarppu 
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General properties: 
¦À¡ÐìÌ½õ: 
“¸Õïº£ Ã¸ò¾¡ý ¸ÃôÀ¦É¡ÎÒñÏõ 
ÅÕïº¢Ã¡öô À£¿¢ºÓ Á¡üÚõ -«Õó¾¢É¡ø 
¸¡öîºø ¾¨ÄÅÄ¢Ôí ¸ñÅÄ¢Ôõ §À¡ÓÄ¸¢ø 
Å¡öîº ÁÕó¦¾É§Å ¨Å”                -«¸ò¾¢Â÷ Ì½Å¡¸¼õ  
Chemical constituents: 
Carvone, d – limonene,Cymene, Nigellone, Melanthin, Melanthigenin, 
Nigellidine –Indazole, Campesterol, Citronellyl Acetate.                  (Ref: Database Vol 
– VI, P – 422) 
The seeds contain a fatty oil rich in unsaturated fatty acids. The two main 
    unsaturated fatty acids are: 
Linoleic acid (omega-6) 57.9% 
Oleic acid 23.7% 
   The two main ones present are: 
Palmitic acid 13.7% 
Stearic acid 2.6% 
Actions: 
Carminative, Stomachic, Anthelmintic, Diuretic. 
NALLENNAI 
Botanical Name  : Sesamum indicam 
English Name  : Ginglly oil 
Family   : Pedaliaceae  
Action: 
       Demulcent, Laxative, Nutritive, Emollient 
General properties: 
"Òò¾¢ÉÂÉìÌÇ¢÷îº¢ âÃ¢ôÒ ¦ÁöôÒÇ¸ï 
ºòÐÅí ¸ó¾¢ ¾É¢Â¢Ç¨Á - ¦Áò¾Å¢ñ¼¡í 
 ¸ñ§½¡ö ¦ºÅ¢§¿¡ö ¸À¡ÄÅÆø ¸¡º§¿¡ö 
Òñ§½¡ö§À¡ ¦Áñ¦½öÂ¡ü §À¡üÚ". 
-  
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Chemical constituents: 
Vitamin E, Sesamin, Sesamolin, Phytosterol 
It cures 
Eyes and Ear disease, Skin disease, Relieves Cough, Gives internal happiness, 
Strengthen the body. 
THANDRIKKAAI 
Botanical Name : TerminaliaBellerica. Roxb. 
Family  : Combretaceae 
Organoleptic Characters 
Taste  : Thuvarppu 
Potency : Veppam 
Division : Inippu 
General properties: 
¦À¡ÐìÌ½õ: 
“º¢Äó¾¢Å¢¼õ ¸¡Á¢ÂôÒñ ¸£Æ¡É §Á¸í 
¸Ä óÐÅÕõ Å¡¾À¢ò¾í ¸¡§Ä¡- ¼Ä¡óÐ¼Ä¢ø 
°ýÈ¢ì¸¡ö ¦ÅôÀ Ó¾¢ÃÀ¢òÐí¸ÃìÌó 
¾¡ýÈ¢ì¸¡ö ¨¸Â¢¦ÄÎò ¾¡ø”               - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
Chemical constituents: 
Main chemical constitutes are tannins mainly include ß- sitosterol, gallic acid, 
ellagic acid, ethyl gallate, galloyl glucose and chebulaginic acid. 
Actions: 
Tannins: It shows scavenging activity against mitochondrial lipid peroxidation. 
It causes significant decrease in cholesterol level and it also shows antimicrobial activity 
against bacteria and virus with a significant inhibition of microsomal lipid peroxidation 
and reduction in triglyceride levels in liver and reduction in total acidity and peptic 
activity and increase in mucin content. 
(Ref: Indian Herbal Pharmacopoeia) 
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THALISAPATHRI 
Botanical Name : Ablesspectabilis. 
Family  : Pinaceae 
Part used  : Leaf 
Organoleptic Characters 
Taste  : Pungent 
Potency : Hot 
Division : Pungent 
 
General properties: 
¦À¡ÐìÌ½õ: 
“º¢Äó¾¢Å¢¼õ ¸¡Á¢ÂôÒñ ¸£Æ¡É §Á¸í 
¸Ä óÐÅÕõ Å¡¾À¢ò¾í ¸¡§Ä¡- ¼Ä¡óÐ¼Ä¢ø 
°ýÈ¢ì¸¡ö ¦ÅôÀ Ó¾¢ÃÀ¢òÐí¸ÃìÌó 
¾¡ýÈ¢ì¸¡ö ¨¸Â¢¦ÄÎò ¾¡ø”                  -«¸ò¾¢Â÷Ì½Å¡¸¼õ 
Chemical constituents: 
Main chemical constitutes are tannins mainly include ß- sitosterol, gallic acid, 
ellagic acid, ethyl gallate, galloyl glucose and chebulaginic acid. 
Actions: 
Tannins: It shows scavenging activity against mitochondrial lipid peroxidation. 
It causes significant decrease in cholesterol level and it also shows antimicrobial activity 
against bacteria and virus with a significant inhibition of microsomal lipid peroxidation 
and reduction in triglyceride levels in liver and reduction in total acidity and peptic 
activity and increase in mucin content. 
(Ref: Indian Herbal Pharmacopoeia) 
¦À¡ÐìÌ½õ: 
³ÂÅ¢ â¾¢ ÂÅÃ¢ ¸¢Ö¸¢Öô¨À 
¨Â¨ÂÅ¢ â¾¢ ÂÈÁ¢ÃðÊ 
§Â¸Áð¼ Á£É Á¢Ãð¨¼ ÐÄ¡ó¾Û§Å¡ 
§Â¸Áð¼ Á£ÉÅÉ¢ Â¢ø 
- Pathartha guna sindhamani 
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The following vitamins are found in high amounts in butter: 
Vitamin A: The most abundant vitamin in butter. One tablespoon (14 g) can provide   
                   about 11% of the daily recommended allowance. 
Vitamin D: Butter is a good source of vitamin D. 
Vitamin E: A powerful antioxidant, often found in fatty foods. 
Vitamin B12: Also called cobalamin, vitamin B12 is only found in foods of animal  
                      origin, such as eggs, meat, and dairy products. 
Vitamin K2: A form of vitamin K, also called menaquinone. May protect against   
                     cardiovascular disease and osteoporosis  
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`   INTERNAL MEDICINE- INGREDIENTS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Milagu Sirukurinchaan 
Karunchoorai Milagaranai ver 
65 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kodiveli Atthipattai 
Karuvel pattai 
Aakasa karudan 
Vellarugu 
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EXTERNAL MEDICINE- INGREDIENTS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thandrikkai Thalisapathiri 
Karuncheerakam Kodiveli 
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Gingely oil 
Milk  
Butter 
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MATERIALS AND METHODS 
   
STANDARD OPERATING PROCEDURE: 
Source of Raw Drugs 
 The required raw drugs for the trial medicine were purchased from a well 
reputed country raw drug shop and drugs were authenticated by the competent authority 
of department of Medicinal Botany, National Institute of Siddha. After that the raw 
drugs were purified separately then the trial drugs prepared in Gunapadam laboratory of 
National Institute of Siddha. 
PREPERATION OF TRIAL DRUGS  
Internal Medicine: KARUNCHOORAI CHOORANAM 
Ingredients  
 Karunchooraipattai (bark of Capparissepiaria)        
 Chithramoolamver(root ofPlumbagoindica)                    
 Vellaruguver(root ofEnicostemmaaxillare)                          
 Milagaranaiver(root ofToddaliaasiatica)                           
 Milagu(Piper nigrum)                                                                         Equal amount 
 Sirukurinjanilai ( leaves of Gymnemasylvestre)                             
 Aagasagarudankizhangu(tuber ofCorallocarpusepigaeus)    
 Karuvelpattai (bark of Acacianilotica)         
 Aththipattai(root ofFicusracemosa)  
 
METHOD OF PURIFICATION OF RAW DRUG 
Karunchooraipattai (bark of Capparissepiaria) 
 Cleaned the barkwith white cloth then removed the outer 
layer.(Ref:Sigicharathinatheebam:28) 
Chitiramoolamver (root of Plumbago indigo) 
 Remove the inner nerve of the root and powder the outer part of root.Take a pot 
with milk and its mouth is covered with white cloth then the powder over it and closed it 
with another vessel.Gently heat it for 3 hours then dry and grind                      
(Ref:Sigicharathinatheepam :29) 
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Vellaruguver (root ofEnicostemmaaxillare) 
 Washed and removed the dust particle over the root and dried
 (Ref:sigicharathinatheepam :28) 
Millagaranaiver (root of Toddaliaasiatica) 
 Washed and removed the dust particle over the root and dried. (Ref: 
sigicharathinatheepam :28) 
Millagu(Piper nigrum)  
 Soak in the buttermilk for three hours then dried and powdered (Ref: 
SigichaRathinaTheepam :28) 
Sirukurinjanilai (leaves of Gymnemasylvestre) 
 Removed the dust particle dried.(Ref: Sigicharathinatheepam :28) 
Aagasagarudankizhangu (tuber of Corollocarpusepigaeus) 
 Boil the tuber with milk then peel the skin, dry and powder it. (Ref: 
SigichaRathinaDeepam :28) 
Karuvelpattai (bark of Acacianilotica) 
 Removed the dust particle over the bark and dried (ref: sigicharathinatheepam :28) 
Aththipattai(root ofFicusracemosa) 
Cleaned it with white cloth and removed the outer layer. (ref: 
sigicharathinatheebam:28) 
 
METHOD OF PREPERATION 
 All the above mentioned ingredients are taken in equal amountand dried, 
then made into fine powdered. The powder is purified. Then the medicine stored in an 
air tight container.  
METHOD OF PURIFICATION OF CHOORANAM (PITTAVIYAL METHOD) 
 Take a pot with milk and its mouth is covered with white cloth then the powder 
over it and closed it with another vessel.Gently heat it for 3 hours then dried and 
grinded. 
DOSAGE:          2 gram twice a day with ghee 
DURATION:     48 days  
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External Medicine: KODIVELI THYLAM 
Ingredients 
Kodiveliver (root of Plumbagoindica)    - 10 Palam (350 gm) 
Neer (Water)                          - 1 Pathakku(10.7lit) 
Karunjeeragam (Nigella sativa) 
Thaalisapathiri (Abiesspectabilis)    - Each 1 Palam (35 gm) 
Thaanrikai (Terminaliabellerica) 
Paal(Cow‟s milk)                             - QS 
Nallennai (Gingelly oil)     - 1 Padi  
Vennai (Butter)              - Punnaikaipiramanam 
METHOD OF PREPARATION:  
             The purified kodiveliver(root of Plumbagoindica) 350 gms) mixed with 10.7 litre 
of  water and heated upto 1/8
th
  ratio of water and take it as decoction. Then 
Karunjeeragam (Nigella sativa), Thaalisapathiri (Abiesspectabilis), Thaanrikai 
(Terminaliabellerica)are grinded along with milk and make it into paste (karkam). Then 
the paste mixed with above d 
ecoction then added oil and butter. Then boiled till it attained the suitable consistency 
and filter it. 
DOSAGE: QS 
DRUG STORAGE 
The trial drug Karunchooraichooranamis stored in clean and dry 
containerKodiveliThylamis stored in clean and dry narrow mouthed bottles. 
DISPENSING 
The Chooranam is given in packets and oil is given in bottle 
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CHEMICAL EVALUATION 
  Experimental procedure:  
       5 g of Karunchoorai chooranam was taken in a 250 ml of clean beaker and 50ml of 
distilled water was added to it. Then it was boiled well for about 10 min. Then it is 
allowed to cool and filtered in a 100 ml volumetric flask and made up to 100 ml with 
distilled water. This preparation is used for the qualitative analysis of acidic/ basic 
radicals and biochemical constituents in it. 
Preparation of extract:  
5gm of Karunchoorai chooranamis weighed accurately and placed in a 250ml clean 
beaker and 50ml of distilled water was added with it. Then it was boiled well for about 
10 minutes. Then it was allowed to cool and filtered in a 100ml volumetric flask and 
made up to 100ml with distilled water. The bio-chemical analysis of Karunchoorai 
chooranamwas done at Biochemistry lab, National Institute of siddha, Chennai-47. 
Preliminary test for Copper, Sodium, Silicate and Carbonate: 
 Test for Silicate: 
a. A little (500mg) of the sample is shaken well with distilled water. 
b. A little (500mg) of the sample is shaken well with con. HCl/Con. H2So4. 
 Action of Heat: A small amount (500mg) of the sample is taken in a dry test 
tube and heated gently at first and then strong. 
 Action of Heat: A small amount (500mg) of the sample is taken in a dry test 
tube and heated gently at first and then strong. 
 Flame Test: A small amount (500mg) of the sample is made into a paste with 
con. HCl in a watch glass and introduced into non-luminous part of the Bunsen 
flame. 
 Ash Test: A filter paper is soaked into a mixture of sample and dil. cobalt 
nitrate solution and introduced into the Bunsen flame and ignited. 
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Test For Acid Radicals 
 Test For Sulphate: 2ml of the above prepared extract was taken in a test tube 
and 2ml of 4% dil. ammonium oxalate solution was added. 
 Test For Chloride: 2ml of the above prepared extracts was added with 2ml of 
dil-HNO3 until the effervescence ceases off. Then 2 ml of silver nitrate solution 
was added. 
 Test For Phosphate: 2ml of the extract was treated with 2ml of con.HNo3 and 
2ml of dil. ammonium molybdate solution.   
 Test For Carbonate: 2ml of the extract was treated with 2ml dil. magnesium 
sulphate solution 
 Test For Nitrate:1gm of the substance was heated with copper turning and 
concentrated H2SO4 and viewed the test tube vertically down. 
 Test For Sulphide: 1gm of the substance was treated with 2ml of con. HCL 
 Test For Fluoride & Oxalate: 2ml of extract was added with 2ml of dil. 
Acetic acid and 2ml dil.calcium chloride solution and heated. 
 Test For Nitrite: 3drops of the extract was placed on a filter paper, on that-2 
drops of dil.acetic acid and 2 drops of dil. Benzidine solution were placed. 
Test For Basic Radicals 
 Test For Lead: 2ml of the extract was added with 2ml of dil. potassium iodine 
solution. 
 Test For Copper: One pinch (50mg) of substance was made into paste with 
con. HCl in a watch glass and introduced into the non-luminous part of the 
flame. 
 Test For Aluminium: In the 2ml of extract dil. sodium hydroxide was added in 
5 drops to excess. 
 Test For Iron: 
a. To the 2ml of extract add 2ml of dil. ammonium solution 
b. To the 2ml of extract 2ml  thiocyanate solution and 2ml  of con HNo3 is        
                     added 
 Test For Zinc: In 2ml of the extract dil.sodium hydroxide solution was added 
in 5 drops to excess and dil.ammonium chloride was added.  
73 
 
 Test For Calcium: 2ml of the extract was added with 2ml of 4% 
dil.ammonium oxalate solution  
 Test For Magnesium: In 2ml of extract dil.sodium hydroxide solution was 
added in drops toexcess. 
 Test For Ammonium:In 2ml of extract 1 ml of Nessler's reagent and excess of 
dil. sodium hydroxide solution were added. 
 Test For Potassium:A pinch (25mg) of substance  was treated  with 2ml of 
dil. sodium nitrite solution and then treated with 2ml of dil. cobalt nitrate in 
30% dil. glacial acetic acid. 
 Test For Sodium: 2 pinches (50mg) of the substance was made into paste by 
using HCl and introduced into the blue flame of Bunsen burner. 
 
 Test For Mercury: 2ml of the extract was treated with 2ml of dil. sodium 
hydroxide solution.  
 Test For Arsenic: 2ml of the extract was treated with 2ml of dil. sodium 
hydroxide solution. 
Other constituents 
 Test For Starch : 2ml of extract was treated with weak dil. iodine solution  
 Test For Reducing Sugar: 5ml of Benedict's qualitative solution was taken in a 
test tube and allowed to boil for 2 minutes and added 8 to 10 drops of the extract 
and again boil it for 2 minutes.  
 Test For The Alkaloids: 
a) 2ml of the extract is treated with 2ml of dil. potassium iodide solution.    
b) 2ml of the extract is treated with 2ml of dil. picric acid. 
 Test For Tannic Acid: 2ml of extract was treated with 2ml of dil. ferric 
chloride solution 
 Test For Unsaturated Compound: In the 2ml of extract 2ml of dil. Potassium 
permanganate solution was added.  
 Test For Amino Acid: 2 drops of the extract was placed on a filter paper and 
dried well, and then 20ml of Burette reagent was added in it. 
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CLINICAL STUDY: 
STUDY TYPE : An open clinical trial 
STUDY PLACE : OPD and IPD of AyothidossPandithar Hospital 
      National Institute of Siddha 
      Tambaram sanatorium, Chennai-47 
STUDY PERIOD :  2014-2017 
SAMPLE SIZE :  40 Patients 
 
SUBJECT SELECTION: 
         Patients reporting with symptoms of inclusion criteria will be subjected to 
screening test and documentation. 
INCLUSION CRITERIA 
 Age : 20-60 years 
 Sex : Both male and female 
 Erythema 
 Thickness 
 Scaling   
 With or without itching 
 Auspitz sign + 
 Candle crease sign + 
 Willing to participate in trial and signing consent by fulfilling the condition 
mentioned in proforma. 
 Willing to give specimen of blood and urine for the investigation while 
before and after the treatment  
  Willing to take photograph before and after treatment. 
EXCLUSION CRITERIA 
 Insulin Dependent Diabetes Mellitus 
 Pregnancy and lactation 
 Psoriasis with evidence of any other skin disease  
75 
 
 Psoriatic arthropathy 
 Cardiac diseases 
 Hansen‟s disease 
 Evidences of secondary infection in the lesions. 
 Any other chronic illness 
WITHDRAWAL CRITERIA 
 Intolerance to the drug and development of any serious adverse effect during 
drug trial. 
 Poor patient compliance & defaulters 
 Patient unwilling to continue the course of clinical Study. 
 Occurrence of any other systemic illness 
TESTS AND ASSESMENTS 
            1. Clinical assessment  
2. Siddha system assessment 
3. Routine investigations 
1. CLINICAL ASSESMENT 
 Erythema 
 Thickness 
 Macules 
 Papules 
 Plaques 
 Itching 
 Coin –shapedlesion 
 Scaling 
 Candle –greasesign 
 Auspitzsign 
 Koebner‟sphenomenon 
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2. INVESTIGATIONS BASED ON SIDDHA SYSTEM 
1. Naadi 
2. Sparisam 
3. Naa 
4. Niram 
5. Mozhi 
6. Vizhi 
7. Malam 
8. Moothiram 
● Neerkkuri :     
●  Neikkuri   : 
3. INVESTIGATION 
BLOOD 
 Haemoglobin  
 Total WBC Count 
 DC 
 Polymorphs 
 Lymphocytes  
 Eosinophils 
 Monocytes  
 Basophils  
 Total RBC count  
 ESR  ½ Hr:       1 Hr: 
 Blood sugar  Fasting:  PP: 
 Serum cholesterol 
URINE 
 Albumin 
 Sugar(F)                          (PP) 
 Deposits 
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RENAL FUNCTION TESTS 
             Blood Urea 
             Serum Creatinine 
             Uric acid 
LIVER FUNCTION TESTS 
              Serum total bilirubin 
              Direct bilirubin 
              Indirect bilirubin 
              Serum Alkaline phosphatases 
              SGOT &SGPT 
DATA COLLECTION 
Required information will be collected from each patient by using the following 
forms: 
FORMS:  
 FORM  - I            Screening and selection Proforma 
 FORM-II           Clinical assessment Proforma 
 FORM  -III          Laboratory investigation Proforma 
 FORM  - IV         Drug compliance form 
 FORM-V          Patient information sheet 
 FORM  -VI         Consent form 
 FORM  -VII       Withdrawal form/Pharmacovigilance 
 FORM  -VIII      Dietary Advice form 
 FORM  -IX       Adverse reaction form 
 
STUDY ENROLLMENT 
 Patients reporting at the OPD with clinical feature of erythematous patches, 
scaling, itching are chosen for enrollment based on the inclusion and exclusion 
criteria. 
 The enrolled patients were informed about the study, trial drugs, possible 
outcomes and the objectives of the study in the language and terms 
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understandable to them and getting consent in the Informed Consent form 
(Form V). 
 All these patients were given unique registration card in which patients‟ 
Registration number of the study, Address, Phone number and Doctors 
phonenumber etc. So as to report easily whenever any complication arise. 
 Complete clinical history, complaints and duration, examination findings 
would be recorded in the prescribed Proformas. 
 Patients were advised to take the trial drug and to follow the appropriate 
dietary advice. 
 
 
 
CONDUCT OF THE STUDY 
 On the first day of the treatment Purgation was given with Meganathagulikai-2 
tablet in the early morning with Hot water for balancing the vitiated Mukkutram. Then 
the trial drugs “Karunchoorai Chooranam” (internal) and “Kodiveli Thylam” 
(external) will be given for 48 days.  
  OPD patients were visit the hospital once in 7 days. In each and every visit 
clinical assessment and prognosis were recorded. For IPD patients the clinical 
assessment and prognosis were recorded daily  
 Laboratory investigations was done on the first day and also at the end of the 
trial At the end of the trial, the patients are advised to visit the OPD for further 6 
months for follow-up for any recurrence. Defaulters are not be allowed to continue and 
withdrawn from the study with fresh case being inducted. 
ADVERSE/SERIOUS EFFECTS MANAGEMENT 
 If the trial patient develops any adverse reaction, he/she would be immediately 
withdrawn from the trial and treatment given in OPD of NIS.   
DATA ANALYSIS 
 After enrolling the patients in the study, a separate file for each patient was 
maintained and all forms were kept in the file. Study No. and patient‟s No. were 
entered on the top of the file for easy identification. Whenever the patients visit OPD 
during the study period, necessary entries was made at the assessment forms.  
The screening forms were filled separately. 
79 
 
 All forms were further scrutinized by Sr. Research Officer (Statistics) for 
logical errors and incompleteness of data to avoid any bias. No modification in the 
results is permitted for unbiased reports. 
OUTCOME 
 The outcome of the study was clinically observed by the PASI Score. 
 Good outcome - Clearance of lesions and 75% reduction in the PASI Score in 
before and after treatment. 
 Moderate outcome -Partial clearance of lesions and 50% reduction in the PASI 
Score in before and after treatment. 
 Mild outcome -   Slight clearance of lesions and 25% reduction in the PASI 
Score in before and after treatment. 
 Nil outcome - No Clearance of lesions or No reduction PASI Score   
PSORIASIS AREA AND SEVERITY INDEX (PASI) 
 
A Psoriasis Area and Severity Index(PASI) is a quantitative rating scale for 
measuring the severity of psoriatic lesions based on area coverage and plaque 
appearance 
 
Erythema/ Thickness/Scaling-Rating score   Area Scoring 
0 - None        0-Nil  
1- Slight        1-1-9% 
2- Moderate        2- 10%-29% 
3-Severe        3-30%-49% 
4-Very severe        4-50%-69% 
         5-70%-89% 
         6-90%-100% 
 
 
 
80 
 
 
 
 
 
 
PASI CALCULATION 
Patient name   
Date   
Plaque 
Characteristic 
Rating Score 
Body region and weighting factor 
Head 
Upper 
Limbs 
Trunk 
Lower 
Limbs 
Erythema 
  
0 = None         
Thickness 
1 = Slight 
        
2 = Moderate 
Scaling 
3 = Severe 
        
4 = Very Severe 
      Totals A1= A2= A3= A4= 
Weighting Factor 
A1x0.1=B
1 
A2x0.2=B
2 
A3x0.3=B
3 
A4x0.4=B
4 
Surface area totals B1= B2= B3= B4= 
  
Degree of involvement 
as  
% for each body region  
affected (score each  
region between 0 and 6) 
0 = None 
    
1 = 1-9% 
2 = 10-29% 
3 = 30-49% 
4 = 50-69% 
5 = 70-89% 
6 = 90-
100% 
Surface area totals x % involvement 
totals 
Sum Scores above = 
B1xscore=C
1 
B2xscore=C
2 
B3xscore=C
3 
B4xscore=C
4 
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 Add together each of Erythema/ Thickness/Scaling scores for each of the body 
regions to give 4 separate sub totals A1, A2, A3 and A4 
 Multiply each sub total by amount of body surface area represented by that 
region i.e. A1 x 0.1 for head, A2 x 0.2 for upper limbs, A3 x 0.3 for trunk, A4 
x 0.4 for lower limbs to give a value B1, B2, B3 and B4 for each body region 
respectively. 
 A1 x 0.1=B1;   A2 x 0.2=B2;  A3 x0.3=B3;  A4 x 0.4=B4 
 For each body region multiply sub total B1, B2, B3 and B4 by the score(0-6) 
of the % of body region involved to give 4 sub totals C1, C2, C3 and C4 
 The patient‟s PASI score is the sum of C1+C2+C3+C4 
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TRIAL DRUGS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTERNAL DRUG KARUNCHOORAI CHOORANAM 
EXTERNAL DRUG KODIVELI THYLAM 
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RESULTS OF CHEMICAL ANALYSIS 
                                                  Qualitative Analysis  
SL.
NO 
EXPERIMENT OBSERVATION INFERENCE 
1. Appearance of the sample 
Lighter Brown in 
Colour 
 
2. Solubility:   
a. A little of the sample is 
shaken well with distilled 
water. 
b. A little of the sample is 
Shaken well with con. Hcl 
 Con. H2SO4. 
 
Completely soluble 
 
 
 
Completely soluble 
 
 
 
 
 
Absence of 
Silicate 
3. Action of Heat: 
A small amount of the sample 
is taken in a dry test tube and 
heated gently at first and then 
Strong. 
 
White fumes  
evolved 
Brown fumes not 
evolved 
 
Presence of 
Carbonate.                         
Absence of 
Nitrate. 
4. Flame  Test: 
A small amount of the sample 
is made into a paste with con. 
Hcl in a watch glass and 
introduced into non-luminous 
part of the Bunsen flame. 
 
White flame  is 
appeared 
 
 
Absence of 
Copper. 
5 Ash Test: 
A filter paper is soaked into a 
mixture of sample and cobalt 
nitrate solution and introduced 
into the Bunsen flame and 
ignited. 
 
No Yellow colour 
flame. 
 
Absence of 
Sodium. 
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Preparation of the Extract 
 5 gm of Karunchoorai chooranam was weighed accurately and placed in a 250 
ml clean beaker. Then 50 ml distilled water was added and dissolved well. Then it is 
boiled well for about 10 minutes. It was cooled and filtered in a 100 ml volumetric 
flask and then it was made up to 100 ml with distilled water. This fluid was taken for 
analysis. 
 
SL. 
NO. 
EXPERIMENT OBSERVATION INFERENCE 
I.TEST FOR ACID RADICALS 
1. Test For Sulphate: 
a. 2 ml of the above prepared 
extract is taken in a test tube to 
this added 2ml of 4% ammonium 
oxalate solution. 
b. 2ml of the above prepared 
extract is added with 2 ml of dil-
Hcl is added until the 
effervescence ceases off. Then 
2ml of Barium chloride solution 
is added. 
Cloudy appearance 
present 
 
 
 
A white precipitate 
insoluble in con. 
Hcl is obtained 
Presence of 
Sulphate 
 
 
 
Sulphate is 
Confirmed. 
2. Test For Chloride: 
2 ml of the above prepared 
Extract is added with dil. HNO3 
till the effervescence ceases. 
Then 2 ml of silver nitrate 
solution is added. 
 
Cloudy appearance 
present (Mild trace 
element) 
 
Presence of 
Chloride 
3. Test For Phosphate: 
2 ml of the extract is treated with 
2ml of ammonium molybdate 
solution and 2 ml of con. HNO3 
Cloudy yellow 
appearance Present 
Presence of 
 Phosphate 
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4. Test For Carbonate: 
2m1 of the extract is treated with 
2m1 magnesium sulphate 
solution 
 cloudy appearance 
Presence of 
Carbonate 
5 
 
Test For Nitrate: 
1gm of the substance is heated 
with copper turnings and 
concentrated H2SO4   and viewed 
the test tube vertically down. 
 
Brown gas is not 
evolved 
 
 
Absence of 
Nitrate 
 
 
 
6. Test For Sulphide: 
1 gm of the substance is 
treated with 2m1 of con. Hcl. 
 
No Rotten egg 
Smelling gas 
evolved 
 
Absence of 
Sulphide. 
 
7. 
 
 
 
 
Test for fluoride & oxalate 
 2 m1 of The Extract Is Added 
With 2m1of Acetic Acid and 2 
m1 calcium Chloride solution 
and heated. 
 
 
No Cloudy 
appearance. 
 
 
 
Absence of  
Fluoride & 
Oxalate 
8.  
 
 
 
Test for Nitrite: 
3drops of extract is placed on a 
filter paper,on that 2 drops of 
acetic Acid and 2 drops of 
benzidine solution is placed. 
 
 
No characteristic 
Changes. 
 
 
 
Absence of 
nitrite. 
9. 
 
 
 
 
 
Test For Borate: 
2 pinches of the substance is 
made into paste by using 
sulphuric acid and alcohol (95%) 
and introduced into the blue 
flame. 
 
 
Bluish green colour 
flame not appeared  
 
 
Absence of 
borate. 
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II. TEST FOR BASIC RADICALS 
1 Test For Lead: 
2 m1of the extract is added with 
2m1of potassium iodide solution. 
 
 No Yellow 
precipitate 
is obtained 
 
Absence of Lead. 
2. Test for Copper: 
a. One pinch of substance is 
made into paste with con. Hcl 
in a watch glass and  introduced 
into the non-luminous part of the 
flame. 
b. 2 ml of extract is added with 
excess of ammonia solution. 
 
No Blue colour 
flame  
precipitate 
 
 
 
No Blue colour 
precipitate  
 
Absence of 
Copper. 
 
 
 
 
Absence of 
Copper. 
3. Test For Aluminium: 
Take the 2m1of the extract 
sodium hydroxide is added in 
drops to excess. 
 
No characteristic 
changes 
 
 
Absence of 
Aluminium. 
 
4. Test  For  Iron: (Ferrous) 
To the 2 ml of extract 2m1                                         
ammonium thiocyanate solution                                                                 
and 2m1of con.HNO3 is added. 
 
 
 
 
 
 
 
 
Blood red colour 
Appeared
 
 
 
 
Presence of Iron 
 
 
 
 
 
5. Test For Zinc: 
To 2m1 of the extract sodium 
hydroxide solution is added in 
drops to excess. 
 
White precipitate is 
not 
Formed 
 
Absence of Zinc. 
 
6. Test For Calcium: 
2m1 of the extract is added with 
2m1 of 4% ammonium oxalate 
Solution. 
Cloudy appearance 
and white 
precipitate                       
is obtained 
 
Presence of 
Calcium. 
 
87 
 
7. Test For Magnesium: 
To 2ml of extract sodium                                   
hydroxide solution is added in 
drops to excess. 
 
White precipitate 
is not 
obtained. 
 
Absence of 
Magnesium. 
8. Test For Ammonium: 
To 2ml of extract few ml of 
Nessler's reagent and excess of 
sodium hydroxide solution are 
added. 
 
 
No brown colour 
appeared. 
 
 
 
Absence of 
Ammonium. 
9. Test For Potassium: 
A pinch of substance is treated 
with 2ml of sodium nitrite 
solutionand then treated with 
2m1 of cobalt nitrate in 30% 
glacial acetic acid. 
 
Yellowish 
precipitate is 
obtained 
 
 
 
Presence of 
Potassium. 
10. Test For Sodium:  
2 pinches of the substance is 
made into paste by using HCL 
and introduced into the blue 
flame of Bunsen burner. 
 
 
 No Yellow colour  
Flame appeared. 
 
 
 Absence of 
Sodium. 
 
11. Test For Mercury: 
2m1 of the extract is treated with 
2ml of sodium hydroxide 
solution. 
 
 
 
 
 Yellow precipitate                           
is not obtained 
 
 
 
Absence of 
Mercury. 
 
12. Test For Arsenic: 
 2m1 of the extract is treated 
with 2m1 of sodium hydroxide 
solution. 
 
 
No brownish red 
Precipitate is 
obtained 
 
 
Absence of 
Arsenic. 
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III. MISCELLANEOUS 
1. Test for Starch: 
2ml of extract is treated with weak 
iodine solution. 
 
 
 Blue colour 
developed 
 
Presence of 
Strarch 
 
2. Test For Reducing Sugar: 
5. ml of Benedict's qualitative 
solution is taken in a test tube and 
allowed to boil for 2 minutes and 
added 8 to 10 drops of the extract 
and again boil it for   2 minutes. 
The colour changes are noted. 
 
 
 
Brick red colour 
developed 
 
 
Presence of 
Reducing sugar. 
3. Test For The Alkaloids: 
a. 2m1 of the extract is treated 
with 2ml of potassium Iodide 
solution.                        
 
b. 2m1 of extract is treated with  
2ml of picric acid. 
 
c. 2m1 of the extract is treated with 
2ml of phosphotungstic acid. 
 
Red colour 
developed 
 
 
 
Trace Yellow 
colour developed 
 
White precipitate 
developed 
 
Presence of 
Alkaloid. 
 
 
Trace of  
Alkaloid present. 
 
Presence of 
Alkaloid. 
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4. Test for Tannic Acid: 
   2ml of extract is treated with  
2ml of ferric chloride solution. 
 
Black precipitate 
is obtained 
 
Presence of 
Tannic acid. 
 
 
 
5. Test for Unsaturated 
Compound: 
   To the 2ml of extract 2ml of 
Potassium Permanganate solution 
is added. 
 
Potassium 
Permanganate is  
not decolourised 
 
Absence of 
Unsaturated 
Compound 
6. Test For Amino Acid: 
2 drops of the extract is placed on 
a filter paper and dried well and 2 
ml of biuret reagent is added 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No Violet colour 
developed 
 
Absence of 
Amino acids. 
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7. Test For type of Compound: 
2ml of the extract is treated with 2 
ml of ferric chloride solution. 
 
No Green colour 
developed 
 
 
 
 
No Red colour 
developed 
 
 
 
 
No Violet colour 
developed 
 
 
 
No blue colour 
 Developed 
 
Absence of oxy 
quinole 
epinephrine 
and pyro 
catechol. 
 
Anti pyrine, 
Aliphatic          
amino acids and 
Meconic acid are 
absent. 
 
Apomorphine, 
Salicylate and 
Resorcinol are 
absent. 
 
Morphine, 
Phenol 
cresol and hydro 
quinone are 
absent 
 
RESULT: 
 The Bio-chemical analysis of Karunchoorai chooranam had shown the 
presence of Carbonate, Sulphate, Chloride, Phosphate, Reducing Sugar, Iron, and 
Alkaloids. 
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CLINICAL STUDY  
OBSERVATION AND RESULTS 
  
The observation and results were studied and tabulated under the following heading. 
 
1) Age distribution 
2) Sex distribution 
3) Occupational History 
4) Family History 
5) Diet habits 
6) Thinai reference 
7) Paruvakaalam 
8) Kaalam distribution (According to age) 
9) Yakkai Ilakkanam (Physical Constitution) 
10)  Gunam reference 
11) Duration of illness 
12) History of remission and relapse 
13) Clinical features 
14) Distributions  of three thodams 
15) UdarKattukkal reference 
16) En Vagaithervugal 
17) Neerkkuri reference 
18) Neikkuri reference 
19) Results 
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1)  Age Distribution 
  
Sl. No Age No of Cases Percentage 
1 20-30 12 30% 
2 31-40 15 37.5% 
3 41-50 10 25% 
4 51-60 3 7.5% 
 
 
 
  
 
 
Observation: 
 The patients were selected from all age groups as given above and the 
maximum numbers of Patients (15) were in the age between 31 and 40 Years. 
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2) Sex Distribution 
Sl. No Sex No of Cases Percentage 
1 Male 28 70% 
2 Female 12 30% 
 
   
  
 
 
Observation: 
  Among the 40 patients selected for this study, 70% were males and 30% 
werefemales. 
  
 
 
 
 
 
 
 
Female
30%
Male
70%
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3) Occupational Status 
Sl. No Nature of Work No. of Cases Percentage 
1 Teacher 3 7.5% 
2 Tailor 1 2.5% 
3 Student 4 10% 
4 Housewife 4 10% 
5 Driver 4 10% 
6 Shop keeper 3 7.5% 
7 IT professionals 2 5% 
8 Business 3           7.5% 
9 Engineer 4           10% 
10 Coolly 7         17.5% 
11 Clerk 1          2.5% 
12 Director 1          2.5% 
13 Electrician 3         7.5% 
 
 
 
Observation:  
 The majority of patients in this study were coolly, driver, homemakers and 
students. 
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4) Family History 
Sl. No Criteria No of Cases Percentage 
1 
 
Family History (+ve) 
 
4 10% 
2 
 
Family History (-ve) 
 
36 90% 
   
 
 
 
Observation: 
 In this study, 4 number (10%) of cases had positive family history. 
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5) Dietary Habits 
 
Sl. No Dietary Habits No of Cases Percentage 
1 Vegetarian 2 5% 
2 Non Vegetarian 38 95% 
 
 
 
 
Observation: 
 In this study only 5% of Patients were Vegetarian. 
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6) Thinai Reference 
 
Sl. 
No 
Thinai No. of Cases Percentage 
1 Kurinji (Hill Area) 4 10% 
2 Mullai (Forest Area) - - 
3 Marutham (Fertile Land) 9 22.5% 
4 Neithal (Coastal Area) 27 67.5% 
5 Paalai (Desert Land) - - 
 
 
  
 
 
Observation: 
  In this study 67.5% of the patients were from neithal, 22.5% were from 
marutham and the remaining (10%) from Kurinji. 
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7) Paruvakaalam:  
 
S.no Kaalam distribution No of cases Percentage 
1. Kaar kaalam - - 
2. Koothir kaalam - - 
3. Munpani kaalam 1 2.5% 
4. Pinpani kaalam 26 65% 
5. Ilavenil kaalam 13 32.5% 
6. Muthuvenil - - 
 
  
 
 
Observation 
 Among40 patients, 65% of patients were admitted in Pinpani kaalam, 32.5% of 
patients in Ilavenil kaalam and 2.5% of patients in Munpani kaalam. 
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8)  Kaalam Distribution (According to Age) 
 In Siddha literature human life has been divided into three periods as follows 
1) Vaatham 
2) Pitham 
3) Kabam 
The duration of each period is said to be 33 years 
Sl No Kaalam No of Cases Percentage 
1 Vaatha Kaalam (1-33 Years) 15 37.5% 
2 Pitha  Kaalam (34-66 years) 25 62.5% 
3 Kaba Kaalam (67-100 years) - - 
 
 
  
Observation: 
 Out of 40 patients, 37.5% in Vaatha kaalam and the remaining 62.5% of 
patients reported in Pitha kaalam. 
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9) Yaakai Ilakkanam (Physical Constitution) 
 
Sl. No Yaakai Ilakkanam No. of Cases Percentage 
1 VaathaUdal - - 
2 PiththaUdal -             - 
3 KabaUdal - - 
4 ThonthaUdal 40 100% 
 
 
  
 
Observation: 
 All the patients (100%) had ThonthaUdal. 
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10) Gunam (Quality and Characters) 
 
Sl. No Gunam No of Cases Percentage 
1 Sathuva Gunam - - 
2 Rajo Gunam 40 100% 
3 Thamo Gunam - - 
  
 
 
  
 
Observation: 
 All the patients (100%) had “Rajo Gunam”. 
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11) Duration of Illness 
 
Sl. No Duration of Illness No of Cases Percentage 
1. 1-6 Months 8 20% 
2. 7 Months – 1 year 3 7.5% 
3. 2 years -5 year 15 37.5% 
4. 6 year – 10 year 10 25% 
5. > 10 year 4 10% 
 
 
 
 
Observation: 
 Among 40 patients 37.5% of cases were suffering in the duration of 2- 5 years, 
25% of cases suffering in the duration of 6-10 years, 7.5% were in the duration of 7 
months -1 year, 20 % of cases with the duration of 1-6 months, and 10% of cases in 
above 10 years duration.
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12) History of Remissions and Relapses 
 
Sl. No 
Remissions and 
relapses 
No of Cases Percentage 
1 Present 27 67.5% 
2 Absent 13 32.5% 
 
 
 
 
 
Observation: 
 In this study 67.5% of patients had remission and relapse. 
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13) Clinical Features: 
 
Sl. No Clinical Features No of Cases Percentage 
1 Scaling 40 100% 
2 Moderate itching 40 100% 
3 Scalp lesion 40 100% 
4 Auspitz sign 40 100% 
5 Candle Grease sign 40 100% 
6 Nail changes 2 5% 
7 Palm and sole lesions 4 10% 
8 Joint involvement 0 0% 
 
 
 
 
 
Observation: 
  Among 40 cases recruited, all the patients had clinical features of itching, 
scaling, Scalp lesion, Auspitz sign and Candle grease sign. 10% of patients had Palm 
and sole lesions, only 5% of cases had Nail changes.
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14) Distribution of Mukkutram 
The derangement of Vaatham, Pitham and Kabam in Kaalanjagapadai are as follows 
Vaatham 
 
Sl. No Classification of Vaatham No of Cases Percentage 
1 Praanan 0 0% 
2 Abaanan 5 12.5% 
3 Udhaanan 0 0% 
4 Samaanan 40 100% 
5 Viyaanan 40 100% 
6 Naagan 0 0% 
7 Koorman 0 0% 
8 Kirukaran 0 0% 
9 Devathaththan 0 0% 
10 Dananjayan 0 0% 
 
  
 
Observation:  
 Samaanan and Viyaanan were affected in all the 40 patients. Abaanan was 
affected in 12.5 % cases. 
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Pitham 
 
Sl. 
No 
Classification of Pitham 
No. of 
Cases 
Percentage 
1 Aakkanal 0 0% 
2 Vanna eri 0 0% 
3 Aatralangi 40 100% 
4 Nokkazhal 0 0% 
5 Olloli thee  40 100% 
 
   
 
 
Observation: 
 Olloli theeandAatralangi was affected in all the cases.  
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15) Udal Kattukkal 
 
Sl. No UdarKattukkl No of Cases Percentage 
1 Saaram 40 100% 
2 Senneer 40 100% 
3 Oon 0 0% 
4 Kozhuppu 0 0% 
5 Enbu 0 0% 
6 Moolai 0 0% 
7 Sukkilam/Suronitham 0 0% 
 
 
Observation: 
 Among the 40 patients, all of them were affected with Saaram and senneer. 
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16) Envagai Thervugal 
 
Sl. 
No 
Envagai Thervugal No. of Cases Percentage 
1 Naadi 
 
a. Vaathapitham 25 62.5% 
b. Pithavaatham 10 25% 
c. Pitha kabam 4 10% 
d. Kaba pitham 1 2.5% 
2 Sparisam 40 100.00% 
3 Naa 0 0.00% 
4 Niram 40 100.00% 
5 Mozhi 0 0.00% 
6 Vizhi 0 0.00% 
7 Malam 5 17.50% 
8 Moothiram 0 0.00% 
 
Observation 
 In Envagai thervugal, Niram and Sparisam were affected in all the 40 cases. 
The Naadinadai seen in Kaalanjagapadai patients were Vaathapitham 62.5%, 
Pithavaatham 25%, Pithakabam 10%, Kabapitham 2.5%. 
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17)  Neerkkuri, Neikkuri Reference  
 
Sl. 
No 
Type of Test No. of Cases Percentage 
1 
Neerkkuri: 
“ Niram” - straw yellow 40 100% 
2 
Neikkuri: 
(Vaatham) “AravanaNeendal” 
 
24 
 
60% 
(Piththam)“Aazhipol 
Paraviyathu” 
12 30% 
 
(Kabam) “Muththothu ninrathu” 
 
4 10% 
Others 0 0 
 
 
  
 
Observation:  
 Among 40 cases, 60 % of patients had Vaatha neer neikkuri, 30% hadPitha ner 
neikkuri and only 10% had Kaba neer neikkuri. 
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18) PASI SCORE  
 
S. 
No. 
OP NO. NAME 
AGE / 
SEX 
BT AT PASI RESULT 
1. IP 8702 Miss. Snekha kumari 22/F 52.8 4.6 PASI 75 GOOD 
2. IP 9400 Mr. Shakthi 38/M 53.2 30.3 PASI 25 MILD 
3. I 65155 Mr. Krishnan 32/M 55.4 12 PASI 75 GOOD 
4. IP 9489 Mr. Nandha kumar 38/M 40 20 PASI 50 MODERATE 
5. IP 9488 Mr. Raju 35/M 52.6 8 PASI 75 GOOD 
6. IP 9490 Mr. Pandiyan 48/M 48 32 PASI 25 MILD 
7. IP 8803 Mrs. Vairam 37/F 50.8 5.1 PASI 75 GOOD 
8. IP 9574 Mr. Selvam 58/M 42.2 29.8 PASI 25 MILD 
9. IP 9603 Mr. Manikandan 37/M 51 7.7 PASI 75 GOOD 
10. IP 9590 Mr. Kasiraj 32/M 45.4 6.2 PASI 75 GOOD 
11. IP 8960 Miss. Saranya 21/F 47.2 23.2 PASI 50 MODERATE 
12. IP 9632 Mr. Ramesh 45/M 43.8 20.1 PASI 50 MODERATE 
13. IP 9421 Mr. Boopathy 45/F 46.9 24.9 PASI 50 MODERATE 
14. I 54289 Miss. Latha 20/F 48.9 6.8 PASI 75 GOOD 
15. I 60874 Mrs. Rani 50/F 51.1 5.9 PASI 75 GOOD 
16. I 26349 Mrs. Saranya 26/F 47.7 7.4 PASI 75 GOOD 
17. I 34453 Mr. Selvam 40/M 53.5 39 PASI 25 MILD 
18. I 49777 Mr.Sivachandran 28/M 58.5 7.4 PASI 75 GOOD 
19. F 98782 Mr.Thirumurugan 58/M 45.9 6.5 PASI 75 GOOD 
20. I 52906 Mr. Muruganandham 26/M 43.2 7.2 PASI 75 GOOD 
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S. 
No. 
OP NO. NAME 
AGE / 
SEX 
BT AT PASI RESULT 
21. I 64432 Mr. Raman 53/M 41.6 7.2 PASI 75 GOOD 
22. I 57851 Mr. Rajinikanth 42/M 42 15.2 PASI 50 MODERATE 
23. I 70352 Mr. Ragupathi 36/M 45.1 7.1 PASI 75 GOOD 
24. D 001218 Mr. Bakya Raj 40/M 53 23.1 PASI 50 MODERATE 
25. H 33990 Mr. Ravi 42/M 42.6 6.3 PASI 75 GOOD 
26. I 56818 Mrs. Metha 36/F 55.4 11.8 PASI 75 GOOD 
27. I 63161 Mrs. Tamilarasi 28/F 57 25 PASI 50 MODERATE 
28. H 23026 Mr. Ansar Basha 46/M 56.8 26.8 PASI 50 MODERATE 
29. I 91916 Mr. Abdul 30/M 59.9 47 PASI 25 MILD 
30. H 25851 Mr. Balamurugan 36/M 56.4 38.5 PASI 25 MILD 
31. I 87278 Mr. Vijayakumar 35/M 40 8.6 PASI 75 GOOD 
32. H 82449 Mr. Siraj 39/M 53.4 7.5 PASI 75 GOOD 
33. I 87056 Mr. Muthukrishnan 41/M 51 10 PASI 75 GOOD 
34. I 57801 Mrs. Sivasuganthi 26/F 48.2 32.4 PASI 25 MILD 
35. I 65195 Mrs. Thillai 32/F 47 7.2 PASI 75 GOOD 
36. H 84477 Mis. Vasiya 21/F 56.6 8.2 PASI 75 GOOD 
37 F 68773 Mr. Chellam 47/M 43.2 6 PASI 75 GOOD 
38. I 16766 Miss. Pradeepa 29/F 52 4.8 PASI 75 GOOD 
39. I 60567 
Mr. Sivashankar 
Reddy 
27/M 46.4 10.8 PASI 75 GOOD 
40 H 49213 Mr. Sundaram 50/M 55.3 9 PASI 75 GOOD 
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19) RESULTS 
 
  
 
  
 
Observation:  
 The trial drug Karunchoorai chooranam (Internal) and Kodiveli thylam 
(External) 
Were given in 40 Patients for 40 days. Among 40 cases, 62.5 % of cases showed Good 
improvement, 20% of Patients showed Moderate improvement and only 17.5% of 
patients showed Mild improvement. 
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RESULTS
Sl. No Results 
No of Cases 
(Among the 40 
patients) 
Percentage 
1 Good 25 62.5% 
2 Moderate 8 20% 
3 Mild 7 17.5% 
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Mr. Kasiraj 32/M, PASI Score45.4 
 
Before Treatment 
Mr. Kasiraj 32/M, PASI Score 6.2 
 
After Treatment 
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Mrs. Thillai 32/F, PASI Score 47 
Before Treatment 
Mrs. Thillai 32/F, PASI Score 7.2 
After Treatment 
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INVESTIGATIONS BEFORE AND AFTER TREATMENT 
S. 
NO. 
IP / OP 
NO. 
NAME 
AGE / 
SEX 
Hb (gm/dl) 
TOTAL RBC 
COUNT 
(million/cu.mm) 
ESR 
(mm/hour) 
TOTAL 
WBC 
(cells/cu.mm) 
BT AT BT AT BT AT BT AT 
1 IP 8702 Miss. Snekhakumari 22/F 12.2 13.4 4.1 4.5 70/100 8/18 6300 7900 
2 IP 9400 Mr.Shakthi 38/M 16 16.2 5.1 5.3 4/8 2/4 7500 7700 
3 I 65155 Mr. Krishnan 32/M 15.8 16.4 4.7 5.2 8/12 4/6 6400 6800 
4 IP 9489 Mr.Nandhakumar 38/M 15.6 15.3 5.6 5.4 4/8 2/4 9000 9200 
5 IP 9488 Mr.Raju 35/M 13.8 13.6 4.5 4.7 30/62 8/16 9200 9600 
6 IP 9490 Mr.Pandiyan 48/M 16 16.2 5.2 5.2 12/18 4/8 8000 8200 
7 IP 8803 Mrs.Vairam 37/F 11.5 11.7 4.8 5.1 18/24 4/8 6700 7000 
8 IP 9574 Mr.Selvam 58/M 14.8 15.2 4.7 5.1 4/8 2/12 7300 7500 
9 IP 9603 Mr.Manikandan 37/M 16.2 16 5.2 5.4 4/8 4/8 7600 8000 
10 IP 9590 Mr.Kasiraj 32/M 15.4 15.6 5.1 4.8 2/4 4/12 9300 8900 
11 IP 8960 Miss. Saranya 21/F 11.2 12 4.7 4.9 12/16 4/8 6900 7100 
12 IP 9632 Mr. Ramesh 45/M 16.6 16.2 5.3 5.1 2/4 2/8 9400 8800 
13 IP 9421 Mr.Boopathy 45/F 15 14.8 5.1 4.9 12/20 2/4 8100 7900 
14 I 54289 Miss. Latha 20/F 13.3 12 4.5 4.0 2/4 12/18 6600 8100 
15 I 60874 Mrs. Rani 50/F 13.1 12.5 4.5 4.4 12/24 20/40 9900 7300 
16 I 26349 Mrs.Saranya 26/F 10.5 11.2 4.7 5.1 2/14 4/8 7200 6900 
17 I 34453 Mr.Selvam 40/M 16 13.8 5.1 4.5 6/14 20/40 8300 7900 
18 I 49777 Mr.Sivachandran 28/M 15.7 15.5 5.2 5.8 2/4 4/8 70000 7200 
19 F 98782 Mr.Thirumurugan 58/M 15.7 15.4 4.7 4.5 08/18 2/6 6600 6500 
20 I 52906 Mr.Muruganandham 26/M 15.9 15.5 5.4 5.2 6/14 4/8 10000 9600 
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INVESTIGATIONS BEFORE AND AFTER TREATMENT 
 
S.No. 
OP/IP 
No. 
NAME 
AGE / 
SEX 
Hb (gm/dl) 
TOTAL 
RBC 
COUNT 
(million / 
cu.mm) 
ESR 
(mm/hour) 
TOTAL WBC 
(cells / cu.mm) 
BT AT BT AT BT AT BT AT 
21. I 64432 Mr. Raman 53/M 14.6 15 4.7 4.6 4/8 8/12 9500 8400 
22. I 57851 Mr.Rajinikanth 42/M 13.8 14.2 4.8 5.2 2/4 8/12 8600 9200 
23. I 70352 Mr.Ragupathi 36/M 15.9 14.5 4.9 4.9 2/4 2/4 6400 6500 
24. 
D 
001218 
Mr.Bakya Raj 40/M 16.6 16.2 4.5 5.2 4/6 2/8 7000 6900 
25. H 33990 Mr. Ravi 42/M 15.9 15.4 5.3 5.1 2/4 2/4 8400 7600 
26. I 56818 Mrs.Metha 36/F 12.8 13 4.5 4.5 10/20 2/8 7500 7800 
27. I 63161 Mrs.Tamilarasi 28/F 12.2 14 4.3 4.5 12/24 2/4 10700 9500 
28. H 23026 Mr.AnsarBasha 46/M 15 14.7 5.2 5.0 2/4 6/12 5900 6500 
29. I 91916 Mr. Abdul 30/M 13.8 15.0 4.7 4.6 4/8 4/6 6200 6400 
30. H 25851 Mr.Balamurugan 36/M 16.2 16.2 5.3 5.5 20/40 10/20 7700 5000 
31. I 87278 Mr.Vijaykumar 35/M 16 16.2 5.3 5.2 2/4 2/8 9700 9600 
32. H 82449 Mr.Siraj 39/M 15.6 14.8 5.1 5.3 2/4 2/4 8500 8400 
33. I 87056 Mr.Muthukrishnan 41/M 16 15.6 4.9 5.1 8/16 4/8 6200 6600 
34. I 57801 Mrs.Sivasuganthi 26/F 13.7 12.9 4.9 4.7 10/20 24/50 8000 7500 
35. I 65195 Mrs.Thillai 32/F 11.2 11.5 4.3 4.4 30/62 52/102 11100 114 
36. H 84477 Mrs.Vasiya 21/F 13.8 13.8 5.2 5.4 50/100 8/12 9200 8600 
37 F 68773 Mrs.Chellam 47/M 14.8 15.2 5.1 5.6 4/8 4/8 7700 7500 
38. I 16766 Miss. Pradeepa 29/F 15.9 15.4 5.8 5.6 6/12 6/12 6800 6600 
39. I 60567 
Mrs.Sivashankar 
Reddy 
27/M 15.8 16 5.2 5.8 2/4 4/8 7200 7800 
40 H 49213 Mr.Sundaram 50/M 16.2 16.2 5.3 5.5 20/40 10/20 7700 5000 
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INVESTIGATIONS BEFORE AND AFTER TREATMENT 
 
S. No. OP / IP No. NAME 
AGE / 
SEX 
SGOT 
(IU/L) 
SGPT 
(IU/L) 
Alkaline 
phosphatase 
BT AT BT BT AT BT 
1 IP 8702 Miss. Snekhakumari 22/F 31 31 23 23 109 109 
2 IP 9400 Mr.Shakthi 38/M 25 26 26 30 80 90 
3 I 65155 Mr. Krishnan 32/M 37 35 33 30 85 82 
4 IP 9489 Mr.Nandhakumar 38/M 20 20 30 35 110 120 
5 IP 9488 Mr.Raju 35/M 20 20 30 30 110 110 
6 IP 9490 Mr.Pandiyan 48/M 26 26 30 35 98 110 
7 IP 8803 Mrs.Vairam 37/F 20 20 30 30 150 150 
8 IP 9574 Mr.Selvam 58/M 20 20 26 28 105 110 
9 IP 9603 Mr.Manikandan 37/M 33 35 25 26 130 130 
10 IP 9590 Mr.Kasiraj 32/M 38 38 23 23 150 150 
11 IP 8960 Miss. Saranya 21/F 30 30 35 35 110 110 
12 IP 9632 Mr. Ramesh 45/M 17 21 11 115 87 92 
13 IP 9421 Mr.Boopathy 45/F 20 25 30 30 90 95 
14 I 54289 Miss. Latha 20/F 30 30 35 35 110 110 
15 I 60874 Mrs. Rani 50/F 28 25 36 36 95 89 
16 I 26349 Mrs.Saranya 26/F 32 30 39 40 85 88 
17 I 34453 Mr.Selvam 40/M 19 17 15 14 95 107 
18 I 49777 Mr.Sivachandran 28/M 24 25 35 37 87 86 
19 F 98782 Mr.Thirumurugan 58/M 16 14 20 18 99 97 
20 I 52906 Mr.Muruganandham 26/M 40 40 35 38 90 95 
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INVESTIGATIONS BEFORE AND AFTER TREATMENT 
          
S.No. OP/IP No. NAME 
AGE 
/ SEX 
SGOT (IU/L) SGPT (IU/L) 
Alkaline 
phosphatase 
BT AT BT AT BT AT 
21. I 64432 Mr. Raman 53/M 20   18 24  22  82  90  
22. I 57851 Mr.Rajinikanth 42/M 16  18  20  22  64  65  
23. I 70352 Mr.Ragupathi 36/M 22 21 46 44 61 71 
24. D 001218 Mr.Bakya Raj 40/M 16  22  13  26  97  112  
25. H 33990 Mr. Ravi 42/M 16  14  18  20  80  83  
26. I 56818 Mrs.Metha 36/F 16 18 16 12 78 85 
27. I 63161 Mrs.Tamilarasi 28/F 19 25 23 18 75 80 
28. H 23026 Mr.AnsarBasha 46/M 16 16 16 23 43 35 
29. I 91916 Mr. Abdul 30/M 20  20  25  35  90  110  
30. H 25851 Mr.Balamurugan 36/M 18 25 24 25 76 60 
31. I 87278 Mr.Vijaykumar 35/M 16 18 16 19 74 85 
32. H 82449 Mr.Siraj 39/M 20  30  30  35  90  110  
33. I 87056 Mr.Muthukrishnan 41/M 18  18  25  36  110  120  
34. I 57801 Mrs.Sivasuganthi 26/F 22 19 26 11 118 95 
35. I 65195 Mrs.Thillai 32/F 09 12 15 14 60 67 
36. H 84477 Mrs.Vasiya 21/F 29  34  36  35  100  110  
37 F 68773 Mrs.Chellam 47/M 20  30  35  20  110  120  
38. I 16766 Miss. Pradeepa 29/F  23  20 21  19  90  85  
39. I 60567        Mr.Sivashankar Reddy 27/M 21  25  19  21   101  120 
40 H 49213 Mr.Sundaram 50/M 20 23 20 16 71 56 
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INVESTIGATIONS BEFORE AND AFTER TREATMENT 
 
 
        
S.NO. IP/OP NO NAME 
AGE / 
SEX 
TOTAL 
BILIRUBIN 
DIRECT 
BILIRUBIN 
INDIRECT 
BILIRUBIN 
BT AT BT AT BT AT 
21. I 64432 Mr. Raman 53/M 0.3  0.4 0.2  0.2  0.4  0.3  
22. I 57851 Mr.Rajinikanth 42/M 0.8  0.7  0.7  0.6  0.5  0.5  
23. I 70352 Mr.Ragupathi 36/M 0.5 0.5 0.2 0.2 0.3 0.3 
24. D 001218 Mr.Bakya Raj 40/M 1.0  0.9  0.8  0.9  0.6  0.7  
25. H 33990 Mr. Ravi 42/M 0.8  0.8  0.1  0.1  0.8  0.8  
26. I 56818 Mrs.Metha 36/F 0.9 0.6 0.4 0.2 0.5 0.3 
27. I 63161 Mrs.Tamilarasi 28/F 0.7 0.5 0.3 0.2 0.4 0.2 
28. H 23026 Mr.AnsarBasha 46/M 1.2 1.6 0.5 0.6 0.7 1.0 
29. I 91916 Mr. Abdul 30/M 0.4  0.4  0.3  0.4  0.6  0.7  
30. H 25851 Mr.Balamurugan 36/M 1.1 1.6 0.4 0.5 0.7 1.1 
31. I 87278 Mr.Vijayakumar 35/M 0.5 0.3 0.2 0.2 0.3 0.2 
32. H 82449 Mr.Siraj 39/M 0.8   0.2  0.1  0.3  0.4  0.4  
33. I 87056 Mr.Muthukrishnan 41/M 0.8  0.8  0.3  0.8  0.3  0.3  
34. I 57801 Mrs.Sivasuganthi 26/F 06 0.6 0.2 0.3 0.4 0.3 
35. I 65195 Mrs.Thillai 32/F 0.3 0.5 0.1 0.2 0.9 0.3 
36. H 84477 Mrs.Vasiya 21/F  1 0.8  1.1  0.6  0.4  0.6  
37 F 68773 Mrs.Chellam 47/M  0.3 0.4  0.2  0.6  0.4  0.4  
38. I 16766 Miss. Pradeepa 29/F  1.9 1.7  0.5  0.5  1.4  1.4  
39. I 60567 
Mrs.Sivashankar 
Reddy 
27/M 0.4  0.3  0.2  0.1  0.2  0.2  
40 H 49213 Mr.Sundaram 50/M 0.4 0.9 0.2 0.4 0.2 0.5 
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INVESTIGATIONS BEFORE AND AFTER TREATMENT 
 
 
        
S. NO. IP / OP NO. NAME 
AGE 
/ 
SEX 
TOTAL 
BILIRUBIN 
DIRECT 
BILIRUBIN 
INDIRECT 
BILIRUBIN 
BT AT BT AT BT AT 
1 IP 8702 Miss. Snekhakumari 22/F 0.8 0.6 0.2 0.2 0.6 0.6 
2 IP 9400 Mr.Shakthi 38/M 0.3 0.4 0.3 0.4 0.4 0.6 
3 I 65155 Mr. Krishnan 32/M 0.9 0.5 0.3 0.3 0.6 0.6 
4 IP 9489 Mr.Nandhakumar 38/M 0.8 0.8 1 1 0.5 0.7 
5 IP 9488 Mr.Raju 35/M 0.7 0.7 0.1 0.1 0.3 0.4 
6 IP 9490 Mr.Pandiyan 48/M 0.4 0.4 0.8 0.8 0.7 0.8 
7 IP 8803 Mrs.Vairam 37/F 0.3 0.4 0.1 0.2 0.3 0.4 
8 IP 9574 Mr.Selvam 58/M 1 1 1 1 0.8 0.7 
9 IP 9603 Mr.Manikandan 37/M 0.6 0.8 0.8 0.8 0.4 0.5 
10 IP 9590 Mr.Kasiraj 32/M 1 1 1 1 0.3 0.3 
11 IP 8960 Miss. Saranya 21/F 0.7 0.6 0.6 0.7 0.6 0.6 
12 IP 9632 Mr. Ramesh 45/M 0.5 03 0.2 0.2 0.3 0.2 
13 IP 9421 Mr.Boopathy 45/F 0.9 0.9 1 0.9 0.6 0.6 
14 I 54289 Miss. Latha 20/F 0.8 0.7 1 0.8 0.6 0.7 
15 I 60874 Mrs. Rani 50/F 0.8 0.7 0.6 0.8 0.4 0.7 
16 I 26349 Mrs.Saranya 26/F 0.6 0.8 0.6 0.7 0.7 0.6 
17 I 34453 Mr.Selvam 40/M 0.2 0.3 0.1 0.1 0.3 0.2 
18 I 49777 Mr.Sivachandran 28/M 0.9 1 0.7 1.2 0.4 0.5 
19 F 98782 Mr.Thirumurugan 58/M 0.5 0.5 0.2 0.2 0.3 0.3 
20 I 52906 Mr.Muruganandham 26/M 0.8 0.7 0.6 0.7 0.3 0.3 
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INVESTIGATIONS BEFORE AND AFTER TREATMENT 
S. 
No. 
OP / IP No. NAME 
AGE 
/ SEX 
BLOOD (mg/dl) 
UREA  
CREATI
NINE 
(mg/dl) 
FASTING 
(mg/dl) 
POST 
PRANDIA
L(mg/dl) 
BT AT BT AT BT AT BT AT 
1 IP 8702 Miss. Snekhakumari 22/F 99 90 121 121 18 18 0.8 0.8 
2 IP 9400 Mr.Shakthi 38/M 80 84 110 120 16 18 0.6 0.7 
3 I 65155 Mr. Krishnan 32/M 82 80 101 100 20 18 0.8 0.6 
4 IP 9489 Mr.Nandhakumar 38/M 108 110 145 130 14 18 0.7 0.7 
5 IP 9488 Mr.Raju 35/M 100 100 120 120 18 17 0.8 0.7 
6 IP 9490 Mr.Pandiyan 48/M 80 90 110 110 18 18 0.8 0.7 
7 IP 8803 Mrs.Vairam 37/F 80 90 110 120 16 18 0.7 0.6 
8 IP 9574 Mr.Selvam 58/M 80 90 135 130 18 18 0.8 0.8 
9 IP 9603 Mr.Manikandan 37/M 80 85 110 110 18 16 0.8 1 
10 IP 9590 Mr.Kasiraj 32/M 90 95 130 130 18 18 0.8 0.7 
11 IP 8960 Miss. Saranya 21/F 80 80 130 135 18 16 0.7 0.6 
12 IP 9632 Mr. Ramesh 45/M 93 110 120 128 14 12 1.1 1.0 
13 IP 9421 Mr.Boopathy 45/F 90 100 110 110 18 16 0.8 0.7 
14 I 54289 Miss. Latha 20/F 80 90 130 130 16 14 0.7 0.8 
15 I 60874 Mrs. Rani 50/F 85 90 120 140 16 14 0.5 0.6 
16 I 26349 Mrs.Saranya 26/F 110 100 130 130 16 16 0.5 0.6 
17 I 34453 Mr.Selvam 40/M 77 88.5 82 99 15 9 1 1 
18 I 49777 Mr.Sivachandran 28/M 90 90 100 110 16 15 0.7 0.8 
19 F 98782 Mr.Thirumurugan 58/M 110 100 148 128 20 18 0.8 0.6 
20 I 52906 Mr.Muruganandham 26/M 99 90 121 21 18 16 0.8 0.7 
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INVESTIGATIONS BEFORE AND AFTER TREATMENT 
 
           
S.No. OP/IP No. NAME 
AGE 
/ SEX 
BLOOD (mg/dl) 
UREA  
CREATININE 
(mg/dl) FASTING 
(mg/dl) 
POST 
PRANDIAL 
(mg/dl) 
BT AT BT AT BT AT BT AT 
21. I 64432 Mr. Raman 53/M 90  100  100  124  35  26  0.8  0.7  
22. I 57851 Mr.Rajinikanth 42/M 94  90  120  124  17  14  0.8  0.7  
23. I 70352 Mr.Ragupathi 36/M 100 110 128 140 14 15 1.1 0.8 
24. D 001218 Mr.Bakya Raj 40/M 100   95 127  121  18  20  0.7  0.9  
25. H 33990 Mr. Ravi 42/M 95  93  106  108  16  19  0.8  0.8  
26. I 56818 Mrs.Metha 36/F 91 100 125 140 06 11 0.6 0.9 
27. I 63161 Mrs.Tamilarasi 28/F 104 110 119 99 11 14 0.8 1.1 
28. H 23026 Mr.AnsarBasha 46/M 97 91 116 91 28 29 1.1 1.0 
29. I 91916 Mr. Abdul 30/M  90  100 110  110  18  18  0.7  0.8  
30. H 25851 Mr.Balamurugan 36/M 109 103 113 129 10 07 1.0 0.9 
31. I 87278 Mr.Vijaykumar 35/M 93 110 120 126 18 16 1.0 1.0 
32. H 82449 Mr.Siraj 39/M  100 100  120  130  18  19  0.8  0.1  
33. I 87056 Mr.Muthukrishnan 41/M 90  100  120  140  16  16  0.8  0.8  
34. I 57801 Mrs.Sivasuganthi 26/F 98 86 108 79 14 14 0.8 0.9 
35. I 65195 Mrs.Thillai 32/F 100 86 174 193 09 12 0.8 0.8 
36. H 84477 Mrs.Vasiya 21/F 80  75  110  130  18  16  1  0.8  
37 F 68773 Mrs.Chellam 47/M 80  90  110   120  18 18  0.7  1  
38. I 16766 Miss. Pradeepa 29/F  90  110 120  140  18  19  0.4  0.7  
39. I 60567 Mr.Sivashankar Reddy 27/M 95  90  115  110  17  15  0.8  0.6  
40 H 49213 Mr.Sundaram 50/M 100 93 193 147 20 19 1.1 1.2 
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INVESTIGATIONS BEFORE AND AFTER TREATMENT 
              
S. 
No. 
OP / IP 
No. 
NAME 
AGE 
/ 
SEX 
URINE   
SUGAR 
(F) 
URINE 
SUGAR 
(PP) 
ALBUMIN 
DEPOSITS 
Epithelial 
cells 
Pus cells 
BT AT BT AT BT AT BT AT BT AT 
1 IP 8702 Miss. Snekhakumari 22/F NIL NIL NIL NIL NIL NIL  2-3 2-3  2-3  2-3  
2 IP 9400 Mr.Shakthi 38/M NIL NIL NIL NIL NIL NIL  4-6 4-6  2-3  2-3  
3 I 65155 Mr. Krishnan 32/M NIL NIL NIL NIL NIL NIL 2-3  2-4  2-6  2-6  
4 IP 9489 Mr.Nandhakumar 38/M NIL NIL NIL NIL NIL NIL 4-6  4-6  2-3  2-3  
5 IP 9488 Mr.Raju 35/M NIL NIL NIL NIL NIL NIL 4-6  4-6  2-3  2-3  
6 IP 9490 Mr.Pandiyan 48/M NIL NIL NIL NIL NIL NIL 4-6  4-6  2-3  2-3  
7 IP 8803 Mrs.Vairam 37/F NIL NIL NIL NIL NIL NIL 4-6  3-5  2-3  2-3  
8 IP 9574 Mr.Selvam 58/M NIL NIL NIL NIL NIL NIL 4-6  2-3  3-5  3-5  
9 IP 9603 Mr.Manikandan 37/M NIL NIL NIL NIL NIL NIL  2-3 3-6  3-6  3-5  
10 IP 9590 Mr.Kasiraj 32/M NIL NIL NIL NIL NIL NIL  3-6 3-6  2-3  2-3  
11 IP 8960 Miss. Saranya 21/F NIL NIL NIL NIL NIL NIL 4-6  4-5  2-3  2-3  
12 IP 9632 Mr. Ramesh 45/M NIL NIL NIL NIL NIL NIL 3-5 2-4 1-2 1-2 
13 IP 9421 Mr.Boopathy 45/F NIL NIL NIL NIL NIL NIL  4-6 4-5  2-3  3-4  
14 I 54289 Miss. Latha 20/F NIL NIL NIL NIL NIL NIL  4-6 4-6  2-3  3-4  
15 I 60874 Mrs. Rani 50/F NIL NIL NIL NIL NIL NIL 3-5  4-6  2-3  4-5  
16 I 26349 Mrs.Saranya 26/F NIL NIL NIL NIL NIL NIL 3-5  3-5  4-6  2-3  
17 I 34453 Mr.Selvam 40/M NIL NIL NIL NIL NIL NIL 1-2 2-3 2-4  6-7  
18 I 49777 Mr.Sivachandran 28/M NIL NIL NIL NIL NIL NIL 4-6  4-6  2-3  2-3  
19 F 98782 Mr.Thirumurugan 58/M NIL NIL NIL NIL NIL NIL 2-3  2-3  2-3  2-3  
20 I 52906 Mr.Muruganandham 26/M NIL NIL NIL NIL NIL NIL 3-5  4-6  2-3  3-5  
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INVESTIGATIONS BEFORE AND AFTER TREATMENT 
              
S.N
o. 
OP/IP No. NAME 
AGE / 
SEX 
URINE 
SUGAR(
F) 
URINE 
SUGAR 
(PP) 
ALBUMI
N 
DEPOSITS 
Epithelial 
cells 
Pus cells 
BT AT BT AT BT AT BT AT BT AT 
21. I 64432 Mr. Raman 53/M Nil Nil Nil Nil Nil Nil 4-6  4-8  2-4  1-2  
22. I 57851 Mr.Rajinikanth 42/M Nil Nil Nil Nil Nil Nil  2-4 2-4  1-2  1-2  
23. I 70352 Mr.Ragupathi 36/M Nil Nil Nil Nil Nil Nil 1-2  1-2  1-2  1-3  
24. D001218 Mr.Bakya Raj 40/M Nil Nil Nil Nil Nil Nil 3-6  3-5  2-4  2-4  
25. H 33990 Mr. Ravi 42/M Nil Nil Nil Nil Nil Nil  3-6 3-5  2-4  2-4  
26. I 56818 Mrs.Metha 36/F Nil Nil Nil Nil Nil Nil 1-2 1-3 2-3 2-4 
27. I 63161 Mrs.Tamilarasi 28/F Nil Nil Nil Nil Nil Nil 2-4 1-2 2-4 2-4 
28. H 23026 Mr.AnsarBasha 46/M Nil Nil Nil Nil Nil Nil 2-4  6-8  2-4  8-10 
29. I 91916 Mr. Abdul 30/M Nil Nil Nil Nil Nil Nil 4-6 4-6  2-3  2-3  
30. H 25851 Mr.Balamurugan 36/M Nil Nil Nil Nil Nil Nil 1-2 1-2 1-2 3-5 
31. I 87278 Mr.Vijaykumar 35/M Nil Nil Nil Nil Nil Nil  6-7 4-6  4-5  3-5  
32. H 82449 Mr.Siraj 39/M Nil Nil Nil Nil Nil Nil 2-3  2-3  4-6  4-6  
33. I 87056 Mr.Muthukrishnan 41/M Nil Nil Nil Nil Nil Nil  4-6 4-6  2-3  3-5  
34. I 57801 Mrs.Sivasuganthi 26/F Nil Nil Nil Nil Nil Nil  2-3  2-4  1-2  2-4 
35. I 65195 Mrs.Thillai 32/F Nil Nil Nil Nil Nil Nil 3-5 2-3 3-5 1-2 
36. H 84477 Mrs.Vasiya 21/F Nil Nil Nil Nil Nil Nil  4-6 2-3 4 -6 2-3  
37 F 68773 Mrs.Chellam 47/M Nil Nil Nil Nil Nil Nil 4-6  2-6 2-3 3-4 
38. I 16766 Miss. Pradeepa 29/F Nil Nil Nil Nil Nil Nil  4-6 5-6  2-3  2-3  
39. I 60567 
Mr.Sivashankar 
Reddy 
27/M Nil Nil Nil Nil Nil Nil  4-6 4-6  2-3  2-3  
40 H 49213 Mr.Sundaram 50/M Nil Nil Nil Nil Nil Nil 1-2 2-4 2-4 2-4 
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STATISTICAL ANALYSIS 
All collected data were entered into MS Excel software using different columns 
as variables and rows as patients. SPSS software was used to perform statistical 
analysis. Basic descriptive statistics include frequency distributions and cross-
tabulations were performed. The quantity variables were expressed as Mean ± Standard 
Deviation and qualitative data as percentage. A probability value of <0.05 was 
considered to indicate as statistical significance. Paired„t‟ test was performed for 
determining the significance between before and after treatment.  
 
Paired Sample Statistics (PASI Score Before Treatment and After Treatment) 
 
Variable Obs Mean±SD t Value p Value 
Before treatment 40 49.52±5.52 
t=18.93 p <0.0001) 
After treatment 40 15.41±11.52 
 
The mean± standard deviation of PASI score at before and after treatment were 
49.52±5.52and 15.41±11.52 respectively which is considered extremely significant 
(t=18.93, p=0.0001). 
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DISCUSSION 
 
 Kaalanjaga padai (Psoriasis) is one of the commonest dermatological disease 
which affects population. It is a chronic, inflammatory and proliferative skin disease 
with scalingand itching.  
 Eventhough, Kaalanjaga padai is non-contagious disease, the affected 
(Psoriasis) patients are psychological impactedwith self-consciousness, frustration and 
excommunication from the family/society shame, often leading to severe mental 
depression. Remissions and relapse of this disease is quite common and there is no 
specific treatment available in other systems of medicine. However encouraging 
results are obtained in our Siddha system. With this background the disease 
Kaalanjagapadai was chosen for the dissertation work.  
 The Biochemical, study of the trial drug were done and the results were 
documented. The Bio-chemical analysis of Karunchoorai Chooranam had shown the 
presence of Sulphate, Chloride, Carbonate, Iron, Calcium, Pottasium, Phosphate, 
Reducing Sugar, Starch and Alkaloids. 
 For this dissertation study, 40 patients were selected, 27 patients were treated 
in the Outpatient department of Sirappu Maruthuvam and 13 patients were admitted in 
the IP department of Sirappu Maruthuvam, in AyothidossPandithar Hospital - National 
Institute of Siddha, Tambaram Sanatorium, Chennai –600 047. 
 Based on various criteria, the data were collected and tabulated. The criteria 
were age distribution, sex predominance, family history, dietary habits and incidence 
of the disease with reference to thinai, seasonal variation, clinical manifestations and 
assessment of the improvement in the prognosis of the disease with the trial drug. 
 In this trial 40 cases were selected. Among 40 patients 15 (37.5%) patients 
between 31 and 40 years, 12 (30%) patients between 20 and 30 years, 10 (25%) 
patients between 41 and 50 years, 3 (7.5%) patients between 51 and 60 years. In this 
present study, considerable numbers of patients were reported (15 patients) between 
the age of 31-40 among study sample. 
 40 patients of both genders were recruited for this study. Among the 40 cases, 
28 (70%) were males and 12 (30%) were females. Generally Kaalanjaga padai occurs 
with almost equal frequency in males and females.In this study, more number of Male 
cases were reported. 
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 Among 40 cases recruited to this study, 4 number of cases had family history 
of psoriasis. Recent studies regarding psoriasis also emphasize on this concept that 
psoriasis has a genetic predisposition. 
 In this study only 2 (5%) patients were vegetarian, and remaining 38(95%) 
patients were non vegetarian. 
  In this present study, considerable numbers of patients were reported from 
neithal(67.5%), marutham(22.5%), and kurinjithinai(10%).  Highest number of 
patients 26 (65%) were admitted during Pinpani Kaalam (Maasi&Panguni).  
 Among 40 cases, all cases had itching and scaling which were markedly 
reduced after the treatment. 
 Laboratory investigations were done for all the cases before and after 
treatment. There were no variations in hepatic, renal and other parameters. 
 In Siddha System, the first day of treatment is necessary to balancing the 
vitiatedkutram. Hence Meganathakuligai2 tablets with Hot water was given for 
Viresanam (Purgation) in the early morning to normalize the vitiated 
vaathakutram.During the treatment, the patients were advised to follow pathiyam 
(Dietary regimen). 
Internal Drug:Karunchoorai chooranam- 2gmb.dwith ghee. 
External Drug: Kodivelithylam- q.sfor external application. 
 The outcome of this studywas clinically observed by PASI Score, which 
showed encouraging results of good improvement in 25 patients (62..5%), moderate 
improvement in 8 patients (20%), and mild improvement in 7 (17.5%)  of total 40 
cases.  
 In this study, no adverse events were observed during the course of the 
treatment. At the time of discharge, all the patients were advised to attend Out-Patient 
Department of Sirappu Maruthuvam of NIS for 6 months for follow-up treatment. 
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     SUMMARY 
   
The disease Kaalanjaga padai was taken for the clinical study with Karunchoorai 
Chooranam as internal medicine and Kodiveli Thylam as external application. For the 
clinical study, 40 cases were selected based on the approved protocol. 
            The trial was approved by the Institutional Ethical Committee (IEC) (Date of 
IEC Approval & its Number; 26-08-2015, NIS/IEC/9/2014-15/11). The trial was 
registered in Clinical Trial Registry of India (CTRI/2017/06/008923) Hence the study is 
safely executed on patients and there was no adverse drug reactions noted during the 
study period. 
 Out of the 40 cases, 27 cases were treated in OPD and remaining 13 cases were 
treated in IPD of Ayothidoss Pandithar Hospital of National Institute of Siddha, 
Chennai-47. The detailed study on Kaalanjaga padai with reference to its aetiology, 
pathogenesis, investigations, clinical features, diagnosis and treatment with trial drugs 
was done.  
The outcome results of my study was clinically observed by PASI SCORE that is 62.5% 
of cases had shown good improvement, 20% of cases had shown moderate improvement 
and remaining 17.5% of cases had shown mild improvement. 
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CONCLUSION 
 
This clinical study validated the Siddha herbal formulation of the trial drug 
“Karunchoorai Chooranam” is efficacy to human psoriatic population. It was found to 
be good resulting on Kaalanjaga padi patients in reducing clinical signs and symptoms 
like itching, scaling and erythema.  The literature evidence for this drug is Agasthiyar 
paripooranam -400which is well-known Shasthric preparation 
 In this study, no adverse reactions were reported. Hence, it is concluded that the 
trial drugs are clinically safe.  
 The cost of the trial medicines are low. These drugs are easily available and the 
dosage is also convenient. 
 The quantitative outcome of PASI score shows there is extremely significant 
reduction between at the commencement and end of the treatment i.e from 49.52 ±5.52 
to15.41 ± 11.52. The qualitative outcome shows there is 62.5% of cases shown good 
improvement, 20% of cases shown moderate improvement and 17.5 % shown mild 
improvement.The clinical trial conducted in selected patients was very much satisfactory 
and the results were encouraging. 
 From above results the trial drug of herbal formulation of “Karunchoorai 
chooranam” (Internal) and “Kodiveli thylam (External) are well responded in the 
treatment of Kaalanjaga padai. 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF SIDDHA DRUGS“KARUNCHOORAI 
CHOORANAM” (INTERNAL) AND “KODIVELI THYLAM” (EXTERNAL) IN THE 
TREATMENT OF   “KALANJAGAPADAI” (PSORIASIS) 
Principal Investigator: Dr.S.P.KOPPERUNDEVI 
 
FORM I - SCREENING & SELECTION PROFORMA 
 
1.SERIAL NO: …………………   2. OP /IP NO: ………………… 
3.NAME: ……………………………………      4. AGE/GENDER: ………….......  
5.OCCUPATION: ……………………        6.INCOME: ………………… 
 
INCLUSION CRITERIA 
 Erythema        YES\ NO 
 Thickness        YES\ NO  
 Scaling         YES\ NO 
 Itching :with or without       YES\ NO 
 Auspitz sign +        YES\ NO 
 Candle crease sign +       YES\ NO 
 Age : 20-60 years       YES\ NO 
 Sex : Both male and female      M \ F 
 Willing to attend OPD or admission in IPD for the trial  YES\ NO 
 Willing to give specimen of blood for the investigation   YES\ NO 
 Willingness for consent       YES\ NO 
 Willing to take photograph before and after treatment.             YES\ NO 
 
EXCLUSION CRITERIA 
 Insulin Dependent Diabetes Mellitus    YES\ NO 
 Hansen‟s disease       YES\ NO 
 Pregnancy and lactation      YES\ NO 
 Psoriasis with evidence of any other skin disease  YES\ NO 
 Psoriatic arthropathy      YES\ NO 
 Cardiac disease       YES\ NO 
 Any  other chronic illness      YES\ NO 
 Evidences of secondary infection in the lesions   YES\ NO 
 
ADMITTED TO TRAIL 
YES  NO  
If Yes, OPD  IPD  
  Serial NO:  
 
Date:        
Station: 
Signature of the Investigator 
Signature of the Lecturer:                                             Signature of the HOD   
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
AN OPEN CLINICAL TRIAL OF SIDDHA DRUGS“KARUNCHOORAI 
CHOORANAM” (INTERNAL) AND “KODIVELI THYLAM” (EXTERNAL) IN THE 
TREATMENT OF   “KALANJAGAPADAI” (PSORIASIS) 
Principal Investigator: Dr.S.P.KOPPERUNDEVI 
 
FORM II-–HISTORY TAKING PROFORMA 
 
STUDY  NO:   OP / IP NO: 
NAME: AGE / GENDER: 
ADDRESS: CONTACT NO : 
 RELIGION :  H / C / M / O. 
OCCUPATION: INCOME: 
MARITAL STATUS :       1. Married 2. Unmarried 
DATE OF INTIAL ASSESSMENT:  
COMPLAINTS & DURATION:   
 
 
                                                                                                                            
PERSONAL HISTORY: 
PERSONAL HABITS YES NO 
IF YES 
SPECIFY 
DURATION 
AMOUNT/Qty 
Smoking     
Tobacco Chewing     
Alcohol     
Narcotic  Drug Addiction     
 
HISTORY OF PREVIOUS ILLNESS AND TREATMENT TAKEN: 
 
 
 
FAMILY HISTORY: 
Whether this problem runs in family? 1. Yes            2. No    
If yes, mention the relationship of affected 
person(s) 
1._________________ 
 
2._________________ 
 
DIETARY STYLE: 1. Vegetarian    2. Non-vegetarian 
MENSTURAL AND OBSTETRIC HISTORY:  
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FORM II B 
GENERAL EXAMINATION: 
1. Body weight [Kg]    :                      
2. Height [cms]                       :                        
3. Body Temperature [F]       :   
4. Blood Pressure (mm/Hg)  :      
5. Pulse Rate /min.   : 
6. Heart Rate / min.    : 
7. Respiratory Rate /min.  :   
Yes            No   
8. Pallor   :   
9. Jaundice   :   
10. Clubbing   : 
11. Cyanosis   : 
12. Pedal Oedema   : 
13. Lymphadenopathy      :  
14. Jugular venous pulsation  :   
SYSTEMIC EXAMINATION 
  Cardiovascular system   :  
  Respiratory system    :  
  Gastro-intestinal system   :  
  Central Nervous system   :  
  Urogenital system    :  
   Endocrine system               :  
SIDDHA SYSTEM OF EXAMINATION 
1. THEGI (BODY CONSTITUTION): 
1. Vathaudal 
2. Pithaudal 
3. Kabaudal 
4. Thonthaudal 
2. NILAM (LAND WHERE THE PATIENT LIVED MOST):  
1. Kurinji(Hilly terrain) 
2. Mullai (Forest range) 
3. Marutham (Plains) 
4. Neithal (Coastal belt) 
5. Paalai (Aridregion) 
3. KAALAM: 
1. Kaarkaalam (Aavani-Purattasi) 
2. Koothirkaalam (Ippasi-Kaarthigai) 
3. Munpanikaalam (Maargazhi-Thai) 
4. Pinpanikaalam (Maasi-Panguni) 
5. Ilavenilkaalam (Chithirai-Vaigasi) 
6. Muthuvenilkaalam (Aani-Aadi) 
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4. GUNAM: 
1. Sathuvam 
2. Rasatham 
3. Thamasam 
 
5. PORIPULANGAL (SENSORY ORGANS):          
 
 
 
 
 
 
 
 
 
6.KANMENDRIYAM (MOTOR ORGANS) : 
 
 
 
 
 
 
 
 
7. KOSANGAL (SHEATH):           
 
 
 
 
 
 
  
 
 
 
8. SEVEN UDAL THAATHUKKAL (SEVEN SOMATIC COMPONENTS) 
 
 Before treatment After treatment 
Saaram Normal  /Affected Normal  /Affected 
Senneer Normal  /Affected Normal  /Affected 
Oon Normal  /Affected Normal  /Affected 
Kozhuppu Normal  /Affected Normal  /Affected 
Enbu Normal  /Affected Normal  /Affected 
Moolai Normal  /Affected Normal  /Affected 
Sukkilam / Suronitham Normal  /Affected Normal  /Affected 
 
 Before treatment After treatment 
Mei (Skin) Normal  / Affected Normal  / Affected 
Vai (Tongue) Normal  / Affected Normal  / Affected 
Kann (Eye) Normal  / Affected Normal  / Affected 
Mooku (Nose) Normal  / Affected Normal  / Affected 
Sevi (Ear) Normal  / Affected Normal  / Affected 
 Before treatment After treatment 
Kai  Normal  /Affected Normal  /Affected 
Kaal Normal  /Affected Normal  /Affected 
Vai Normal  /Affected Normal  /Affected 
Eruvai Normal  /Affected Normal  /Affected 
Karuvai Normal  /Affected Normal  /Affected 
 Before treatment After treatment 
Annamayakosam Normal  /Affected Normal  /Affected 
Pranamayakosam Normal  /Affected Normal  /Affected 
Manomayakosam Normal  /Affected Normal  /Affected 
Vignanamayakosam Normal  /Affected Normal  /Affected 
Ananthamayakosam Normal  /Affected Normal  /Affected 
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9. UYIR THAATHUKKAL: [THREE HUMORS] (VALI/ AZHAL/ IYYAM) 
 
A) VALI 
 
 1
st 
day 8
th
 day 15
th
 day 22
nd
 day 29
th
 day 36
th
 day 43
rd
 day 49
th
 day 
Praanan         
Abaanan         
Udhaanan         
Viyaanan         
Samaanan         
Naagan         
Koorman         
Kirukaran         
Devathathan         
Dhananjeyan         
 
 
B) AZHAL 
 
 1
st
 day 8
th
 day 15
th
 day 22
nd
 day 29
th
 day 36
th
 day 43
rd
 day 49
th
 day 
Analakam         
Ranjakam          
Saathakam          
Prasakam          
Aalosakam         
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C) IYYAM 
 
 1
st
 day 8
th
 day 15
th
 day 22
nd
 day 29
th
 day 36
th
 day 43
rd
 day 49
th
 day 
Avalambagam         
Kilethagam         
Pothagam         
Tharpagam         
Santhigam         
 
 
10. ENVAGAI THERVU: [EIGHT TYPES OF EXAMINATION] 
 
I.NAADI: [PULSE PERCEPTION] 
 
NAADI 1
st
  day 8
th 
day
 
15
th 
day 22
nd
day 29
th
day 36
th
  day 43
rd
day 49
th
day 
         
 
II. SPARISAM: [PALPATION] 
 
Day SPARISAM 
1
st
 day  
8
th 
day
  
15
th
  day  
22
nd
  day  
29
th
  day  
36
th
  day  
43
rd
 day  
49
th 
day  
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III. NAA: [TONGUE] 
 
NAA 1
st
day 8
th
day
 
15
th
day 22
nd
day 29
th
day 36
th
day 43
rd
day 49
th
day 
         
 
IV.NIRAM: [COMPLEXION]   
 1. Vadham         
 2. Pitham 
 3. Kabam 
 
V.MOZHI: [VOICE] 
1. High Pitched 
      2. Low Pitched 
      3. Medium Pitched 
 
VI.VIZHI: [EYES] 
VIZHI 1
st
  day 8
th 
day
 
15
th
day 22
nd
day 29
th
day 36
th
  day 43
rd
day 49
th
day 
         
 
VII. MALAM: [BOWEL HABITS / STOOLS] 
 Before treatment After treatment 
Niram   
Irugal   
Ilagal   
Others   
 
VIII. MOOTHIRAM [URINE EXAMINATION]  
NEERKKURI: 
Neerkkuri Before treatment After treatment 
Niram   
Manam   
Edai   
Nurai   
Enjal   
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NEIKKURI:  
 
Neikkuri Before treatment After treatment 
Aravananeedathu/ 
Snake like pattern 
 
  
Azhipolparaviyathu 
Annular/Ringedpattern 
 
 
 
paravparaparavoiyadu 
  
Muththothuninrathu 
Pearlbeadepattern 
  
Other patterns   
 
11. CLINICAL EXAMINATION:        
 
   CLINICAL EXAMINATION OF SKIN 
 
1.Site 
2.Shape:        Coin shape                Irregular                  Dispersed  
3. Erythema           :     Present  Absent 
4. Macule              :   
5. Papule               : 
6. Pustule              :  
7. Itching:     No         Mild                  Moderate                 Severe 
8. Scaling:     Mild                    Moderate                 Severe 
9.Fissures           Present                      Absent 
10.Oozing:          No          Mild                  Moderate                Severe          
11.Lichenification:   Present                      Absent 
12. Auspitz sign      :  Present    Absent 
13. Koebner‟s phenomenon: Present     Absent 
14. Candle grease sign: Present     Absent 
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EXAMINATION OF NAILS: 
1.  Pitting:     Present  Absent 
2   Thickening:    Present                        Absent 
3.  Collection of Hyperkeratotic debris: Present            Absent 
4.  Separation of distal portion of nail: Present            Absent 
 
EXAMINATION OF JOINTS: 
                      YES                            NO 
                          Joint Involvement      
 
 
 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                        Signature of the HOD 
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PASI CALCULATION 
Plaque Characteristic Rating Score 
Body region and weighting factor 
Head 
Upper 
Limbs 
Trunk 
Lower 
Limbs 
Erythema 
  
0 = None         
Thickness 
1 = Slight 
        
2 = Moderate 
Scaling 
3 = Severe 
        
4 = Very Severe 
      Totals     
Weighting Factor     x 0.1    x 0.2   x 0.3 x 0.4 
Surface area totals     
  
Degree of involvement as  
% for each body region  
affected (score each  
region between 0 and 6) 
0 = None 
    
1 = 1-9% 
2 = 10-29% 
3 = 30-49% 
4 = 50-69% 
5 = 70-89% 
6 = 90-100% 
Surface area totals x % involvement totals 
Sum Scores above = 
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NATIONAL INSTITUTE OF SIDDHA. 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
AN OPEN CLINICAL STUDY OF SIDDHA DRUG “KARUNCHOORAI CHOORANAM” 
(INTERNAL) AND “KODIVELI THYLAM” (EXTERNAL) IN THE TREATMENT OF   
“KALANJAGAPADAI” (PSORIASIS) 
Principal Investigator:Dr.S.P.KOPPERUNDEVI 
 
FORM  -III   CLINICAL ASSESSMENT DURING & AFTER TRIAL 
 
1. OP/ IP NO: ………… 2. SL. NO: ……… 3.NAME: ………………………….          
4. AGE: ……… 5. GENDER: …...   6. DATE OF RECRUITMENT: …… 
 
 0
th
 day 8
th
 day 15
th
 day 22
nd
 day 29
th
 day 36
th
 day 43
th
 day 49
th
 day 
Shape         
Itching         
Scaling         
Erythema         
Macule         
Papule         
Pustules         
Oozing         
Thickening         
Pigmentation         
 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                         Signature of the HOD 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
AN OPEN CLINICAL TRIALOF SIDDHA DRUGS“KARUNCHOORAI CHOORANAM” 
(INTERNAL) AND “KODIVELI THYLAM” (EXTERNAL) IN THE TREATMENT OF   
“KALANJAGAPADAI” (PSORIASIS)  
 
Principal Investigator:Dr.S.P.KOPPERUNDEVI 
 
FORM-IV - LABORATORY INVESTIGATIONS 
 
BLOOD INVESTIGATIONS 
NORMAL 
VALUES 
BEFORE TMT 
( DATE) 
AFTER TMT 
(DATE) 
Hb (gm/dl) 
M:12-15 
W:11.5-12 
  
T.WBC (cells/cu.mm) 4000-11000   
DIFFERENTIAL 
COUNT (%) 
Polymorphs 40-75   
Lymphocytes 20-40   
Monocytes 2-10   
Eosinophils 1-6   
Basophils 0-1   
 
T.RBC(million cells/cu.mm) 
 
M:4.0-5.5 
W:3.5-4.5 
 
 
 
 
ESR(mm/hour) ½ hr. 
M:6-12 
W:7-18 
  
  1 hr.  
 
 
Blood glucose 
(mg/dl) 
Fasting 70-110   
PP 80-140   
Random 80-120   
RFT (mg/dl) 
Blood urea 16-50   
Serum Creatinine 0.6-1.2   
LFT (mg/dl) 
Total bilirubin 0.2-1.2   
Direct bilirubin 0.1-1.2   
Indirect bilirubin 0.2-0.7   
SGOT 0-40   
SGPT 0-35   
Alkaline 
phosphatase 
80-290   
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Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                         Signature of the HOD 
 
 
 
 
 
 
 
 
 
 
 
 
URINE INVESTIGATION BEFORE TMT( DATE) AFTER TMT ( DATE) 
Albumin   
Fasting sugar   
PP sugar   
Deposits   
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FORM –IV B - DRUG COMPLIANCE FORM 
 
On 1
st    
 day-Date:  Drugs issued: (Gms) Drugs returned:    (Gms) 
On 8
th
   day-Date:   Drugs issued: (Gms) Drugs returned:    (Gms) 
On 15
th
 day-Date:              Drugs issued: (Gms) Drugs returned:    (Gms) 
On 22
th
 day-Date:           Drugs issued: (Gms) Drugs returned:    (Gms) 
On 29
th
 day-Date:             Drugs issued: (Gms) Drugs returned:    (Gms) 
On 36
th
 day-Date:              Drugs issued: (Gms) Drugs returned:    (Gms) 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                          Signature of the HOD 
 
 
SERIAL NO: 
NAME:  
DRUG NAME:  
   Day    Date          Morning   Evening   Day    Date    Morning   Evening 
Day 1    Day21    
Day2    Day22    
Day3    Day23    
Day4    Day24    
Day5    Day25    
Day6    Day26    
Day7    Day27    
Day8    Day28    
Day9    Day29    
Day10    Day30    
Day11    Day31    
Day12    Day32    
Day13    Day33    
Day14    Day34    
Day15    Day35    
Day16    Day36    
Day17    Day37    
Day18    Day38    
Day19    Day39    
Day20    Day40    
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FORM-VI – CONSENT FORM 
 
 
“I have read the foregoing information, or it has been read to me. I have had 
the opportunity to ask questions about it and any questions I have asked have been 
answered to my satisfaction.  
            I consent voluntarily to participate as a participant in this study and understand 
that I have the   right to withdraw from the study at any time without in any way it 
affecting my further medical care”. 
 
"I have received a copy of the information sheet/consent form". 
 
Date:  
Signature of the participant 
In case of illiterate participant 
 
        “I have witnessed the accurate reading of the consent form to the potential 
participant, and the individual has had the opportunity to ask questions. I confirm 
individual has given consent freely.”                                                   
 
Date: 
 
 
Signature of a witness  
(Selected by the participant bearing no connection with the survey team)   
      
 
 
 
 
 
 
 
Left thumb Impressionofthe Participant 
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FORM -V -´ôÒ¾ø ÀÊÅõ 
 
                    ¬öÅ¡ÇÃ¡ø º¡ýÈÇ¢ì¸ôÀð¼Ð 
 
¿¡ý ¸¡Ç¡ïº¸ôÀ¨¼ ±ýÛõ §¿¡Â¢ý ¬ö¨Åì ÌÈ¢ò¾ «¨ÉòÐ 
Å¢ÀÃí¸¨ÇÔõ §¿¡Â¡Ç¢ìÌô ÒÃ¢Ôõ Å¨¸Â¢ø ±ÎòÐ¨Ãò§¾ý ±É 
¯Ú¾¢ÂÇ¢ì¸¢§Èý. 
 
§¾¾¢:                                  ¨¸¦Â¡ôÀõ:                    
þ¼õ:              ¦ÀÂ÷:                                                
                                      
§¿¡Â¡Ç¢Â¢ý ´ôÒ¾ø 
 ±ýÉ¢¼õ  þó¾  ÁÕòÐÅ  ¬öÅ¢ý  ¸¡Ã½ò¨¾Ôõ,  ÁÕó¾¢ý ¾ý¨Á  
ÁüÚõ ÁÕòÐÅ  ÅÆ¢Ó¨È  ÀüÈ¢Ôõ, ¦¾¡¼÷óÐ  ±ÉÐ  ¯¼ø  þÂì¸ò¨¾ì  
¸ñ¸¡½¢ì¸×õ, «¾¨Éô À¡Ð¸¡ì¸×õ ÀÂýÀÎõ  ÁÕòÐÅ  ¬ö×ìÜ¼  
ÀÃ¢§º¡¾¨É¸û  ÀüÈ¢  ¾¢Õô¾¢ «Ç¢ìÌõ  Å¨¸Â¢ø  ¬ö×  ÁÕòÐÅÃ¡ø  
Å¢Çì¸¢ì  ÜÈôÀð¼Ð. 
 ¿¡ý  þó¾  ÁÕòÐÅ  ¬öÅ¢ý  §À¡Ð, ±ô¦À¡ØÐ §ÅñÎÁ¡É¡Öõ  
þó¾  ¬öÅ¢Ä¢ÕóÐ   ±ý¨É Å¢ÎÅ¢òÐ  ¦¸¡ûÙõ  ¯Ã¢¨Á¨Âò 
¦¾Ã¢ó¾¢Õì¸¢ý§Èý. 
       ¿¡ý  ±ýÛ¨¼Â  Í¾ó¾¢ÃÁ¡¸ò  §¾÷×  ¦ºöÔõ  ¯Ã¢¨Á¨Âì  
¦¸¡ñÎ  ¸¡Ç¡ïº¸ôÀ¨¼ì¸¡½ ¸ÕïÝ¨Ã ÝÃ½õ (¯û ÁÕóÐ) ÁüÚõ  
¦¸¡Ê§ÅÄ¢ ¨¾Äõ 
(¦ÅÇ¢ ÁÕóÐ) ÁÕó¾¢ý ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ  ÁÕòÐÅ  ¬öÅ¢üÌ  
±ý¨É  ¯ðÀÎò¾ ´ôÒ¾ø  «Ç¢ì¸¢§Èý. 
 
§¾¾¢:                                       ¨¸¦Â¡ôÀõ : 
þ¼õ:                              ¦ÀÂ÷ :         
                                º¡ðº¢ì¸¡Ã÷¨¸¦Â¡ôÀõ : 
                                                   ¦ÀÂ÷:                         
                         ¯È×Ó¨È :  
Å¢Ã¢×¨ÃÂ¡Ç¡÷ ¨¸¦Â¡ôÀõ:         Ð¨Èò¾¨ÄÅ÷ ¨¸¦Â¡ôÀõ: 
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FORM VI - WITHDRAWAL FORM 
 
1. SERIAL NO OF THE CASE: …………………   
2. OP / IP NO: ......................................    
3. NAME: ………………………     
4.AGE: …………        
5.GENDER:...........                           
6. DATE OF TRIAL COMMENCEMENT: ………………... 
7. DATE OF WITHDRAWAL FROM TRIAL: …………….. 
8. REASONS FOR WITHDRAWAL: 
Long absence at reporting:               Yes/ No 
Irregular treatment:                           Yes/ No 
Shift of locality:                                    Yes/No 
Increase in severity of symptoms:     Yes/No 
Development of severe adverse drug reactions:   Yes/No 
Development of  adverse event :                                          Yes/No 
 
 
 
 
 
Date:          
Station: 
 
Signature of the Investigator: 
  
Signature of the Lecturer:                                                          Signature of the HOD 
  
150 
 
FORM-VII – INFORMATION SHEET 
 
Name of Principal Investigator  : Dr.S.P.Kopperundevi 
Name of the institute                   : National Institute of Siddha, 
                                                         Tambaram Sanatorium, 
                                                         Chennai-47. 
 
INFORMATION SHEET FOR PATIENTS PARTICIPATING IN THE OPEN 
CLINICAL TRIAL: 
I Dr.S.P.Kopperundevi Studying as PG Scholar at National Institute of  Siddha, 
Tambaram Sanatorium is doing a trial on the study Kaalaanjagappadai (Psoriasis). 
Psoriasis is a most common persistent skin disease, occurring throughout the world. In 
this regard, I am in a need to ask you few questions. I will maintain confidentiality of 
your comments and data obtained . There will be no risk of disclosing your identity and 
no physical, psychological or professional risk is involved by taking part in this study. 
Taking part in this study is voluntary. No compensation will be paid to you for  taking  
part in this study. 
           You can choose not to take part. You can choose not to answer a specific question. 
There is no specific benefit for you if you take part in the study. However, taking part in 
the study may be of benefit to the community, as it may help us to understand the 
problem of defaulters and potential solutions. 
             If you agree to be a participant in this study, you will be included in the study 
primarily by signing the consent form and then you will be given the internal medicine 
Karunchoorai chooranam (Internal medicine-2 gram BD with Ghee for 48 days) and 
Kodiveli thylam (External medicine), Treatment will be provided to you assuring that you 
will not be definitely hurt in any course of treatment. 
  The information I am collecting in this study will remain between you and the 
principal investigator (myself).  
            If you wish to find out more about this study before taking part, you can ask me 
all the questions you want or contact Dr.S.P.Kopperundevi, PG Scholar cum principal 
investigator of this study, attached to National Institute of Siddha, Chennai-47. You can 
also contact the Member-secretary of Ethics committee, National Institute 
Siddha,Chennai 600047, Tel no : 8056987496, for rights and participation in the study.             
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FORM-VII ¾¸Åø  ÀÊÅõ 
¸¡Ç¡ïº¸ôÀ¨¼ (§¾¡ø §¿¡ö) §¿¡öì¸¡É º¢ò¾ ÁÕóÐ¸Ç¢ý ¸ÕïÝ¨Ã 
ÝÃ½õ (¯ûÁÕóÐ) ÁüÚõ ¦¸¡Ê§ÅÄ¢ ¨¾Äõ (¦ÅÇ¢ ÁÕóÐ) ÀÃ¢¸Ã¢ôÒò 
¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢ü¸¡É ¾¸Åø ÀÊÅõ. 
 
Ó¾ý¨Á ¬Ã¡öîº¢Â¡Ç÷ ¦ÀÂ÷  : Dr. ¦º.À¢.§¸¡ô¦ÀÕó§¾Å¢ 
¿¢ÚÅÉò¾¢ý ¦ÀÂ÷             : §¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ, 
                               ¾¡õÀÃõ º¡Éð§¼¡Ã¢Âõ, ¦ºý¨É- 47. 
 
   §¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉò¾¢ø Àð¼ §ÁüÀÊôÒ ÀÂ¢ýÚ ÅÕõ ¿¡ý 
¸¡Ç¡ïº¸ôÀ¨¼ ±ýÛõ §¾¡¨Äô À¡¾¢ìÌõ §¿¡Â¢ø ÁÕòÐÅ ¬Ã¡öîº¢Â¢ø 
®ÎÀðÎû§Çý.  
   º¢ò¾ ÁÕòÐÅò¾¢ø ¸¡Ç¡ïº¸ôÀ¨¼ ±ýÛõ §¿¡Â¡ÉÐ §¾¡¨Äô À¡¾¢ìÌõ 
´Õ §¿¡Â¡Ìõ. þó¾ §¿¡Â¢ø §¾¡Ä¢ø º¢ÅôÒ ¿¢È ¾¢ðÎ¸¨Ç ²üÀÎò¾¢ «¾¢ø 
¦º¾¢ø §À¡ø ¯¾¢Ã ¦ºöÔõ º¢Ä ºÁÂõ «Ã¢ôÒ¼§É¡ «øÄÐ «Ã¢ôÀ¢ýÈ¢§Â¡ 
¸¡½ôÀÎõ. þÐ ÁüÈÅ÷¸ÙìÌô ÀÃÅ ÜÊÂ §¿¡ö «øÄ. þó¾ ¬Ã¡öîº¢ 
ºõÁó¾Á¡¸ º¢Ä §¸ûÅ¢¸¨Ç §¸ð¸×õ, §¾¡¨Ä ÀÃ¢§º¡¾¢ì¸×õ,§¾¨ÅÂ¡É 
¬öÅ¸ ÀÃ¢§º¡¾¨ÉìÌõ ¾í¸¨Ç ¯ðÀÎò¾×õ ¯û§Çý. 
   þó¾ ¬Ã¡öîº¢ìÌ ¾¡í¸û Å¢ÕôÀò¾¢ý §ÀÃ¢ø ¯ðÀÎõ Àðºò¾¢ø 
¯ûÁÕó¾¡¸ ¸ÕïÝ¨Ã ÝÃ½õ 2 ¸¢Ã¡õ «Ç× ¦¿öÂ¢ø 2 §Å¨Ç (¸¡¨Ä 
Á¡¨Ä) ¯½×ìÌô À¢ý 48 ¿¡ð¸ÙìÌ ¯ð¦¸¡ûÇ §ÅñÎõ. ¦ÅÇ¢ ÁÕó¾¡¸ 
¦¸¡Ê§ÅÄ¢ ¨¾Äõ 50-100 Á¢Ä¢ 48 ¿¡ð¸ÙìÌ §¿¡ÔûÇ þ¼í¸Ç¢ø ¦ÅÇ¢§Â 
¾¼Å §ÅñÎõ.¦ÅÇ¢ §¿¡Â¡Ç÷¸û 7 ¿¡ð¸ÙìÌ ´ÕÓ¨È ÁÕòÐÅÁ¨ÉìÌ 
ÅÃ§ÅñÎõ.  
   þÐ ºõÀó¾Á¡É ¾í¸ÇÐ «¨ÉòÐ Å¢ÅÃí¸Ùõ Ã¸º¢ÂÁ¡¸ ¨Åì¸ôÀÎõ ±É 
¯Ú¾¢ «Ç¢ì¸¢§Èý. þ¾¢ø ÀÂ½ôÀÊ Ó¾Ä¢Â ±ó¾ ¯¾Å¢ ¦¾¡¨¸Ôõ ÅÆí¸ôÀ¼ 
Á¡ð¼¡Ð. þó¾ ¬Ã¡öîº¢Â¢ý §À¡Ð ¯¼ÖìÌ §ÅÚ À¡¾¢ôÒ ²üÀÎõ Àðºò¾¢ø 
§¾º¢Â º¢ò¾ ÁÕòÐÅÁ¨ÉÂ¢ø ¾ì¸ Á¡üÚ º¢¸¢î¨º «Ç¢ì¸ôÀÎõ. þó¾ 
¬Ã¡öîº¢Â¢ø ¾í¸¨Ç ¯ðÀÎò¾¢Â À¢ÈÌ ¯í¸ÙìÌ Å¢ÕôÀÁ¢ø¨Ä¦ÂÉ¢ø 
±ô§À¡Ð §ÅñÎÁ¡É¡Öõ Å¢Ä¸¢ ¦¸¡ûÇ ÓØ ¯Ã¢¨Á ¯ûÇÐ. 
   þó¾ ¬Ã¡öîº¢ ºõÀó¾Á¡¸ ÁüÈ Å¢ÀÃí¸ÙìÌõ §¿¡Â¢ý ¾ý¨Á ÀüÈ¢Ôõ 
Ó¾ý¨Á 
¬Ã¡öîº¢Â¡ÇÃ¡É Dr ¦º.À¢.§¸¡ô¦ÀÕó§¾Å¢ (Àð¼ §Áü ÀÊôÀ¡Ç÷ º¢ÈôÒ 
ÁÕòÐÅ À¢Ã¢× «Ï¸×õ . ¨¸ô§Àº¢ ±ñ 8056987496. §ÁÖõ þó¾ 
¬Ã¡öîº¢ìÌ IEC º¡ýÚ ¦ÀÈôÀðÎûÇÐ.   
   þó¾ ÁÕóÐ ¸¡Ç¡ïº¸ôÀ¨¼ §¿¡öì¸¡¸ º¢ò¾ ÁÕòÐÅò¾¢ø 
ÜÈôÀðÎûÇÐ.  ²ü¸É§Å ¯À§Â¡¸ò¾¢ø ¯ûÇ þÐ §À¡ýÈ ÁÕóÐ þÐÅ¨Ã 
§¿¡Â¡Ç¢¸Ç¢¼õ ±ó¾Å¢¾ Àì¸ Å¢¨Ç×¸¨ÇÔõ ²üÀÎò¾Å¢ø¨Ä. §ÁÖõ ¯½× 
Ó¨ÈÂ¢ø ¸ò¾Ã¢, À¡¸ø, ¸ÃôÀ¡ý  Àñ¼í¸û, ¯ôÒ, ÒÇ¢ôÒ Ó¾Ä¢Â¨Å¸¨Ç 
¾Å¢÷òÐ Àò¾¢Âõ ¸¡ìÌÁ¡Ú «È¢×Úò¾ôÀÎ¸¢ÈÐ  .    
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FORM VIII – DIETARY ADVICE FORM 
 
     §º÷ì¸ ÜÊÂ ¯½×¸û      ¾Å¢÷ì¸ §ÅñÊÂ¨Å¸û 
 
À¡ø  
¦¿ö  
§Á¡÷  
À¨É¦ÅøÄõ  
º÷ì¸¨Ã  
Å¡¨ÆôÀÆõ  
ÓÕí¨¸ôÀ¢ïÍ 
«Å¨ÃôÀ¢ïÍ 
¦À¡ýÉ¡í¸ñ½¢ 
Á½ò¾ì¸¡Ç¢              
ÓÕí¨¸ì¸£¨Ã 
¸È¢§ÅôÀ¢¨Ä  
Á¡Ð¨Ç 
§ÀÃ£î¨º 
ÀÄ¡ôÀÆõ  
Á¡õÀÆõ 
¯Ä÷ ¾¢Ã¡ð¨º 
      §Å¸¨Åò¾ ¸¡ö¸È¢¸û 
 
¯ôÒ  
¸ÎÌ  
âº½¢  
À¨ÆÂÐ 
§¸¡Æ¢ì¸È¢ 
Á£ý 
¿ñÎ 
¸ÕÅ¡Î 
 Óð¨¼ 
 ÒÇ¢ôÒô ¦À¡Õû¸û  
§Å÷ì¸¼¨Ä 
±ûÙ 
¦Àñ§À¡¸õ 
¦ÅüÈ¢¨Ä,À¡ìÌ  
Ò¨¸Â¢¨Ä  
ÁÐ «ÕóÐ¾ø  
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FORM IX – ADVERSE REACTION FORM / PHARMACO VIGILANCE FORM 
 
SERIAL NO:                                                                                                           
OP/IP NO: 
NAME:                                                             AGE:                     GENDER: 
DATE OF TRIAL COMMENCEMENT: 
DATE OF THE ADVERSE REACTION OCCUR: 
DESCRIPTION OF ADVERSE REACTION: 
 
 
 
 
 
 
 
 
 
 
 
 
Date:                                                                              
Station:  
Signature of the Investigator: 
Signature of the Lecturer:                                                            Signature of the HOD 
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